
<html lang="en"     class="pb-page"  data-request-id="9ee63a49-2edd-49ce-aafd-ca0770164d74"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm300603y;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-16;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists" /></meta><meta name="dc.Creator" content="Xin  Chen" /></meta><meta name="dc.Creator" content="Maria F.  Sassano" /></meta><meta name="dc.Creator" content="Lianyou  Zheng" /></meta><meta name="dc.Creator" content="Vincent  Setola" /></meta><meta name="dc.Creator" content="Meng  Chen" /></meta><meta name="dc.Creator" content="Xu  Bai" /></meta><meta name="dc.Creator" content="Stephen V.  Frye" /></meta><meta name="dc.Creator" content="William C.  Wetsel" /></meta><meta name="dc.Creator" content="Bryan L.  Roth" /></meta><meta name="dc.Creator" content="Jian  Jin" /></meta><meta name="dc.Description" content="Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pa..." /></meta><meta name="Description" content="Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pa..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 13, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300603y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300603y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300603y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300603y" /></link>
        
    
    

<title>Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300603y" /></meta><meta property="og:title" content="Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0015.jpeg" /></meta><meta property="og:description" content="Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pathways essential for both the therapeutic actions and side effects of drugs. However, few such ligands have been created, and very little purposeful attention has been devoted to studying what we term: “structure–functional selectivity relationships” (SFSR). We recently disclosed the first β-arrestin-biased dopamine D2 receptor (D2R) agonists UNC9975 (44) and UNC9994 (36), which have robust in vivo antipsychotic drug-like activities. Here we report the first comprehensive SFSR studies focused on exploring four regions of the aripiprazole scaffold, which resulted in the discovery of these β-arrestin-biased D2R agonists. These studies provide a successful proof-of-concept for how functionally selective ligands can be discovered." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300603y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300603y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300603y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300603y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300603y&amp;href=/doi/10.1021/jm300603y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7141-7153</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300601d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm300648b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D<sub>2</sub> Receptor Agonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Chen">Xin Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+F.++Sassano">Maria F. Sassano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lianyou++Zheng">Lianyou Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Setola">Vincent Setola</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meng++Chen">Meng Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xu++Bai">Xu Bai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+V.++Frye">Stephen V. Frye</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+C.++Wetsel">William C. Wetsel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+L.++Roth">Bryan L. Roth</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Jin">Jian Jin</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Center for Combinatorial Chemistry and Drug Discovery, Jilin University, Changchun, Jilin 130012, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, United States</span></div><div class="corresp-info"><strong>*</strong>For J.J.: phone, 919-843-8459; fax, 919-843-8465; E-mail, <a href="/cdn-cgi/l/email-protection#3852515956525156784d565b165d5c4d"><span class="__cf_email__" data-cfemail="e58f8c848b8f8c8ba5908b86cb808190">[email protected]</span></a>. For B.L.R.: phone, 919-966-7535; fax, 919-843-5788; E-mail, <a href="/cdn-cgi/l/email-protection#dfbdada6beb180adb0abb79fb2babbf1aab1bcf1babbaa"><span class="__cf_email__" data-cfemail="395b4b405857664b564d5179545c5d174c575a175c5d4c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300603y&amp;href=/doi/10.1021%2Fjm300603y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7141–7153</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 30, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 May 2012</li><li><span class="item_label"><b>Published</b> online</span>13 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 August 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300603y" title="DOI URL">https://doi.org/10.1021/jm300603y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7141%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXin%2BChen%252C%2BMaria%2BF.%2BSassano%252C%2BLianyou%2BZheng%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D16%26contentID%3Djm300603y%26title%3DStructure%25E2%2580%2593Functional%2BSelectivity%2BRelationship%2BStudies%2Bof%2B%25CE%25B2-Arrestin-Biased%2BDopamine%2BD2%2BReceptor%2BAgonists%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7153%26publicationDate%3DAugust%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300603y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3611</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">92</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300603y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Functional Selectivity Relationship Studies of β-Arrestin-Biased Dopamine D2 Receptor Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;F. Sassano&quot;},{&quot;first_name&quot;:&quot;Lianyou&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Setola&quot;},{&quot;first_name&quot;:&quot;Meng&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Xu&quot;,&quot;last_name&quot;:&quot;Bai&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;V. Frye&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;C. Wetsel&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;L. Roth&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7141-7153&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300603y&quot;},&quot;abstract&quot;:&quot;Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pathways essential for both the therapeutic actions and side effects of drugs. However, few such ligands have been created, and very little purposeful attention has been devoted to studying what we term: “structure–functional selectivity relationships” (SFSR). We recently disclosed the first β-arrestin-biased dopamine D2 receptor (D2R) agonists UNC9975 (44) and UNC9994 (36), which have robust in vivo antipsychotic drug-like activities. Here we report the first comprehensive SFSR studies focused on exploring four regions of the aripiprazole scaffold, which resulted in the discovery of these β-arrestin-biased D2R agonists. These studies provide a successful proof-of-concept for how functionally selective ligands can be discovered.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300603y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300603y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300603y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300603y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300603y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300603y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300603y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300603y&amp;href=/doi/10.1021/jm300603y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300603y" /></input><a href="/doi/pdf/10.1021/jm300603y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26pmid%3D22845053%26genre%3Darticle%26aulast%3DChen%26date%3D2012%26atitle%3DStructure%25E2%2580%2593Functional%2BSelectivity%2BRelationship%2BStudies%2Bof%2B%25CE%25B2-Arrestin-Biased%2BDopamine%2BD2%2BReceptor%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D16%26spage%3D7141%26epage%3D7153%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jmcmar.2012.55.issue-16/production/jmcmar.2012.55.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Functionally selective G protein-coupled receptor (GPCR) ligands, which differentially modulate canonical and noncanonical signaling, are extremely useful for elucidating key signal transduction pathways essential for both the therapeutic actions and side effects of drugs. However, few such ligands have been created, and very little purposeful attention has been devoted to studying what we term: “structure–functional selectivity relationships” (SFSR). We recently disclosed the first β-arrestin-biased dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) agonists UNC9975 (<b>44</b>) and UNC9994 (<b>36</b>), which have robust in vivo antipsychotic drug-like activities. Here we report the first comprehensive SFSR studies focused on exploring four regions of the aripiprazole scaffold, which resulted in the discovery of these β-arrestin-biased D<sub>2</sub>R agonists. These studies provide a successful proof-of-concept for how functionally selective ligands can be discovered.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Classical notions of receptor pharmacology imply that when a ligand interacts with a receptor, only a unitary outcome is possible. Accordingly, a full or partial agonist can activate only a single signal transduction pathway while an antagonist can only block the actions of an agonist. The key theoretical construct underlying this model was the concept of intrinsic efficacy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> According to this conceptualization, a full agonist has maximum intrinsic efficacy and maximally stimulates <i><b>all</b></i> cellular responses induced by ligand binding. A partial agonist possesses a lower degree of intrinsic efficacy and partially activates all cellular responses induced by an agonist. Antagonists, according to this schema, are neutral entities which possess no intrinsic activity but are able to block the receptor and preclude activation by full or partial agonists.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> An extension of this model has been that a single G protein-coupled receptor (GPCR) interacts with a single G protein subtype and that full and partial agonists activate only a single signal transduction pathway.</div><div class="NLM_p">For many decades, however, it has been clear that these simplistic notions of GPCR function cannot account for the myriad of actions induced by agonist and antagonist binding. This was first convincingly demonstrated for the serotonin and dopamine families of receptors. For example, it has been demonstrated that: (1) agonists differentially activate distinct signal transduction pathways,<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9">(2-9)</a> (2) antagonists can possess negative intrinsic activity (e.g., function as inverse agonists) or be silent and thereby block the actions of an inverse agonist (e.g., neutral antagonists),<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> and (3) antagonists can also induce receptor down regulation<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and receptor internalization in vitro<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and in vivo,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> properties typically associated with agonists.</div><div class="NLM_p last">Functional selectivity<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> refers to the process by which GPCR ligands differentially modulate canonical pathways involving heterotrimeric large G proteins and noncanonical G protein-independent pathways involving other signaling proteins including β-arrestins.<a onclick="showRef(event, 'ref6 ref9 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref21 ref22 ref23 ref24">(6, 9, 21-24)</a> GPCR ligands with distinct functional selectivity patterns will be extremely useful tools for elucidating the key signaling pathways essential for both the therapeutic actions and the side effects of GPCR targeted drugs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Understanding which signaling pathways contribute to antipsychotic efficacy and side effects, for instance, should enable the design of better antipsychotic drug candidates and may, ultimately, lead to safer and more effective therapies for patients. Despite the importance of functionally selective ligands, only a limited number have been reported.<a onclick="showRef(event, 'ref6 ref19 ref20 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref6 ref19 ref20 ref24 ref25 ref26 ref27">(6, 19, 20, 24-27)</a> In addition, to our knowledge, scant attention has been devoted to studying structure–functional selectivity relationships (SFSR). We recently reported the first β-arrestin-biased dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) agonists UNC9975 (<b>44</b>) and UNC9994 (<b>36</b>), which are simultaneously inactive toward G<sub>i</sub>-regulated cyclic adenosine monophosphate (cAMP) production and partial agonists for D<sub>2</sub>R/β-arrestin-2 interactions.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> These β-arrestin-biased D<sub>2</sub>R agonists displayed robust antipsychotic drug-like activities in wild-type mice, and the antipsychotic drug-like activities were significantly attenuated or completely abolished in β-arrestin-2 knockout mice, suggesting that β-arrestin recruitment and signaling can be a significant contributor to antipsychotic efficacy.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Here we report our SFSR studies that resulted in the discovery of these β-arrestin-biased D<sub>2</sub>R agonists. We describe the design, synthesis, and in vitro and in vivo pharmacological evaluation of novel compounds that explore four regions of the scaffold represented by aripiprazole (<b>1</b>), an FDA-approved atypical antipsychotic drug.<a onclick="showRef(event, 'ref24 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref24 ref29 ref30">(24, 29, 30)</a> These first comprehensive SFSR studies provide a successful proof-of-concept for how functionally selective ligands of GPCRs can be discovered.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We selected compound <b>1</b> as the starting point for the following reasons: (1) <b>1</b> is an FDA-approved drug with excellent pharmacokinetic (PK) properties including high oral bioavailability and central nervous system (CNS) penetration,<a onclick="showRef(event, 'ref28 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref31">(28, 31)</a> PK properties likely to be retained by its close analogues,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (2) although some structure–activity relationships (SAR) have been reported,<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> the SFSR of the scaffold represented by compound <b>1</b> have not been studied, and (3) this core template is amenable to rapid multidimensional chemical modifications and optimization, which is ideal for exploring SFSR. To determine whether modifying various structural motifs of compound <b>1</b> could result in biased compounds that favor either cAMP or β-arrestin signaling, we intensively investigated the following four regions of compound <b>1</b>: (1) the left-hand side (LHS) phenyl ring with various mono- or disubstitution, (2) the middle cyclic amino moiety, (3) the central linker, and (4) the right-hand side (RHS) bicyclic aromatic moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Four regions of compound <b>1</b> investigated for SFSR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SFSR of the LHS Phenyl Moiety</h3><div class="NLM_p">To determine the effects of substituents in the LHS phenyl ring on D<sub>2</sub>R functional selectivity, we designed the compounds outlined in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Because Oshiro and co-workers reported that 2-substituents at the LHS phenyl were preferred for D<sub>2</sub>R and enhanced in vivo activity,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> we explored a number of electron donating or withdrawing groups at the 2-position (compounds <b>2</b>–<b>10</b>). In addition, 3- and 4-substitution and 2,3-disubsitution were also investigated (compounds <b>1</b>, <b>11</b>–<b>13</b>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds designed to explore the LHS phenyl moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A representative synthesis of these compounds is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Compounds <b>4</b>, <b>10</b>, and <b>11</b> were produced via nucleophilic displacement of commercially available 7-(4-bromobutoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one with the corresponding 2-subsituted phenylpiperazines in moderate to good yields. The 2-isopropoxy-,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> 2-trifluoromethyl-,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and 3-ethoxyphenyl-<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> piperazine intermediates were prepared according to literature procedures. Synthesis of compounds <b>1</b>–<b>3</b>, <b>5</b>–<b>9, 12</b>, and <b>13</b> were described previously.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds with Various Substituents on the LHS Phenyl Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%.</p></p></figure><div class="NLM_p">The synthesized compounds were evaluated in: (1) D<sub>2</sub>R radioligand binding assay to assess their binding affinity to the receptor, (2) D<sub>2</sub>R-mediated cAMP accumulation assay, which measures inhibition of isoproterenol-stimulated cAMP production via the G<sub>i</sub>-coupled signaling pathway, and (3) D<sub>2</sub>R-mediated β-arrestin-2 recruitment Tango assay to determine their potency and efficacy in activating β-arrestin translocation. Quinpirole, a full agonist of D<sub>2</sub>R,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> was used as the positive control in both cAMP accumulation and β-arrestin-2 recruitment Tango assays. Details of these binding and functional assays were described in our recent paper.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Similar to compound <b>1</b>, which potently activated both D<sub>2</sub>R-mediated G<sub>i</sub>-regulated cAMP accumulation and β-arrestin-2 recruitment, compounds with or without a 2-subsituent (compounds <b>2</b>–<b>10</b>) had high D<sub>2</sub>R binding affinities (<i>K</i><sub>i</sub> < 10 nM) and high potencies for activating both G<sub>i</sub> signaling and β-arrestin-2 recruitment (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). These compounds did not display apparent bias for activating either G<sub>i</sub> signaling or β-arrestin-2 recruitment, suggesting that neither the electronic nature (electron donating or withdrawing, compounds <b>2</b>, <b>5</b>–<b>10</b>) nor the steric bulkiness (compounds <b>2</b>–<b>4</b>) of the 2-substituent significantly modulates functional selectivity profiles. Interestingly, compounds <b>5</b> and <b>6</b> activated both G<sub>i</sub> and β-arrestin signaling with very high potencies (EC<sub>50</sub> < 1 nM) and efficacies (<i>E</i><sub>max</sub> similar to the positive control quinpirole). On the other hand, compound <b>2</b> was a potent, low efficacy partial agonist (<i>E</i><sub>max</sub> = ∼40%) at both signaling pathways. In addition, compounds <b>3</b>, <b>4</b>, and <b>10</b> were about 10-fold more potent at activating β-arrestin than G<sub>i</sub> signaling. Effects of the substitution patterns were also evaluated. Moving the ethoxy group from the <i>ortho</i>-position (compound <b>3</b>) to the <i>meta</i>- (compound <b>11</b>) or <i>para</i>-position (compound <b>12</b>) resulted in significant decreases in binding affinities and agonist potencies. However, these modifications did not lead to significant changes in functional selectivity patterns. Additionally, compound <b>13</b>, which possesses a 2,3-dimethyl phenyl group, displayed similar efficacies (e.g., <i>E</i><sub>max</sub> values) for activating both G<sub>i</sub> and β-arrestin pathways (similar to compound <b>1</b>), although compound <b>13</b> was significantly more potent at activating β-arrestin than G<sub>i</sub> signaling. Overall, the electronic nature and steric bulkiness of substituents on the LHS phenyl ring and various patterns of substitution did not significantly affect patterns of D<sub>2</sub>R functional selectivity for the tested compounds.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SFSR of the LHS Phenyl Moiety<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">β-arrestin</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">cAMP</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cmpd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">D<sub>2</sub>R <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>E</i><sub>max</sub> (%)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>E</i><sub>max</sub> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">2,3-(Cl)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">2-OEt</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">2-OiPr</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">2-H</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3-OEt</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">158</td><td class="colsep0 rowsep0" align="char" char=".">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4-OEt</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">251</td><td class="colsep0 rowsep0" align="char" char=".">69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2,3-(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">200</td><td class="colsep0 rowsep0" align="char" char=".">65</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub>, EC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least two duplicate experiments with standard deviations (SD) values that are 3-fold less than the average.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> SFSR of the Middle Amino Moiety</h3><div class="NLM_p">We next investigated the middle amino moiety of compound <b>1</b>. Compounds <b>18</b> and <b>19</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) were designed and synthesized to modulate the basicity of the inner nitrogen and the ring size of the cyclic amino motif, respectively. 1,4-Addition of the in situ generated Grignard reagent to activated pyridinium species gave the intermediate <b>14</b> in 76% yield, which was then converted to the desired 4-aryl piperidine <b>16</b> via hydrogenation and subsequent deprotection in good overall yield. The nucleophilic displacement of the commercially available 7-(4-bromobutoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one with the intermediate <b>16</b> afforded the targeted compound <b>18</b> in good yield. Synthesis of the intermediate <b>17</b> and the targeted compound <b>19</b> was reported in our previous paper.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds for Exploring the Middle Amino Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClCOOCH<sub>2</sub>Ph, CuI, THF, −10 °C; (b) <i>i</i>-PrMgCl, THF, −20 °C, 76%; (c) H<sub>2</sub>, RhCl(PPh<sub>3</sub>)<sub>3</sub>, toluene, 70 °C, 4 d, 95%; (d) 6 N HCl, reflux, 93%; (e) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 60% for <b>18</b>, 62% for <b>19</b>.</p></p></figure><div class="NLM_p">These compounds were evaluated in the D<sub>2</sub>R radioligand binding, cAMP accumulation, and β-arrestin-2 recruitment assays to assess their binding affinities and patterns of D<sub>2</sub>R functional selectivity. Replacing the piperazine group (compound <b>1</b>) with the more basic piperidine group (compound <b>18</b>) did not result in significant changes in the efficacy of either G<sub>i</sub> or β-arrestin signaling although compound <b>18</b> was significantly more potent at activating β-arrestin than G<sub>i</sub> signaling (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). On the other hand, replacing the piperazine group (compound <b>1</b>) with the homopiperazine group (compound <b>19</b>), which leads to substantial conformation changes, resulted in significant bias for β-arrestin over G<sub>i</sub> signaling. Compound <b>19</b> was a potent partial agonist at activating β-arrestin-2 recruitment (EC<sub>50</sub> = 2.0 nM, <i>E</i><sub>max</sub> = 41%) and was simultaneously inactive at G<sub>i</sub> signaling. The effects of the homopiperazine moiety on biasing for β-arrestin signaling were also observed with other analogues (e.g., compounds <b>44</b> and <b>45</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Both compounds <b>18</b> and <b>19</b> retained high binding affinity to D<sub>2</sub>R.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SFSR of the Middle Amino Moiety<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0010.gif" alt="" id="fx2fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0011.gif" alt="" id="GRAPHIC-d168e1125-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub>, EC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least two duplicate experiments with standard deviations (SD) values that are 3-fold less than the average.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SFSR of the Central Linker</h3><div class="NLM_p">To examine effects of the central linker on patterns of D<sub>2</sub>R functional selectivity, we designed the compounds outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, which contain either shorter or conformationally constrained linkers. Compounds <b>22</b>–<b>24</b> were synthesized by a two-step sequence similar to that previously developed for compound <b>21</b>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Thus, the commercially available 7-hydroxy-3,4-dihydroquinolin-2(1<i>H</i>)-one was refluxed with various dibromides or dichlorides to give the bromo or chloro intermediates, which were then reacted with commercially available 1-(2,3-dichlorophenyl)piperazine hydrochloride (<b>20</b>) to afford the target compounds <b>22</b>–<b>24</b>. Synthesis of compounds <b>25</b> and <b>26</b> started from the piperazine <b>20</b> reacting with 1-bromo-3-(bromomethyl)benzene and 1-bromo-4-(bromomethyl)benzene to give the intermediates <b>27</b> and <b>28</b>, which were then treated with 7-hydroxy-3,4-dihydroquinolin-2(1<i>H</i>)-one to afford the target compounds <b>25</b> and <b>26</b>, respectively.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds for Exploring the Central Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux, overnight, 35–80%; (b) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%; (c) Et<sub>3</sub>N, CH<sub>3</sub>CN, reflux, 4 h, 70–75%; (d) CuCl, Cs<sub>2</sub>CO<sub>3</sub>, TMHD, NMP, 120 °C, 7.5 h, 40–50%.</p></p></figure><div class="NLM_p">Results of these compounds in D<sub>2</sub>R binding, cAMP accumulation, and β-arrestin-2 recruitment assays are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Compound <b>21</b>, which contains a shorter linker (3-carbon versus 4-carbon in compound <b>1</b>), had slightly higher efficacy at activating β-arrestin-2 recruitment than G<sub>i</sub> signaling although compound <b>21</b> had a lower binding affinity and agonist potency than compound <b>1</b>. Interestingly, the cyclohexyl group containing compound <b>22</b>, the acetylene containing compound <b>23</b>, the <i>meta</i>-benzyl group containing compound <b>25</b>, and the <i>para</i>-benzyl group containing compound <b>26</b> were all biased ligands for β-arrestin: partial agonists at β-arrestin-2 recruitment and simultaneously inactive at G<sub>i</sub> signaling. However, all four compounds suffered from significant lower binding affinities and agonist potencies. On the other hand, the cyclopropyl group containing compound <b>24</b> did not display significant bias for activating β-arrestin-2 recruitment over G<sub>i</sub> signaling. Taken together, these results suggest that the central linker plays an important role in modulating functional selectivity and potency of these compounds. This finding is consistent with previously reported results: the linker flexibility significantly affects ligand binding affinities and intrinsic efficacies.<a onclick="showRef(event, 'ref32 ref33 ref34 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref40 ref41 ref42">(32-34, 40-42)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SFSR of the Central Linker<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0012.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0013.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub>, EC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least two duplicate experiments with standard deviations (SD) values that are 3-fold less than the average.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> SFSR of the RHS Bicyclic Aromatic Moiety</h3><div class="NLM_p">We next explored the RHS bicyclic aromatic moiety of compound <b>1</b>. We selected six different bicyclic aromatic groups (outlined in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) to evaluate their effects on patterns of D<sub>2</sub>R functional selectivity. The previously described two-step nucleophilic displacement sequence for synthesizing compounds <b>29</b> and <b>30</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> was applied to the preparation of compounds <b>31</b>–<b>34</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The corresponding commercially available phenols were reacted with butyl-1,4-dibromide to give the bromo intermediates, which were then reacted with the piperazine <b>20</b> to yield the target compounds <b>31</b>–<b>34</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0008.jpeg" id="GRAPHIC-d168e1379-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds with Various RHS Bicyclic Aromatic Groups<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3,</sub> EtOH, reflux, 6 h, 30–80%; (b) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%.</p></p></figure><div class="NLM_p">Results of these compounds in D<sub>2</sub>R binding, cAMP accumulation, and β-arrestin-2 recruitment assays are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. In contrast to compound <b>1</b>, compound <b>29</b>, which contains a quinoline-2-one moiety, exhibited a higher efficacy for activating D<sub>2</sub>R mediated β-arrestin translocation than D<sub>2</sub>R-mediated G<sub>i</sub> activity. Similar effects were observed with compound <b>30</b>, which contains a dihydro-1,8-naphthyridin-2-one moiety. Importantly, replacing the dihydroquinolin-2-one (<b>1</b>) with the dihydroisoquinolinone (compound <b>31</b>), indazole (compound <b>32</b>), benzimidazolone (compound <b>33</b>), or benzothiazole (compound <b>34</b>) resulted in apparent bias for D<sub>2</sub>R-mediated β-arrestin over G<sub>i</sub> signaling. These four compounds were partial agonists at D<sub>2</sub>R-mediated β-arrestin-2 recruitment, with moderate to high potencies and simultaneously inactive at D<sub>2</sub>R-mediated G<sub>i</sub> signaling. In general, the RHS bicyclic aromatic moiety plays a critical role in modulating functional selectivity of these analogues. All six investigated RHS aryl groups exhibited some degree of bias for β-arrestin over G<sub>i</sub> signaling.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SFSR of the RHS Bicyclic Aromatic Moiety<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0017.gif" alt="" id="GRAPHIC-d168e1469-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0018.gif" alt="" id="GRAPHIC-d168e1470-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub>, EC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least two duplicate experiments with standard deviations (SD) values that are 3-fold less than the average.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Synthesis and in Vitro Pharmacological Evaluation of Combination Compounds</h3><div class="NLM_p">After exploring the above four regions of compound <b>1</b> and studying their SFSR, we next designed and synthesized a number of combination compounds (outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>), which combined the structural motifs that contribute to the bias for β-arrestin recruitment into single molecules. We selected all three middle amino groups, 3- and 4-carbon linkers, and all six RHS aromatic groups for this study. The synthetic routes for these combination compounds were shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. These compounds (<b>35</b>–<b>45</b>) were prepared following the same synthetic approach developed for compounds <b>29</b>–<b>34</b> using the corresponding amino groups, central linkers, and RHS aromatic groups.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0019.jpeg" id="GRAPHIC-d168e1521-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Combination Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3,</sub> EtOH, reflux, 6 h, 30–80%; (b) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%.</p></p></figure><div class="NLM_p">We next evaluated compounds <b>35</b>–<b>45</b> in the D<sub>2</sub>R radioligand binding, cAMP accumulation, and β-arrestin-2 recruitment assays (results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). As expected, these combination compounds were all significantly biased for D<sub>2</sub>R-mediated β-arrestin over G<sub>i</sub> signaling. With the exception of compound <b>40</b>, all compounds were agonists at D<sub>2</sub>R mediated β-arrestin-2 recruitment with moderate to high potencies and simultaneously inactive at D<sub>2</sub>R-mediated G<sub>i</sub> signaling. Most notably, compounds <b>36</b> and <b>37</b> were the most biased for β-arrestin, with <i>E</i><sub>max</sub> values similar to the positive control quinpirole. Notably, compounds <b>44</b> and <b>45</b> had extremely high potencies (EC<sub>50</sub> < 5 nM) but relatively low efficacies (<i>E</i><sub>max</sub> = 40–50%) at D<sub>2</sub>R-mediated β-arrestin translocation. These unique patterns of D<sub>2</sub>R-mediated functional selectivity profiles will be extremely useful for elucidating which signaling pathways contribute to antipsychotic efficacies and side effects.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SFSR of Combination Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0014.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub>, EC<sub>50</sub>, and <i>E</i><sub>max</sub> values are the average of at least two duplicate experiments with standard deviations (SD) values that are 3-fold less than the average.</p></div></div><div></div></div><div class="NLM_p">From these SFSR studies, we observed the following general trends: (1) the electronic nature (e.g., electron donating or withdrawing), steric bulkiness, and substitution pattern of substituents on the LHS phenyl ring did not, apparently, have significant effects on patterns of D<sub>2</sub>R functional selectivity, (2) the homopiperazine group as a middle amino moiety reduced efficacy for activating both β-arrestin and G<sub>i</sub> pathways, (3) several conformationally constrained central linkers could lead to significant bias for D<sub>2</sub>R-mediated β-arrestin-2 over G<sub>i</sub> activities. However, these central linkers resulted in significant losses of potency, and (4) a number of RHS aromatic groups such as benzothiazole, dihydroisoquinolinone, indazole, and benzimidazolone led to significant bias for D<sub>2</sub>R-mediated β-arrestin-2 over G<sub>i</sub> activities. Importantly, we observed that subtle structural changes could result in substantial changes in functional selectivity.</div><div class="NLM_p">We subsequently confirmed that compounds <b>19</b>, <b>36</b>, and <b>44</b> were β-arrestin-biased agonists in several orthologous β-arrestin-2 translocation and signaling assays.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p last">In addition, we determined selectivity of compounds <b>19</b>, <b>35</b>, <b>36</b>, and <b>44</b> against a number of dopamine and serotonin receptors. Compound <b>19</b> displayed high affinities to D<sub>2</sub> and D<sub>3</sub> receptors and low affinities to D<sub>1</sub>, D<sub>4</sub>, and D<sub>5</sub> receptors, while compound <b>35</b> displayed high affinities to D<sub>2</sub>, D<sub>3</sub>, and D<sub>4</sub> receptors and low affinities to D<sub>1</sub> and D<sub>5</sub> receptors (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>). At serotonin receptors, although compounds <b>19</b> and <b>35</b> displayed moderate to high binding affinities (<i>K</i><sub>i</sub>’s: 0.6–138 nM) for 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>2C</sub>, and 5-HT<sub>1A</sub> (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>), compound <b>19</b> was significantly less potent in functional assays (Ca<sup>2+</sup> mobilization fluorometric imaging plate reader (FLIPR) or cAMP biosensor).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Similarly, compounds <b>36</b> and <b>44</b> displayed much lower functional potencies compared to their binding affinities to 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>2C</sub>, and 5-HT<sub>1A</sub> receptors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Selectivity of compounds <b>36</b> and <b>44</b> against dopamine D<sub>1</sub>–D<sub>5</sub> receptors was reported previously.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Behavioral Studies in Mice</h3><div class="NLM_p">We previously reported that compounds <b>36</b> and <b>44</b> displayed robust antipsychotic drug-like activities and did not induce catalepsy in wild-type mice.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In β-arrestin-2 knockout mice, however, the antipsychotic drug-like activities of these compounds were significantly attenuated or completely abolished.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> To extend and confirm these findings, we evaluated the effect of two additional β-arrestin-biased D<sub>2</sub>R agonists (compound <b>19</b> and <b>35</b>) on phencyclidine (PCP)-induced hyperlocomotion<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> in β-arrestin-2 knockout mice and the wild-type littermate controls.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Compound <b>19</b> (2 mg/kg, intraperitoneal (ip) administration) markedly inhibited PCP-induced hyperlocomotion in wild-type mice. Importantly, this significant antipsychotic-like activity of compound <b>19</b> was completely abolished in β-arrestin-2 knockout mice (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Similarly, compound <b>35</b> (2 mg/kg, ip) significantly reduced PCP-induced hyperlocomotion in wild-type mice and this antipsychotic-like activity was significantly attenuated in β-arrestin-2 knockout mice (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Taken together, these results suggest that β-arrestin recruitment and signaling can be a significant contributor to antipsychotic efficacy.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>19</b> and <b>35</b> exhibit potent antipsychotic-like activities in mouse hyperlocomotion studies, which are completely abolished or significantly attenuated in β-arrestin-2 knockout mice. Locomotor activities shown as 5 min binned intervals for wild-type (WT) or β-arrestin-2 knockout (β-ARR2 KO) littermate mice given vehicle or 2.0 mg/kg <b>19</b> or <b>35</b> (ip), followed 30 min later with 6 mg/kg phencyclidine (PCP, ip). <i>n</i> = 8–13 WT and β-ARR2 KO pairs/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we designed and synthesized a series of novel compounds for exploring four regions of the scaffold represented by compound <b>1</b>. Comprehensive evaluation of these compounds in D<sub>2</sub>R radioligand binding, cAMP accumulation, and β-arrestin-2 recruitment assays revealed a number of important SFSR findings. Combining the best structural motifs identified from these studies into single molecules resulted in the discovery of extremely β-arrestin-biased D<sub>2</sub>R agonists <b>35</b>–<b>37</b> and high potency and low efficacy β-arrestin-biased D<sub>2</sub>R agonists <b>19</b> and <b>44</b>. Findings from our in vivo studies of these β-arrestin-biased D<sub>2</sub>R agonists in wild-type and β-arrestin-2 knockout mice suggest that β-arrestin recruitment and signaling can be a significant contributor to antipsychotic efficacy. Our combined medicinal chemistry and pharmacological profiling approach provides the biomedical community a successful proof-of-concept for how functionally selective ligands can be discovered.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry General Procedures</h3><div class="NLM_p">Unless stated to the contrary, where applicable, the following conditions apply: all commercial grade reagents were used without further purification. MeCN and CH<sub>2</sub>Cl<sub>2</sub> were distilled from CaH<sub>2</sub> under a N<sub>2</sub> atmosphere before use, THF was distilled from Na/benzophenone under N<sub>2</sub>. All other dry solvents were of anhydrous quality purchased from Sigma-Aldrich. Brine (NaCl), NaHCO<sub>3</sub>, and NH<sub>4</sub>Cl refer to saturated aqueous (satd aq) solutions. Column chromatography was performed on silica gel G (200–300 mesh) with reagent grade solvents. Melting points were uncorrected. NMR spectra were recorded on a Varian spectrometer (400 or 300 MHz for <sup>1</sup>H NMR and 100 MHz or 75 MHz for <sup>13</sup>C NMR, respectively) at ambient temperature. All <sup>1</sup>H and <sup>13</sup>C chemical shifts are reported in ppm (δ) relative to CDCl<sub>3</sub> (7.26 and 77.16, respectively) or CD<sub>3</sub>OD (3.30 and 49.00, respectively).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> HPLC data for all compounds were acquired using an Agilent 6110 series system with a UV detector set to 220 nm. Samples were injected (<10 μL) onto an Agilent Eclipse Plus 4.6 mm × 50 mm, 1.8 μm, C18 column at room temperature (rt) at a flow rate of 1.0 mL/min. A linear gradient from 10% to 100% (v/v) B over 5.0 min followed by 2.0 min at 100% B with a mobile phase of (A) H<sub>2</sub>O + 0.1% acetic acid and (B) MeOH + 0.1% acetic acid was used. Mass spectra (MS) data were acquired in positive ion mode using an Agilent 6110 series single quadrupole mass spectrometer with an electrospray ionization (ESI) source. High-resolution (positive ion) mass spectrum (HRMS) for compound <b>35</b> was acquired using a Shimadzu LCMS-IT-Tof time-of-flight mass spectrometer. HRMS (positive ion) for compounds <b>37</b>, <b>38</b>, <b>41</b>, and <b>42</b> were recorded on Agilent 6210 ESI-LCT-TOF mass spectrometer with dual source for reference and sample. HPLC was used to establish the purity of targeted compounds. All compounds that were evaluated in biological assays had >95% purity using the HPLC methods described above.</div><div class="NLM_p last">Compounds <b>1</b>–<b>3</b>, <b>5</b>–<b>9</b>, <b>12</b>, and <b>13</b> were synthesized as previously reported.<a onclick="showRef(event, 'ref31 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref33">(31, 33)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 7-(4-(4-(2-Isopropoxyphenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>4</b>)</h3><div class="NLM_p last">A mixture of intermediate 7-(4-bromobutoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (119 mg, 0.4 mmol) and NaI (119.6 mg, 0.8 mmol) in CH<sub>3</sub>CN was heated to reflux for 30 min and then cooled to rt. Compound 1-(2-isopropoxyphenyl)piperazine (97.0 mg, 0.44 mmol) and anhydrous K<sub>2</sub>CO<sub>3</sub> (121.6 mg, 0.88 mmol) were added to the mixture. The resulting mixture was heated to reflux and stirred for 6 h. Precipitated crystals were filtered off, and the filtrate was evaporated under reduced pressure. The residue was extracted with EtOAc. The combined EtOAc layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography on silica gel column (elution with DCM/MeOH = 30:1) to give compound <b>4</b> as light-yellow solid (75.3 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.59 (br s, 1H), 8.24 (d, <i>J</i> = 8.0 Hz, 1H), 7.41 (app t, <i>J</i> = 7.6 Hz, 1H), 7.06 (d, <i>J</i> = 8.4 Hz, 1H), 7.02–6.96 [m, 2H, containing a d at δ 7.00 (<i>J</i> = 8.4 Hz)], 6.49 (s, 1H), 6.46 (d, <i>J</i> = 8.4 Hz, 1H), 4.99–4.86 (m, 2H), 4.80 (sept, <i>J</i> = 6.0 Hz, 1H), 4.63–4.49 (m, 2H), 4.01–3.92 (m, 2H), 3.76–3.61 (m, 4H), 3.31–3.20 (m, 2H), 2.85 (app t, <i>J</i> = 7.4 Hz, 2H), 2.56 (app t, <i>J</i> = 7.4 Hz, 2H), 2.20–2.08 (m, 2H), 1.91–1.81 (m, 2H), 1.56 (d, <i>J</i> = 6.0 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 171.7, 158.2, 151.1, 138.5, 132.3, 128.8, 128.2, 124.7, 121.4, 116.2, 114.7, 108.9, 102.6, 72.7, 67.2, 57.3, 49.8, 48.0, 31.2, 26.4, 24.7, 21.9, 20.9. HPLC 99%, RT 4.39 min. MS (ESI) <i>m</i>/<i>z</i> 438.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 7-(4-(4-(2-(Trifluoromethyl)phenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> (188 mg) was prepared as white solid by the same procedure as preparing <b>4</b>, yield 62%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.17 (br s, 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.52 (app t, <i>J</i> = 7.8 Hz, 1H), 7.40 (d, <i>J</i> = 8.0 Hz, 1H), 7.23 (app t, <i>J</i> = 7.6 Hz, 1H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.52 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 6.34 (d, <i>J</i> = 2.4 Hz, 1H), 4.01–3.92 (m, 2H), 3.18–2.93 (m, 4H), 2.92–2.44 [m, 10H, containing an app t at δ 2.89 (<i>J</i> = 7.6 Hz) and an app t at δ 2.61 (<i>J</i> = 7.6 Hz)], 1.93–1.71 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 171.8, 158.7, 138.3, 133.0, 129.3, 128.8, 127.5 (q, <i>J</i><sub>CF</sub> = 29.0 Hz), 127.3 (q, <i>J</i><sub>CF</sub> = 5.4 Hz), 125.2, 124.3, 124.2 (q, <i>J</i><sub>CF</sub> = 274.4 Hz), 115.9, 108.8, 102.3, 67.9, 58.2, 53.5, 53.0, 31.2, 27.3, 24.8, 23.1. HPLC 99%, RT 4.36 min. MS (ESI) <i>m</i>/<i>z</i> 448.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 7-(4-(4-(3-Ethoxyphenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>11</b>)</h3><div class="NLM_p last">Compound <b>11</b> (48 mg) was prepared as white solid by the same procedure as preparing compound <b>4</b>, yield 57%. <sup>1</sup>H NMR (400 MHz, CDCl3): δ 7.76 (s, 1H), 7.15 (t, <i>J</i> = 8.1 Hz, 1H), 7.04 (d, <i>J</i> = 8.1 Hz, 1H), 6.56–6.49 (m, 2H), 6.47 (s, 1H), 6.40 (d, <i>J</i> = 8.1 Hz, 1H), 6.29 (s, 1H), 4.06–3.91 (m, 4H), 3.25–3.14 (m, 4H), 2.90 (t, <i>J</i> = 7.4 Hz, 2H), 2.67–2.56 (m, 6H), 2.46 (t, <i>J</i> = 7.2 Hz, 2H), 1.88–1.77 (m, 2H), 1.76–1.66 (m, 2H), 1.40 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 171.6, 160.1, 158.8, 152.8, 138.2, 129.9, 128.9, 115.9, 108.9, 108.8, 105.1, 103.2, 102.3, 68.1, 63.5, 58.4, 53.4, 49.19, 31.3, 27.4, 24.8, 23.6, 15.1. HPLC 99%, RT 4.26 min. MS (ESI) <i>m</i>/<i>z</i> 424.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (4-(2,3-Dichlorophenyl)pyridin-1(4<i>H</i>)-yl)(phenyl)methanone (<b>14</b>)</h3><div class="NLM_p last">To a −30 °C solution of 1-bromo-2,3-dichlorobenzene (10 g, 44 mmol) in THF (120 mL) was added <i>i</i>-PrMgCl (2.0 M in THF, 35 mL, 70 mmol) at a rate such that the temperature <−20 °C. Meanwhile, to a −10 °C solution of CuI (420 mg, 2.2 mmol) in THF (120 mL) was added pyridine (7.1 mL, 88 mmol) and then benzyl carbonochloridate (9.7 mL, 68 mmol) such that the temperature <0 °C. To this heterogeneous mixture was added the initially formed Grignard at a rate such that the temperature <0 °C. The resulting solution was stirred at 0 °C for 30 min and then allowed to warm to rt. The reaction was then quenched with 10% aq NH<sub>4</sub>Cl. EtOAc was added, and the blue aqueous layer was removed. The organic layer was washed with 10% aq NH<sub>4</sub>Cl, 1 N HCl, and a 20% aq NaCl solution. The organic layer was then concentrated, and the residue was dissolved and crystallized from MeOH. The slurry was filtered and the filtercake washed with MeOH to give benzyl 4-(2,3-dichlorophenyl)pyridine-1(4<i>H</i>)-carboxylate (<b>14</b>) (12 g, 76%) as an off-white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.42–7.21 (m, 8H), 7.04 (d, <i>J</i> = 9.2 Hz, 1H), 6.92 (d, <i>J</i> = 6.4 Hz, 1H), 5.25 (s, 2H), 5.02 (d, <i>J</i> = 6.4 Hz, 1H), 4.93 (d, <i>J</i> = 9.2 Hz, 1H), 4.73–4.71 (m, 1H). HPLC: 99%, RT 4.069 min. MS (ESI) <i>m</i>/<i>z</i> 360.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (4-(2,3-Dichlorophenyl)piperidin-1-yl)(phenyl)methanone (<b>15</b>)</h3><div class="NLM_p last">To a solution of intermediate <b>15</b> (7.0 g, 19.5 mmol) in toluene (150 mL) was added RhCl(PPh<sub>3</sub>)<sub>3</sub> (2.1 g, 2.0 mmol) as a slurry in toluene (50 mL). The reaction was subjected to an atmosphere of H<sub>2</sub> at 40 psi and heated to 70 °C. After 6 h, the reaction was filtered through silica gel and washed with 1:9 EtOAc/toluene. The filtrate was dissolved in toluene, concentrated in vacuo, and purified by flash chromatography on silica gel column (elution with PE/EtOAc = 50:1) to give benzyl 4-(2,3-dichlorophenyl)piperidine-1-yl)(phenyl)methanone (<b>15</b>) (6.8 g, 96%) as an oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.41–7.28 (m, 5H), 7.26–7.25 (m, 1H), 7.18 (t, <i>J</i> = 7.8 Hz, 1H), 7.13–7.10 (m, 1H), 5.16 (s, 2H), 4.35 (d, <i>J</i> = 12.0 Hz, 2H), 3.24–3.19 (m, 1H), 2.93 (t, <i>J</i> = 12.6 Hz, 2H), 1.86 (d, <i>J</i> = 13.0 Hz, 2H), 1.59 (t, <i>J</i> = 10.5 Hz, 2H). HPLC: 99%, RT 3.881 min. MS (ESI) <i>m</i>/<i>z</i> 364.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(2,3-Dichlorophenyl)piperidine Hydrochloride (<b>16</b>)</h3><div class="NLM_p last">To 6N HCl (30 mL) was added a solution of compound <b>15</b> (5.2 g, 14 mmol) in THF (10 mL). The mixture was heated to reflux for 3 h and then concentrated in vacuo. The residue was washed with Et<sub>2</sub>O to give 4-(2,3-dichlorophenyl)piperidine hydrochloride (<b>16</b>) (3.5 g, 92%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.48–7.42 (m, 1H), 7.36–7.31 (m, 2H), 3.51–3.41 (m, 3H), 3.33–3.15 (m, 3H), 2.11–2.07 (m, 2H), 1.99–1.85 (m, 2H). HPLC: 99%, RT 2.090 min. MS (ESI) <i>m</i>/<i>z</i> 230.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 7-(4-(4-(2,3-Dichlorophenyl)piperidin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one (<b>18</b>)</h3><div class="NLM_p">Compound <b>18</b> (106.8 mg) was prepared as white solid by the same procedure as preparing compound <b>4</b> from intermediate 7-(4-bromobutoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (119 mg, 0.4 mmol) and compound <b>16</b> (117.3 mg, 0.44 mmol), yield 60%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.85 (s, 1H), 7.33 (d, <i>J</i> = 8.1 Hz, 1H), 7.23–7.17 (m, 2H), 7.05 (d, <i>J</i> = 8.1 Hz, 1H), 6.54 (dd, <i>J</i> = 2.1 Hz, 8.1 Hz, 1H), 6.31 (d, <i>J</i> = 2.1 Hz, 1H), 3.96 (t, <i>J</i> = 6.0 Hz, 2H), 3.15–3.05 (m, 3H), 2.90 (t, <i>J</i> = 7.3 Hz, 2H), 2.62 (t, <i>J</i> = 7.3 Hz, 2H), 2.50 (t, <i>J</i> = 7.2 Hz, 2H), 2.30–2.10 (m, 2H), 1.91–1.72 (m, 8H). HPLC: 99%, RT 2.504 min. MS (ESI) <i>m</i>/<i>z</i> 447.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">Intermediate <b>17</b> and compounds <b>19</b> and <b>21</b> were prepared according to previous procedures.<a onclick="showRef(event, 'ref27 ref37 ref39'); return false;" href="javascript:void(0);" class="ref ref27 ref37 ref39">(27, 37, 39)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>trans</i>-7-((4-((4-(2,3-Dichlorophenyl)piperazin-1-yl)methyl)cyclohexyl)methoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>22</b>)</h3><div class="NLM_p last">A mixture of 7-hydroxy-3,4-dihydroquinolin-2(1<i>H</i>)-one (105 mg, 0.65 mmol), 1,4-bis(bromomethyl)cyclohexane (523 mg, 1.9 mmol), and anhydrous K<sub>2</sub>CO<sub>3</sub> (89 mg, 0.65 mmol) was dissolved in EtOH, and the solution was heated to reflux for 6 h. The solution was diluted with water and extracted with EtOAc. The combined organic layers were washed with satd aq NaHCO<sub>3</sub>, brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography on silica gel column to give 7-((4-(bromomethyl)cyclohexyl)methoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (70 mg, 30%, 0.2 mmol) as a white solid, which was redissolved in CH<sub>3</sub>CN. To this mixture was added NaI (60 mg, 0.4 mmol), and the reaction mixture was heated to reflux for 30 min and then cooled to rt. The commercial available compound <b>20</b> (81 mg, 0.3 mmol) and anhydrous K<sub>2</sub>CO<sub>3</sub> (110 mg, 0.8 mmol) were added to the mixture. The resulting mixture was heated to reflux and stirred for 6 h. Precipitated crystals were filtered off, and the filtrate was evaporated under reduced pressure. The residue was extracted with EtOAc. The combined EtOAc layers was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography on silica gel column (elution with DCM/MeOH = 50:1) to give <i>trans</i>-7-((4-((4-(2,3-dichlorophenyl)piperazin-1-yl)methyl)cyclohexyl)methoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>22</b>) as a white solid (63 mg, yield 63%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.06 (s, 1H), 7.15–7.13 (m, 2H), 7.04 (d, <i>J</i> = 8.4 Hz, 1H), 6.97–6.94 (m, 1H), 6.52 (dd, <i>J</i> = 2.4 Hz, 8.4 Hz, 1H), 6.32 (d, <i>J</i> = 2.1 Hz, 1H), 3.74–3.71 (m, 2H), 3.07–3.05 (m, 4H), 2.92–2.87 (m, 2H), 2.64–2.59 (m, 6H), 2.24 (d, <i>J</i> = 6.9 Hz, 2H), 1.83 (d, <i>J</i> = 6.9 Hz, 2H), 1.53–1.69 (m, 4H), 1.10–0.94 (m, 4H). HPLC: 99%, RT 2.652 min. MS (ESI) <i>m</i>/<i>z</i> 502.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)but-2-ynyloxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> (280 mg) was prepared as yellow solid by the same procedure as preparing <b>22</b>, yield 79%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.62 (s, 1H), 7.20–7.11 (m, 2H), 7.07 (d, <i>J</i> = 8.3 Hz, 1H), 6.96 (dd, <i>J</i> = 7.1, 2.5 Hz, 1H), 6.62 (dd, <i>J</i> = 8.3, 2.5 Hz, 1H), 6.39 (d, <i>J</i> = 2.4 Hz, 1H), 4.72 (t, <i>J</i> = 1.7 Hz, 2H), 3.41 (t, <i>J</i> = 1.7 Hz, 2H), 3.08 (bs, 4H), 2.93–2.85 (m, 2H), 2.78–2.68 (m, 2H), 2.63–2.57 (m, 2H). HPLC: 99%, RT 2.403 min. MS (ESI) <i>m</i>/<i>z</i> 444.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>trans</i>-7-((2-((4-(2,3-Dichlorophenyl)piperazin-1-yl)methyl)cyclopropyl)methoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> (82 mg) was prepared as white solid by the same procedure as prepaing <b>22</b>, yield 48%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.69 (s, 1H), 7.19–7.09 (m, 2H), 7.03 (d, <i>J</i> = 8.2 Hz, 1H), 6.98–6.91 (m, 1H), 6.57 (d, <i>J</i> = 8.4 Hz, 1H), 6.35 (s, 1H), 3.89 (s, 2H), 3.04 (s, 4H), 2.88 (t, <i>J</i> = 7.3 Hz, 2H), 2.80–2.56 (m, 6H), 2.46 (s, 2H), 0.65 (s, 2H), 0.48 (s, 2H). <sup>13</sup>C NMR (101 MHz, CDCl3): δ 171.6, 159.2, 151.5, 138.1, 134.2, 128.7, 127.6, 127.6, 124.6, 118.7, 115.8, 109.1, 102.5, 72.3, 62.8, 53.7, 51.4, 31.3, 24.8, 18.0, 9.5, 2.1. HPLC: 99%, RT 2.541 min. MS (ESI) <i>m</i>/<i>z</i> 460.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(3-Bromobenzyl)-4-(2,3-dichlorophenyl)piperazine (<b>27</b>)</h3><div class="NLM_p last">A mixture of 1-(2,3-dichlorophenyl)piperazine hydrochloride (<b>20</b>) (294 mg, 1.1 mmol), 1-bromo-3-(bromomethyl)benzene (250 mg, 1 mmol), and anhydrous triethylamine (253 mg, 2.5 mmol) was dissolved in CH<sub>3</sub>CN, and the solution was heated to reflux for 4 h. The solution was diluted with water and extracted with EtOAc. The combined organic layers were washed with sd aq NaHCO<sub>3</sub>, brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by flash chromatography on silica gel column (elution with PE/EtOAc = 8:1) to give 1-(3-bromobenzyl)-4-(2,3-dichlorophenyl)piperazine (<b>27</b>) (220 mg, 74%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.54 (s, 1H), 7.40 (d, <i>J</i> = 7.8 Hz, 1H), 7.28 (d, <i>J</i> = 7.8 Hz, 1H), 7.21 (d, <i>J</i> = 7.8 Hz, 1H), 7.17–7.10 (m, 2H), 6.97–6.94 (m, 1H), 3.55 (s, 2H), 3.07 (br, 4H), 2.64 (br, 4H). HPLC: 99%, RT 2.542 min. MS (ESI) <i>m</i>/<i>z</i> 399.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 7-(3-((4-(2,3-Dichlorophenyl)piperazin-1-yl)methyl)phenoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>25</b>)</h3><div class="NLM_p last">To a solution of 7-hydroxy-3,4-dihydroquinolin-2(1<i>H</i>)-one (196 mg, 1.2 mmol) in NMP was added Cs<sub>2</sub>CO<sub>3</sub> (391 mg, 1.2 mmol). The slurry was degassed by evacuating and filling the reaction flask with N<sub>2</sub> three times. Compound <b>27</b> (240 mg, 0.6 mmol) and TMHD (11 mg, 0.06 mmol) were added, followed by the addition of CuCl (60 mg, 0.6 mmol). The reaction mixture was degassed by evacuating and filling the reaction flask with N<sub>2</sub> three times and then warmed to 120 °C under N<sub>2</sub> for 7.5 h. The reaction mixture was cooled to rt and diluted with Et<sub>2</sub>O. The slurry was filtered, and the filtercake was washed with Et<sub>2</sub>O. Combined filtrates were washed with 2 N HCl, 0.6 N HCl, 2 M NaOH, and 10% aq NaCl. The resulting organic layer was dried, concentrated, and purified by flash chromatography on a silica gel column (elution with PE/EtOAc = 1:1) to give 7-(3-((4-(2,3-dichlorophenyl)piperazin-1-yl)methyl)phenoxy)-3,4-dihydro quinolin-2(1<i>H</i>)-one (Compound <b>25</b>) (off-white solid, 110 mg, 38%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.62 (s, 1H), 7.31 (d, <i>J</i> = 7.2 Hz, 2H), 7.15–7.05 (m, 4H), 6.96–6.89 (m, 2H), 6.62 (dd, <i>J</i> = 2.1 Hz, 8.1 Hz, 1H), 6.41 (d, <i>J</i> = 2.1 Hz, 1H), 3.57 (s, 2H), 3.06 (m, 4H), 2.94 (t, <i>J</i> = 7.5 Hz, 2H), 2.66–2.61 (m, 5H). HPLC: 99%, RT 2.637 min. MS (ESI) <i>m</i>/<i>z</i> 482.1 [M + H]<sup>+</sup>. Mp: 182–183 °C.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-(4-Bromobenzyl)-4-(2,3-dichlorophenyl)piperazine (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> (220 mg) was prepared as white solid from <b>20</b> (294 mg, 1.1 mmol), 1-bromo-4-(bromomethyl) benzene (250 mg, 1.0 mmol), and anhydrous triethylamine (253 mg, 2.5 mmol) by the same procedure as preparing <b>27</b>, yield 74%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.27–7.23 (m, 2H), 7.15–7.13 (m, 2H), 6.96–6.93 (m, 2H), 3.54 (s, 2H), 3.06 (br, 4H), 2.63 (m, 4H). HPLC: 99%, RT 2.541 min. MS (ESI) <i>m</i>/<i>z</i> 398.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 7-(4-((4-(2,3-Dichlorophenyl)piperazin-1-yl)methyl)phenoxy)-3,4-dihydroquinolin-2(1<i>H</i>)-one (<b>26</b>)</h3><div class="NLM_p">Compound <b>26</b> (120 mg) was prepared as off-white solid by the same procedure as preparing <b>25</b>, yield 35%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.67 (s, 1H), 7.32 (d, <i>J</i> = 8.7 Hz, 2H), 7.16–7.09 (m, 3H), 6.98–6.94 (m, 3H), 6.64–6.61 (m, 1H), 6.41 (d, <i>J</i> = 3.0 Hz, 1H), 3.56 (s, 2H), 3.07 (m, 4H), 2.94 (t, <i>J</i> = 6.6 Hz, 2H), 2.66–2.61 (m, 6H). HPLC: 99%, RT 2.626 min. MS (ESI) <i>m</i>/<i>z</i> 482.1 [M + H]<sup>+</sup>. Melting point: 185–186 °C.</div><div class="NLM_p last">Compounds <b>29</b> and <b>30</b> were synthesized as previously described.<a onclick="showRef(event, 'ref27 ref32'); return false;" href="javascript:void(0);" class="ref ref27 ref32">(27, 32)</a></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> (215 mg) was prepared as white solid by the same procedure as preparing <b>22</b>, yield 65%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.58 (d, <i>J</i> = 2.7 Hz, 1H), 7.14–7.11 (m, 3H), 7.01–6.94 (m, 2H), 6.18 (brs, 1H), 4.05 (t, <i>J</i> = 6.3 Hz, 2H), 3.56–3.51 (m, 2H), 3.07 (m, 4H), 2.90 (t, <i>J</i> = 8.1 Hz, 2H), 2.66 (m, 4H), 2.49–2.46 (m, 2H), 1.86–1.68 (m, 4H). HPLC: 99%, RT 2.374 min. MS (ESI) <i>m</i>/<i>z</i> 448.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-1<i>H</i>-indazole (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> (off-white solid, 35 mg) was prepared by the same procedure as preparing <b>22</b>, yield 45%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.97 (s, 1H), 7.61 (d, <i>J</i> = 8.7 Hz 1H), 7.17–7.15 (m, 2H), 6.96 (dd, <i>J</i> = 3.0 Hz, 6.6 Hz, 1H), 6.86–6.81 (m, 2H), 4.05 (t, <i>J</i> = 5.4 Hz, 2H), 3.16 (s, 4H), 2.79 (s, 4H), 2.64–2.60 (m, 2H), 1.89–1.83 (m, 4H). HPLC: 99%, RT 2.491 min. MS (ESI) <i>m</i>/<i>z</i> 419.2 [M + H]<sup>+</sup>. Melting point: 101–103 °C.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> (54 mg) was prepared as white solid by the same procedure as preparing <b>22</b>, yield 42%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.53 (s, 1H), 9.24 (s, 1H), 7.17–7.13 (m, 2H), 6.97–6.91 (m, 2H), 6.66–6.60 (m, 2H), 3.95 (t, <i>J</i> = 5.7 Hz, 2H), 3.20–3.01 (m, 4H), 2.80–2.61 (m, 4H), 2.52 (t, <i>J</i> = 7.5 Hz, 2H), 1.82–1.73 (m, 4H). HPLC: 99%, RT 2.325 min. MS (ESI) <i>m</i>/<i>z</i> 435.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)benzo[<i>d</i>]thiazole (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> (light-yellow soild, 98 mg) was prepared by the same procedure as preparing <b>22</b>, yield 60%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.97 (s, 1H), 7.79 (d, <i>J</i> = 8.7 Hz, 1H), 7.61 (s, 1H), 7.16–7.08 (m, 3H), 6.97–6.94 (m, 1H), 4.11 (t, <i>J</i> = 5.7 Hz, 2H), 3.09 (br, 4H), 2.68 (brs, 4H), 2.55–2.50 (m, 2H), 1.92–1.76 (m, 4H). HPLC: 99%, RT 2.651 min. MS (ESI) <i>m</i>/<i>z</i> 436.3 [M + H]<sup>+</sup>. Melting point: 93–94.5 °C.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-(4-(4-(2,3-Dichlorophenyl)piperidin-1-yl)butoxy)benzo[<i>d</i>]thiazole (<b>35</b>)</h3><div class="NLM_p">Compound <b>35</b> (144 mg) was prepared as light-yellow solid by the same procedure as preparing <b>22</b>, yield 66%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.97 (s, 1H), 7.79 (d, <i>J</i> = 8.8 Hz, 1H), 7.61 (d, <i>J</i> = 2.4 Hz, 1H), 7.31 (dd, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.23–7.12 (m, 2H), 7.09 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 4.10 (t, <i>J</i> = 6.3 Hz, 2H), 3.16–3.01 (m, 3H), 2.55–2.45 (m, 2H), 2.14 (t, <i>J</i> = 10.9 Hz, 2H), 1.96–1.68 (m, 8H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.6, 155.0, 154.8, 133.2, 131.9, 128.2, 127.5, 125.6, 125.5, 122.1, 116.6, 106.6, 68.3, 58.7, 54.4, 39.9, 32.1, 27.4, 23.7. HPLC: 99%, RT 2.689 min. MS (ESI) <i>m</i>/<i>z</i> 435.3 [M + H]<sup>+</sup>. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>2</sub>OS 435.1065, found 435.1039. Melting point:79–81 °C.</div><div class="NLM_p last">Synthesis of compound <b>36</b> was described previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(3-(4-(2,3-Dichlorophenyl)piperazin-1-yl)propoxy)benzo[<i>d</i>]thiazole (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> (light-yellow solid, 209 mg) was prepared by the same procedure as preparing <b>22</b>, yield 62%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.97 (s, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.62 (d, <i>J</i> = 2.4 Hz, 1H), 7.15 (dd, <i>J</i> = 7.0, 4.7 Hz, 2H), 7.10 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.97 (dd, <i>J</i> = 6.6, 2.8 Hz, 1H), 4.15 (t, <i>J</i> = 6.3 Hz, 2H), 3.11 (bs, 4H), 2.81–2.61 (m, 6H), 2.15–2.05 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 158.5, 155.1, 154.8, 151.3, 134.2, 127.7, 127.6, 125.7, 124.8, 122.2, 118.8, 116.5, 106.7, 66.7, 55.3, 53.4, 51.3, 26.7. HPLC: 99%, RT 2.607 min. MS (ESI) <i>m</i>/<i>z</i> 422.0 [M + H]<sup>+</sup>. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>3</sub>OS 422.0861, found 422.0885. Melting point: 127–129 °C.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-(3-(4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl)propoxy)benzo[<i>d</i>]thiazole (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> (light-brown solid, 98 mg) was prepared by the same procedure as preparing <b>22</b>, yield 60%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 9.91 (s, 1H), 8.10 (t, <i>J</i> = 8.7 Hz, 1H), 7.65 (s, 1H), 7.34 (t, <i>J</i> = 7.7 Hz, 1H), 7.29–7.15 (m, 3H), 4.31 (t, <i>J</i> = 5.2 Hz, 2H), 3.87–3.71 (m, 2H), 3.67–3.43 (m, 6H), 3.42–3.29 (m, 2H), 2.48–2.24 (m, 4H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD): δ 162.1, 160.9, 152.9, 134.9, 129.1, 128.6, 126.4, 125.8, 125.2, 122.1, 119.5, 119.2, 103.6, 67.2, 56.5, 56.3, 54.6, 53.4, 50.9, 25.8, 25.5. HPLC: 99%, RT 2.601 min. MS (ESI) <i>m</i>/<i>z</i> 436.3 [M + H]<sup>+</sup>. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>3</sub>OS 436.1017, found 436.1038. mp: 93–94 °C.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(4-(4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl)butoxy)benzo[<i>d</i>]thiazole (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> (light-brown solid, 98 mg) was prepared by the same procedure as preparing <b>22</b>, yield 60%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.97 (s, 1H), 7.80 (d, <i>J</i> = 8.7 Hz, 1H), 7.60 (d, <i>J</i> = 3.0 Hz, 1H), 7.11–7.07 (m, 3H), 7.01–6.98 (m, 1H), 4.10 (t, <i>J</i> = 5.7 Hz, 2H), 3.76–3.68 (m, 2H), 3.33–3.27 (m, 4H), 2.96–2.95 (m, 4H), 2.73–2.71 (m, 2H), 2.06–2.04 (m, 2H), 1.92–1.80 (m, 2H). HPLC: 99%, RT 2.702 min. MS (ESI) <i>m</i>/<i>z</i> 450.1 [M + H]<sup>+</sup>. Melting point: 82–84 °C.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-(4-(4-(2,3-Dichlorophenyl)piperidin-1-yl)butoxy)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> (61 mg) was prepared as off-white solid by the same procedure as preparing <b>22</b>, yield 40%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.59 (brs, 1H), 9.29 (brs, 1H), 7.33–7.30 (m, 2H), 7.20–7.13 (m, 1H), 6.92 (d, <i>J</i> = 8.7 Hz, 1H), 6.65–6.59 (m, 2H), 3.94–3.91 (m, 2H), 3.15–3.04 (m, 3H), 2.51–2.49 (m, 2H), 2.15(t, <i>J</i> = 11.1 Hz, 2H), 1.90–1.74 (m, 8H). HPLC: 99%, RT 2.332 min. MS (ESI) <i>m</i>/<i>z</i> 434.0 [M + H]<sup>+</sup>. Melting point: 180–182 °C.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 6-(3-(4-(2,3-Dichlorophenyl)piperazin-1-yl)propoxy)-1<i>H</i>-indazole (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> (90 mg) was prepared by the same procedure as preparing <b>22</b>, yield 71%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.38 (bs, 1H), 7.97 (s, 1H), 7.60 (d, <i>J</i> = 8.7 Hz, 1H), 7.20–7.08 (m, 2H), 6.95 (dd, <i>J</i> = 7.1, 2.5 Hz, 1H), 6.90–6.78 (m, 2H), 4.08 (t, <i>J</i> = 6.3 Hz, 2H), 3.09 (bs, 4H), 2.77–2.61 (m, 6H), 2.12–2.00 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 159.2, 151.3, 141.5, 135.0, 134.2, 127.6, 127.5, 124.7, 121.7, 118.7, 118.1, 113.5, 91.7, 66.6, 55.3, 53.5, 51.4, 26.8. HPLC: 99%, RT 2.462 min. MS (ESI) <i>m</i>/<i>z</i> 405.2 [M + H]<sup>+</sup>. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>3</sub>OS 405.1249, found 405.1273. Melting point: 159–161 °C.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 7-(3-(4-(2,3-Dichlorophenyl)piperazin-1-yl)propoxy)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> (88 mg) was prepared as a white solid by the same procedure as preparing <b>22</b>, yield 52%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.60 (d, <i>J</i> = 2.7 Hz, 1H), 7.18–7.09 (m, 3H), 7.01 (dd, <i>J</i> = 8.3, 2.8 Hz, 1H), 6.96 (dd, <i>J</i> = 6.2, 3.4 Hz, 1H), 6.15 (bs, 1H), 4.10 (t, <i>J</i> = 6.4 Hz, 2H), 3.54 (td, <i>J</i> = 6.6, 2.8 Hz, 2H), 3.08 (bs, 4H), 2.93 (t, <i>J</i> = 6.6 Hz, 2H), 2.73–2.57 (m, 6H), 2.06–1.97 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>): δ 166.4, 158.3, 151.5, 134.1, 131.1, 129.9, 128.5, 127.7, 127.6, 124.7, 120.4, 118.8, 112.0, 66.7, 55.2, 53.5, 51.4, 40.7, 27.7, 26.9. HPLC: 99%, RT 2.612 min. MS (ESI) <i>m</i>/<i>z</i> 434.1 [M + H]<sup>+</sup>. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> 434.1402, found 434.1425. Melting point: 162–164 °C.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 7-(3-(4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl)propoxy)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (<b>43</b>)</h3><div class="NLM_p">Compound <b>43</b> (125 mg) was prepared as a white solid by the same procedure as preparing <b>22</b>, yield 71%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.60 (d, <i>J</i> = 2.1 Hz, 1H), 7.14–7.08 (m, 3H), 7.02–7.00 (m, 2H), 6.02 (br., 1H), 4.10 (t, <i>J</i> = 6.3 Hz, 2H), 3.56–3.53 (m, 2H), 3.31–3.27 (m, 4H), 2.96–2.88 (m, 6H), 2.77–2.72 (m, 2H), 2.01(m, 4H). HPLC: 99%, RT 2.578 min. MS (ESI) <i>m</i>/<i>z</i> 448.1 [M + H]<sup>+</sup>. Melting point: 116–117 °C.</div><div class="NLM_p last">Synthesis of compound <b>44</b> was described previously.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 7-(4-(4-(2,3-Dichlorophenyl)-1,4-diazepan-1-yl)butoxy)quinolin-2(1<i>H</i>)-one (<b>45</b>)</h3><div class="NLM_p last">Compound <b>45</b> (50 mg) was prepared as a white solid by the same procedure as preparing <b>22</b>, yield 46%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 11.54 (br, 1H), 7.71 (d, <i>J</i> = 6.9 Hz, 1H) 7.44 (d, <i>J</i> = 8.1 Hz, 1H), 7.09–7.07 (m, 2H), 7.01–6.97 (m, 1H), 6.82–6.78 (m, 2H), 6.53 (d, <i>J</i> = 9.3 Hz, 1H), 4.10 (t, <i>J</i> = 6.6 Hz, 2H), 3.30 (d, <i>J</i> = 5.1 Hz, 4H), 2.87–2.81 (m, 4H), 2.62 (t, <i>J</i> = 7.5 Hz, 2H), 2.01–1.99 (m, 2H), 1.92–1.82 (m, 2H), 1.76–1.68 (m, 2H). HPLC: 99%, RT 2.461 min. MS(ESI) <i>m</i>/<i>z</i> 460.2 [M + H]<sup>+</sup>. mp: 55–57 °C.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Experimental Procedures for in Vitro Biochemical Assays</h3><div id="sec4_29_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> General Procedures</h4><div class="NLM_p last">Experimental procedures for the radioligand binding assays for the GPCRs listed in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table S1">Supporting Information Table S1</a> (including D<sub>1</sub>, D<sub>3</sub>, D<sub>4</sub>, D<sub>5</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>2C</sub>, and 5-HT<sub>1A</sub>) are available online through the Psychoactive Drug Screening Program (PDSP) Web site: <a href="http://pdsp.med.unc.edu/" class="extLink">http://pdsp.med.unc.edu/</a>. The PDSP Assay Protocol book is freely available at <a href="http://pdsp.med.unc.edu/UNC–CH%20Protocol%20Book.pdf" class="extLink">http://pdsp.med.unc.edu/UNC–CH%20Protocol%20Book.pdf</a>. The dopamine D<sub>2</sub> radioligand binding, cAMP biosensor, and β-arrestin recruitment Tango assays are detailed below.</div></div><div id="sec4_29_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> CHO–D<sub>2</sub> Membrane Preparation and Radioligand Binding Assay</h4><div class="NLM_p last">CHO–D<sub>2</sub> membrane preparation. Cells stably expressing human D<sub>2 L</sub> receptors (CHO–D<sub>2 L</sub>) were plated in 15 cm dishes (in DMEM containing 10% FBS) and grown to 90% confluence. Then cells were washed with PBS, pH 7.4, and harvested by scraping into PBS, pH 7.4. Harvested cells were centrifuged at 1000<i>g</i> for 10 min and then hypotonically lysed by resuspension into ice-cold 50 mM Hepes, 1% BSA, pH 7.4. Membranes were isolated by centrifugation at 21000<i>g</i> for 20 min. The supernatant was removed, and the membrane pellets were stored at −80 °C until used for radioligand binding assays.</div></div><div id="sec4_29_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Radioligand Binding Assay</h4><div class="NLM_p last">Membranes prepared as above were resuspended to 1 μg protein/μL (measured by Bradford assay using BSA as standard), and 50 μL was added to each well of a polypropylene 96-well plate containing (per well) 50 μL of buffer (20 mM Hepes, 10 mM MgCl<sub>2</sub>, 1 mM EDTA, 1 mM EGTA, 100 mM <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-gluconate, pH 7.4), 50 μL of 1.5 nM [<sup>3</sup>H]<i>N</i>-methylspiperone (final concentration 0.3 nM), and reference or D<sub>2</sub> test ligands at various concentrations ranging from 50 pM to 50 μM (final concentrations ranging from 10 pM to 10 μM, triplicate determinations for each concentration of D<sub>2</sub> test ligand). After a 1.5 h incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4, using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried and placed on a hot plate (100 °C), and Melitilex-A (Wallac) scintillant was applied. The filters were then removed from the hot plate and allowed to cool. The filters were counted on a Wallac TriLux microbeta counter (3 min/well). Residual [<sup>3</sup>H]<i>N</i>-methylspiperone binding to filtered membranes was plotted as a function of log [reference] or log [D<sub>2</sub> test ligand], and the data were regressed using the one-site competition model built into Prism 4.0 (GraphPad software).</div></div><div id="sec4_29_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> D<sub>2</sub>-Mediated cAMP Assay</h4><div class="NLM_p last">HEK293T cells coexpressing the cAMP biosensor GloSensor-22F (Promega) and hD<sub>2 L</sub> receptors were seeded (20000 cells/20 μL/well) into white, clear-bottom, tissue culture plates in HBSS, 20 mM Hepes, pH 7.4. After 30 min of recovery, cells were treated with 10 μL of 3× test or reference drug prepared in HBSS, 20 mM Hepes, pH 7.4. After 30 min, cells were treated with 10 μL of 1200 nM (4×) isoproterenol in 8% (4×) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose–response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD<sub>2</sub>) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP, either by quinpirole or by the test compounds, suggesting that the effect observed in hD<sub>2 L</sub>-expressing cells was due to compound acting via the recombinant receptor.</div></div><div id="sec4_29_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> D<sub>2</sub> β-Arrestin Recruitment Tango Assay</h4><div class="NLM_p last">Recruitment of β-arrestin to agonist-stimulated D<sub>2 L</sub> receptors was performed using a previously described “Tango”-type assay.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Briefly, HTLA cells stably expressing β-arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15 cm dishes in DMEM containing 10% FBS and transfected (via calcium phosphate) with 16 μg of a D<sub>2</sub>V<sub>2</sub>-TCS-tTA construct.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner; 15000 cells/well, 50 μL/well) in DMEM containing 1% dialyzed FBS. The following day, the cells were challenged with 10 μL/well of reference agonist (6 μM) or D<sub>2</sub> test ligand (6 μM) prepared in HBSS, 20 mM Hepes, pH 7.4, and 6% DMSO (final ligand concentrations are 1 μM, final DMSO concentration is 1%). After 18 h, the medium was removed and replaced with 1× BriteGlo reagent (Promega), and luminescence per well was read using a TriLux plate reader (1 s/well). Data were normalized to vehicle (0%) and quinpirole (100%) controls and regressed using the sigmoidal dose–response function built into GraphPad Prism 4.0.0</div></div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Experimental Procedures for in Vivo Studies in Mice</h3><div id="sec4_30_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> General Procedures</h4><div class="NLM_p last">All experiments were approved by the Institutional Animal Care and Use Committees at the University of North Carolina, Chapel Hill, and Duke University. Wild-type and β-arrestin-2 knockout mice were housed under standard conditions −14 h light/dark cycle (lights on 0600 h) with food and water provided ad libitum. Adult, age-matched male and female wild-type and β-arrestin-2 knockout drug-naive mice were used for all behavioral testing.</div></div><div id="sec4_30_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Locomotor Activity of Compounds <b>19</b> and <b>35</b></h4><div class="NLM_p">Wild-type and β-arrestin-2 knockout mice were treated with vehicle or 2 mg/kg compounds <b>19</b> or <b>35</b> (ip) and were immediately placed into an open field. Thirty minutes later, the animals were administered 6 mg/kg PCP (ip) and were immediately returned to the open field for 90 min. Horizontal activity, measured as distance traveled, was recorded over 5 min segments for the duration of testing. RMANOVA for the first 30 min of testing (baseline) revealed a significance within subject effects of time [<i>F</i>(5300) = 38.344, <i>p</i> < 0.001]; the time by genotype, time by treatment, or the time by treatment by genotype interactions were not significant (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><div class="NLM_p last">A second analysis was run to analyze the locomotor activity of the mice following PCP treatment over the entire 90 min following injection. A RMANOVA noted a significant within subject effects of time [<i>F</i>(171020) = 64.520, <i>p</i> < 0.001] and significant time by genotype [<i>F</i>(171020) = 1.592, <i>p</i> < 0.012] and time by treatment interactions [<i>F</i>(341020) = 2.316, <i>p</i> < 0.001]. Because these analyses indicated significant genotype and treatment effects, the RMANOVA was run within each treatment condition as a function of genotype. For the PCP-treated mice, no genotype differences were discerned across time (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). For mice treated with <b>19</b>, there was a significant within subjects effect of time [<i>F</i>(17340) = 26.012, <i>p</i> < 0.001] and time by genotype interaction [<i>F</i>(17340) = 1.901, <i>p</i> < 0.017]. The Bonferroni test reported that <b>19</b> suppressed PCP-induced locomotion in the WT relative to the β-arrestin 2 knockout mice at 50, 55, 60, 65, 75, and 105 min (ps <0.042). For mice treated with <b>35</b>, there was a significant within subject effect of time [<i>F</i>(17272) = 14.194, <i>p</i> < 0.001] and time by genotype interaction [<i>F</i>(17272) = 1.729, <i>p</i> < 0.038]. The Bonferroni test found that 35 suppressed PCP-induced locomotion in the WT relative to the β-arrestin 2 knockout mice at 90 min (<i>p</i> < 0.050). Hence, these data show that at 2 mg/kg <b>19</b> is more efficacious than <b>35</b> in reducing PCP-stimulated locomotion in wild-type mice; neither compound affected PCP-induced activity in the β-arrestin-2 knockout mice.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/jm300603y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Radioligand binding affinities of compounds <b>19</b> and <b>35</b> at select dopamine and serotonin receptors. <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds <b>35</b> and <b>37</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300603y/suppl_file/jm300603y_si_001.pdf">jm300603y_si_001.pdf (171.4 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300603y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan L. Roth</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and
National Institute of Mental Health Psychoactive Drug Screening Program,
School of Medicine, University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 27599, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#52383b333c383b3c12273c317c3736277230202b333c0d203d263a123f37367c273c317c373627"><span class="__cf_email__" data-cfemail="e08a89818e8a898ea0958e83ce858495">[email protected]</span> <span class="__cf_email__" data-cfemail="5331212a323d0c213c273b133e36377d263d307d363726">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jin</span> - <span class="hlFld-Affiliation affiliation">Center for Integrative Chemical
Biology and Drug Discovery, Division of Chemical Biology and Medicinal
Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f993909897939097b98c979ad79c9d8cd99b8b809897a68b968d91b9949c9dd78c979ad79c9d8c"><span class="__cf_email__" data-cfemail="2d47444c434744436d58434e03484958">[email protected]</span> <span class="__cf_email__" data-cfemail="2745555e4649785548534f674a42430952494409424352">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Chen</span> - <span class="hlFld-Affiliation affiliation">Center for Integrative Chemical
Biology and Drug Discovery, Division of Chemical Biology and Medicinal
Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria F. Sassano</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and
National Institute of Mental Health Psychoactive Drug Screening Program,
School of Medicine, University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lianyou Zheng</span> - <span class="hlFld-Affiliation affiliation">Center for Integrative Chemical
Biology and Drug Discovery, Division of Chemical Biology and Medicinal
Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center for Combinatorial Chemistry
and Drug Discovery, Jilin University, Changchun, Jilin 130012, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Setola</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology and
National Institute of Mental Health Psychoactive Drug Screening Program,
School of Medicine, University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meng Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of Psychiatry and
Behavioral Sciences, Cell Biology, and Neurobiology, Duke University
Medical Center, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xu Bai</span> - <span class="hlFld-Affiliation affiliation">Center for Combinatorial Chemistry
and Drug Discovery, Jilin University, Changchun, Jilin 130012, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen V. Frye</span> - <span class="hlFld-Affiliation affiliation">Center for Integrative Chemical
Biology and Drug Discovery, Division of Chemical Biology and Medicinal
Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina
at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William C. Wetsel</span> - <span class="hlFld-Affiliation affiliation">Departments of Psychiatry and
Behavioral Sciences, Cell Biology, and Neurobiology, Duke University
Medical Center, Durham, North Carolina 27710, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d168e3855-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24783" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24783" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the NIH (U19MH082441S1 and U19MH082441) for financial support and Dr. Weihe Zhang for critical reading of synthetic procedures and characterization data.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">SFSR</td><td class="NLM_def"><p class="first last">structure–functional selectivity relationships</p></td></tr><tr><td class="NLM_term">D<sub>2</sub>R</td><td class="NLM_def"><p class="first last">dopamine D<sub>2</sub> receptor</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side</p></td></tr><tr><td class="NLM_term">RHS</td><td class="NLM_def"><p class="first last">right-hand side</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Furchgott, R. F.</span><span> </span><span class="NLM_article-title">The use of haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of agonist-receptor complexes</span>. In  <span class="citation_source-book">Advances in Drug Research</span>; <span class="NLM_contrib-group">Harper, N.; Simmonds, A.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1966</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=21-55&author=R.+F.+Furchgottauthor=N.+Harper&author=A.+Simmonds&title=Advances+in+Drug+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFurchgott%26aufirst%3DR.%2BF.%26atitle%3DThe%2520use%2520of%2520haloalkylamines%2520in%2520the%2520differentiation%2520of%2520receptors%2520and%2520in%2520the%2520determination%2520of%2520dissociation%2520constants%2520of%2520agonist-receptor%2520complexes%26btitle%3DAdvances%2520in%2520Drug%2520Research%26aulast%3DHarper%26aufirst%3DN.%26pub%3DAcademic%2520Press%26date%3D1966%26volume%3D3%26spage%3D21%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. M.</span><span> </span><span class="NLM_article-title">Multiple mechanisms of serotonergic signal transduction</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1987&pages=1051-1064&author=B.+L.+Rothauthor=D.+M.+Chuang&title=Multiple+mechanisms+of+serotonergic+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BM.%26atitle%3DMultiple%2520mechanisms%2520of%2520serotonergic%2520signal%2520transduction%26jtitle%3DLife%2520Sci.%26date%3D1987%26volume%3D41%26spage%3D1051%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Berg, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maayani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfarb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaramellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W. P.</span><span> </span><span class="NLM_article-title">Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fmol.54.1.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=9658194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=94-104&author=K.+A.+Bergauthor=S.+Maayaniauthor=J.+Goldfarbauthor=C.+Scaramelliniauthor=P.+Leffauthor=W.+P.+Clarke&title=Effector+pathway-dependent+relative+efficacy+at+serotonin+type+2A+and+2C+receptors%3A+evidence+for+agonist-directed+trafficking+of+receptor+stimulus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus</span></div><div class="casAuthors">Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">There are many examples of a single receptor coupling directly to more than one cellular signal transduction pathway.  Although traditional receptor theory allows for activation of multiple cellular effectors by agonists, it predicts that the relative degree of activation of each effector pathway by an agonist (relative efficacy) must be the same.  In the current expts., we demonstrate that agonists at the human serotonin2A (5-HT2A) and 5-HT2C receptors activate differentially two signal transduction pathways independently coupled to the receptors [phospholipase C (PLC)-mediated inositol phosphate (IP) accumulation and phospholipase A2 (PLA2)-mediated arachidonic acid (AA) release].  The relative efficacies of agonists differed depending on which signal transduction pathway was measured.  Moreover, relative to 5-HT, some 5-HT2C agonists (e.g., 3-trifluoromethylphenyl-piperazine) preferentially activated the PLC-IP pathway, whereas others (e.g., lysergic acid diethylamide) favored the PLA2-AA pathway.  In contrast, when two dependent responses were measured (IP accumulation and calcium mobilization), agonist relative efficacies were not different.  These data strongly support the hypothesis termed "agonist-directed trafficking of receptor stimulus" recently proposed by Kenakin [Trends Pharmacol Sci 16:232-238 (1995)].  Concn.-response curves to 5-HT2C agonists were fit well by a three-state model of receptor activation, suggesting that two active receptor states may be sufficient to explain pathway-dependent agonist efficacy.  Rational drug design that optimizes preferential effector activity within a group of receptor-selective drugs holds the promise of increased selectivity in clin. useful agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpidEqbbZNg07Vg90H21EOLACvtfcHk0ljpJgeVlZXltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKqt7w%253D&md5=99239b54cc498d1254aad42298ea5684</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fmol.54.1.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.54.1.94%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DMaayani%26aufirst%3DS.%26aulast%3DGoldfarb%26aufirst%3DJ.%26aulast%3DScaramellini%26aufirst%3DC.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26atitle%3DEffector%2520pathway-dependent%2520relative%2520efficacy%2520at%2520serotonin%2520type%25202A%2520and%25202C%2520receptors%253A%2520evidence%2520for%2520agonist-directed%2520trafficking%2520of%2520receptor%2520stimulus%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D94%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Parrish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1575</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1111%2Fj.1471-4159.2005.03477.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=16277614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=1575-1584&author=J.+Parrishauthor=M.+Bradenauthor=E.+Gundyauthor=D.+E.+Nichols&title=Differential+phospholipase+C+activation+by+phenylalkylamine+serotonin+5-HT2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists</span></div><div class="casAuthors">Parrish, Jason C.; Braden, Michael R.; Gundy, Emily; Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1575-1584</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Expts. compared a series of phenethylamine hallucinogens with their phenylisopropylamine analogs for binding affinity and ability to stimulate serotonin 5-HT2A receptor-mediated hydrolysis of phosphatidyl inositol in cells expressing cloned rat and human 5-HT2A receptors.  The (±) phenylisopropylamine analogs had significantly higher intrinsic activities for 5-HT2A receptor-mediated hydrolysis of phosphatidyl inositol compared to their phenethylamine analogs.  With respect to the effects of the stereochem. of the phenylisopropylamines, those with the (R) abs. configuration at the alpha carbon had higher intrinsic activities for hydrolysis of phosphatidyl inositol in a cell line expressing the human 5-HT2A receptor compared to those with the (S) abs. configuration.  In virtual docking studies comparing the (R)- and (S)-phenylisopropylamines with their phenethylamine analogs, there were distinct differences in the orientations of key ligand binding domain residues that have been identified as important by previous mutagenesis studies.  In conclusion, our data support the hypothesis that phenylisopropylamines have higher hallucinogenic potency than their phenethylamine analogs primarily because they have higher intrinsic activities at 5-HT2A receptors.  Although virtual ligand binding led to significant perturbations of certain key residues, our results emphasize the conclusion reached by others that overall three-dimensional structural microdomains within the receptor must be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3fvZj2WkH7Vg90H21EOLACvtfcHk0ljpJgeVlZXltA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVKisw%253D%253D&md5=fcba4d293061d292c540919af92f956f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03477.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03477.x%26sid%3Dliteratum%253Aachs%26aulast%3DParrish%26aufirst%3DJ.%26aulast%3DBraden%26aufirst%3DM.%26aulast%3DGundy%26aufirst%3DE.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DDifferential%2520phospholipase%2520C%2520activation%2520by%2520phenylalkylamine%2520serotonin%25205-HT2A%2520receptor%2520agonists%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26spage%3D1575%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">9-Dihydroxy-2,3,7,11b-tetrahydro-1<i>H</i>-naph[1,2,3-<i>de</i>]isoquinoline: a potent full dopamine D1 agonist containing a rigid beta-phenyldopamine pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950707%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=549-555&author=D.+Ghoshauthor=S.+E.+Snyderauthor=V.+J.+Wattsauthor=R.+B.+Mailmanauthor=D.+E.+Nichols&title=9-Dihydroxy-2%2C3%2C7%2C11b-tetrahydro-1H-naph%5B1%2C2%2C3-de%5Disoquinoline%3A+a+potent+full+dopamine+D1+agonist+containing+a+rigid+beta-phenyldopamine+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm950707%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950707%252B%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DS.%2BE.%26aulast%3DWatts%26aufirst%3DV.%2BJ.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3D9-Dihydroxy-2%252C3%252C7%252C11b-tetrahydro-1H-naph%255B1%252C2%252C3-de%255Disoquinoline%253A%2520a%2520potent%2520full%2520dopamine%2520D1%2520agonist%2520containing%2520a%2520rigid%2520beta-phenyldopamine%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D549%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kilts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connery, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.301.3.1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=12023553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1179-1189&author=J.+D.+Kiltsauthor=H.+S.+Conneryauthor=E.+G.+Arringtonauthor=M.+M.+Lewisauthor=C.+P.+Lawlerauthor=G.+S.+Oxfordauthor=K.+L.+O%E2%80%99Malleyauthor=R.+D.+Toddauthor=B.+L.+Blakeauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+II.+Actions+of+dihydrexidine+in+D2L+receptor-transfected+MN9D+cells+and+pituitary+lactotrophs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs</span></div><div class="casAuthors">Kilts, Jason D.; Connery, Hilary S.; Arrington, Elaine G.; Lewis, Mechelle M.; Lawler, Cindy P.; Oxford, Gerry S.; O'Malley, Karen L.; Todd, Richard D.; Blake, Bonita L.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1189</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">D2-like dopamine receptors mediate functional changes via activation of inhibitory G proteins, including those that affect adenylate cyclase activity, and potassium and calcium channels.  Although it is assumed that the binding of a drug to a single isoform of a D2-like receptor will cause similar changes in all receptor-mediated functions, it has been demonstrated in brain that the dopamine agonists dihydrexidine (DHX) and N-n-propyl-DHX are "functionally selective".  The current study explores the underlying mechanism using transfected MN9D cells and D2-producing anterior pituitary lactotrophs.  Both dopamine and DHX inhibited adenylate cyclase activity in a concn.-dependent manner in both systems, effects blocked by D2, but not D1, antagonists.  In the MN9D cells, quinpirole and R-(-)-N-propylnorapomorphine (NPA) also inhibited the K+-stimulated release of [3H]dopamine in a concn.-responsive, antagonist-reversible manner.  Conversely, neither DHX, nor its analogs, inhibited K+-stimulated [3H]dopamine release, although they antagonized the effects of quinpirole.  S-(+)-NPA actually had the reverse functional selectivity profile from DHX (i.e., it was a full agonist at D2L receptors coupled to inhibition of dopamine release, but a weak partial agonist at D2L receptor-mediated inhibition of adenylate cyclase).  In lactotrophs, DHX had little intrinsic activity at D2 receptors coupled to G protein-coupled inwardly rectifying potassium channels, and actually antagonized the effects of dopamine at these D2 receptors.  Together, these findings provide compelling evidence for agonist-induced functional selectivity with the D2L receptor.  Although the underlying mol. mechanism is controversial (e.g., "conformational induction" vs. "drug-active state selection"), such data are irreconcilable with the widely held view that drugs have "intrinsic efficacy".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKyo-BPUi-LVg90H21EOLACvtfcHk0ljfpSUO-B4GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D&md5=6686ca6fae277969b216781088d74a87</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1179%26sid%3Dliteratum%253Aachs%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DArrington%26aufirst%3DE.%2BG.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DBlake%26aufirst%3DB.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520II.%2520Actions%2520of%2520dihydrexidine%2520in%2520D2L%2520receptor-transfected%2520MN9D%2520cells%2520and%2520pituitary%2520lactotrophs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1179%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mottola, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connery, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyslop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wightman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.301.3.1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=12023552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1166-1178&author=D.+M.+Mottolaauthor=J.+D.+Kiltsauthor=M.+M.+Lewisauthor=H.+S.+Conneryauthor=Q.+D.+Walkerauthor=S.+R.+Jonesauthor=R.+G.+Boothauthor=D.+K.+Hyslopauthor=M.+Pierceyauthor=R.+M.+Wightmanauthor=C.+P.+Lawlerauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+I.+Selective+activation+of+postsynaptic+dopamine+D2+receptors+linked+to+adenylate+cyclase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span></div><div class="casAuthors">Mottola, David M.; Kilts, Jason D.; Lewis, Mechelle M.; Connory, Hilary S.; Walker, Q. David; Jones, Sara R.; Booth, Raymond G.; Hyslop, Deborah K.; Piercey, Monford; Wightman, R. Mark; Lawler, Cindy P.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1166-1179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydrexidine (DHX), the first high-affinity D1 dopamine receptor full agonist, is only 10-fold selective for D1 vs. D2 receptors, having D2 affinity similar to the prototypical agonist quinpirole.  The D2 functional properties of DHX and its more D2 selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary.  DHX and PrDHX had binding characteristics to D2 receptors in rat striatum typical of D2 agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides.  Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equiv. to that of quinpirole.  Unexpectedly, however, DHX and PrDHX had little functional effect at D2 receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis.  Quant. receptor competition autoradiog. demonstrated that DHX bound to D2 receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D2 sites in the substantia nigra (autoreceptor sites).  The data from these expts., coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D2L and D2S receptors, causes agonist-typical functional changes only at some of these receptors.  This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at sep. functions mediated by a single isoform, yielding novel approaches to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpif5JbU-Rs9bVg90H21EOLACvtfcHk0ljfpSUO-B4GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D&md5=b1d65ec3f66b3652deb9f9a4c76b70a3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1166%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DWalker%26aufirst%3DQ.%2BD.%26aulast%3DJones%26aufirst%3DS.%2BR.%26aulast%3DBooth%26aufirst%3DR.%2BG.%26aulast%3DHyslop%26aufirst%3DD.%2BK.%26aulast%3DPiercey%26aufirst%3DM.%26aulast%3DWightman%26aufirst%3DR.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520I.%2520Selective%2520activation%2520of%2520postsynaptic%2520dopamine%2520D2%2520receptors%2520linked%2520to%2520adenylate%2520cyclase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1166%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirotta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotnikova, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salahpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1523%2FJNEUROSCI.5074-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=17251429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Wrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=881-885&author=J.+M.+Beaulieuauthor=E.+Tirottaauthor=T.+D.+Sotnikovaauthor=B.+Masriauthor=A.+Salahpourauthor=R.+R.+Gainetdinovauthor=E.+Borrelliauthor=M.+G.+Caron&title=Regulation+of+Akt+signaling+by+D2+and+D3+dopamine+receptors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Tirotta, Emanuele; Sotnikova, Tatyana D.; Masri, Bernard; Salahpour, Ali; Gainetdinov, Raul R.; Borrelli, Emiliana; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-885</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The serine/threonine kinase Akt is a downstream target of dopamine receptor signaling that is inhibited/dephosphorylated in response to direct and indirect dopamine receptor agonists.  Although pharmacol. studies uncovered the involvement of D2-class dopamine receptors in Akt regulation, they did not identify the role of individual receptor subtypes in this process.  Here we used knock-out mice lacking the D1, D2, D2 long, or D3 dopamine receptors as well as a D4 receptor-selective antagonist to address the function of each of these receptors in the regulation of Akt in vivo.  Under basal conditions, D2, D2 long, and D3 knock-out mice display enhanced striatal Akt activation, whereas D1 knock-out mice and mice treated with the D4 receptor antagonist L 745870 have phospho-Akt levels comparable with those of normal control animals.  Furthermore, both amphetamine and apomorphine lose their ability to inhibit Akt in D2 knock-out mice but retain their normal effect on this signaling mol. in D1 knock-out animals.  Finally, D3 knock-out mice show a reduced sensitivity of Akt-mediated signaling to dopaminergic drugs but retain the action of these drugs on Akt at high dose regimens.  These results indicate that D2 receptors are essential for the inhibition of Akt by dopamine and that D3 receptors also participate in this signaling potentially by enhancing D2 receptor response.  Identification of the functions of individual dopamine receptor subtypes in Akt regulation may help the development of new pharmaceutical approaches for mental disorders related to abnormal dopamine transmission such as bipolar disorder and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgXxur8ijCxLVg90H21EOLACvtfcHk0ljfpSUO-B4GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Wrtrc%253D&md5=9d1c1f4ad5388e4e68ce70b5fddaddf0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5074-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5074-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DTirotta%26aufirst%3DE.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DSalahpour%26aufirst%3DA.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DBorrelli%26aufirst%3DE.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DRegulation%2520of%2520Akt%2520signaling%2520by%2520D2%2520and%2520D3%2520dopamine%2520receptors%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D881%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotnikova, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2005&pages=261-273&author=J.+M.+Beaulieuauthor=T.+D.+Sotnikovaauthor=S.+Marionauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=An+Akt%2Fbeta-arrestin+2%2FPP2A+signaling+complex+mediates+dopaminergic+neurotransmission+and+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26aulast%3DMarion%26aufirst%3DS.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAn%2520Akt%252Fbeta-arrestin%25202%252FPP2A%2520signaling%2520complex%2520mediates%2520dopaminergic%2520neurotransmission%2520and%2520behavior%26jtitle%3DCell%26date%3D2005%26volume%3D122%26spage%3D261%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chidiac, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiquette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Inverse agonist activity of beta-adrenergic antagonists</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=490-499&author=P.+Chidiacauthor=T.+Hebertauthor=M.+Valiquetteauthor=M.+Dennisauthor=M.+Bouvier&title=Inverse+agonist+activity+of+beta-adrenergic+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChidiac%26aufirst%3DP.%26aulast%3DHebert%26aufirst%3DT.%26aulast%3DValiquette%26aufirst%3DM.%26aulast%3DDennis%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DInverse%2520agonist%2520activity%2520of%2520beta-adrenergic%2520antagonists%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D45%26spage%3D490%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Barker, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span> </span><span class="NLM_article-title">Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">11687</span><span class="NLM_x">–</span> <span class="NLM_lpage">11690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=11687-11690&author=E.+L.+Barkerauthor=R.+S.+Westphalauthor=D.+Schmidtauthor=E.+Sanders-Bush&title=Constitutively+active+5-hydroxytryptamine2C+receptors+reveal+novel+inverse+agonist+activity+of+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DE.%2BL.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DSanders-Bush%26aufirst%3DE.%26atitle%3DConstitutively%2520active%25205-hydroxytryptamine2C%2520receptors%2520reveal%2520novel%2520inverse%2520agonist%2520activity%2520of%2520receptor%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D11687%26epage%3D11690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=11561066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=83-89&author=L.+Rauserauthor=J.+E.+Savageauthor=H.+Y.+Meltzerauthor=B.+L.+Roth&title=Inverse+agonist+actions+of+typical+and+atypical+antipsychotic+drugs+at+the+human+5-hydroxytryptamine%282C%29+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine2C receptor</span></div><div class="casAuthors">Rauser, Laura; Savage, Jason E.; Meltzer, Herbert Y.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-89</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Atypical antipsychotic drugs, which are distinguished from typical antipsychotic drugs by a lower incidence of extra-pyramidal side effects and less propensity to elevate serum prolactin levels (e.g., clozapine, olanzapine, risperidone, quetiapine, ziprasidone), have become the most widely used treatments for schizophrenia, although their precise mechanism of action remains controversial.  It has been suggested that this group of atypical antipsychotic drugs is characterized by preferentially high affinities for 5-hydroxytryptamine (5-HT)2A serotonin receptors and relatively low affinities for D2-dopamine receptors.  It has recently been proposed that these atypical antipsychotic drugs may also be distinguished from typical antipsychotic drugs (e.g., haloperidol, fluphenazine, chlorpromazine, and so on) by inverse agonist actions at the 5-HT2C-INI RNA edited isoform of the human 5-HT2C receptor transiently expressed in COS-7 cells.  We have examd. the relation among 5-HT2C inverse agonist potency, efficacy, and atypical antipsychotic drug status in HEK-293 cells of a large no. of typical and atypical antipsychotic drugs using human embryonic kidney (HEK)-293 cells stably transfected with the h5-HT2C-INI receptor.  Inverse agonist actions at h5-HT2C-INI receptors were measured for both typical and atypical antipsychotic drugs.  Thus, some typical antipsychotic drugs (chlorpromazine, mesoridazine, fluphenazine, and loxapine) were efficient inverse agonists, whereas several clin. effective atypical antipsychotic drugs (remoxipride, quetiapine, sulpiride, melperone, amperozide) were not.  Addnl., several drugs without significant antipsychotic actions (M100907, ketanserin, mianserin, ritanserin, and amitriptyline) were potent inverse agonists at the 5-HT2C-INI isoform expressed in HEK-293 cells.  Taken together, these results demonstrate that both typical and atypical antipsychotic drugs may exhibit inverse agonist effects at the 5-HT2C-INI isoform of the human 5-HT2C receptor and that no relation exists between inverse agonist actions and atypicality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQYyIwLMQ1z7Vg90H21EOLACvtfcHk0liIYyBcbGGhSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltrY%253D&md5=1a4485604f512006fcb46a49ec2c2cf4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DInverse%2520agonist%2520actions%2520of%2520typical%2520and%2520atypical%2520antipsychotic%2520drugs%2520at%2520the%2520human%25205-hydroxytryptamine%25282C%2529%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D83%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gilliland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alper, R. H.</span><span> </span><span class="NLM_article-title">Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays</span> <span class="citation_source-journal">Naunyn Schmiedebergs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2000&pages=498-504&author=S.+L.+Gillilandauthor=R.+H.+Alper&title=Characterization+of+dopaminergic+compounds+at+hD2short%2C+hD4.2+and+hD4.7+receptors+in+agonist-stimulated+%5B35S%5DGTPgammaS+binding+assays"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilliland%26aufirst%3DS.%2BL.%26aulast%3DAlper%26aufirst%3DR.%2BH.%26atitle%3DCharacterization%2520of%2520dopaminergic%2520compounds%2520at%2520hD2short%252C%2520hD4.2%2520and%2520hD4.7%2520receptors%2520in%2520agonist-stimulated%2520%255B35S%255DGTPgammaS%2520binding%2520assays%26jtitle%3DNaunyn%2520Schmiedebergs%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D361%26spage%3D498%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brann, M. R.</span><span> </span><span class="NLM_article-title">Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite <i>N</i>-desmethylclozapine as a D2/D3 partial agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.105.092155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=16135699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlalurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=1278-1287&author=E.+S.+Bursteinauthor=J.+Maauthor=S.+Wongauthor=Y.+Gaoauthor=E.+Phamauthor=A.+E.+Knappauthor=N.+R.+Nashauthor=R.+Olssonauthor=R.+E.+Davisauthor=U.+Hacksellauthor=D.+M.+Weinerauthor=M.+R.+Brann&title=Intrinsic+efficacy+of+antipsychotics+at+human+D2%2C+D3%2C+and+D4+dopamine+receptors%3A+identification+of+the+clozapine+metabolite+N-desmethylclozapine+as+a+D2%2FD3+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist</span></div><div class="casAuthors">Burstein, E. S.; Ma, J.; Wong, S.; Gao, Y.; Pham, E.; Knapp, A. E.; Nash, N. R.; Olsson, R.; Davis, R. E.; Hacksell, U.; Weiner, D. M.; Brann, M. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1278-1287</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Drugs that antagonize D2-like receptors are effective antipsychotics, but the debilitating movement disorder side effects assocd. with these drugs cannot be dissocd. from dopamine receptor blockade.  The "atypical" antipsychotics have a lower propensity to cause extrapyramidal symptoms (EPS), but the mol. basis for this is not fully understood nor is the impact of inverse agonism upon their clin. properties.  Using a cell-based functional assay, we demonstrate that overexpression of Gαo induces constitutive activity in the human D2-like receptors (D2, D3, and D4).  A large collection of typical and atypical antipsychotics was profiled for activity at these receptors.  Virtually all were D2 and D3 inverse agonists, whereas none was D4 inverse agonist, although many were potent D4 antagonists.  The inverse agonist activity of haloperidol at D2 and D3 receptors could be reversed by mesoridazine demonstrating that there were significant differences in the degrees of inverse agonism among the compds. tested.  Aripiprazole and the principle active metabolite of clozapine NDMC [8-chloro-11-(1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine] were identified as partial agonists at D2 and D3 receptors, although clozapine itself was an inverse agonist at these receptors.  NDMC-induced functional responses could be reversed by clozapine.  It is proposed that the low incidence of EPS assocd. with clozapine and aripiprazole used may be due, in part, to these partial agonist properties of NDMC and aripiprazole and that bypassing clozapine blockade through direct administration of NDMC to patients may provide superior antipsychotic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJpq7vgFnG8rVg90H21EOLACvtfcHk0liIYyBcbGGhSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlalurnL&md5=327fe47435bf8fa5215af0d2af4b3b40</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092155%26sid%3Dliteratum%253Aachs%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DPham%26aufirst%3DE.%26aulast%3DKnapp%26aufirst%3DA.%2BE.%26aulast%3DNash%26aufirst%3DN.%2BR.%26aulast%3DOlsson%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26atitle%3DIntrinsic%2520efficacy%2520of%2520antipsychotics%2520at%2520human%2520D2%252C%2520D3%252C%2520and%2520D4%2520dopamine%2520receptors%253A%2520identification%2520of%2520the%2520clozapine%2520metabolite%2520N-desmethylclozapine%2520as%2520a%2520D2%252FD3%2520partial%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D1278%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Peroutka, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=1980&pages=88-90&author=S.+J.+Peroutkaauthor=S.+H.+Snyder&title=Long-term+antidepressant+treatment+decreases+spiroperidol-labeled+serotonin+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeroutka%26aufirst%3DS.%2BJ.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DLong-term%2520antidepressant%2520treatment%2520decreases%2520spiroperidol-labeled%2520serotonin%2520receptor%2520binding%26jtitle%3DScience%26date%3D1980%26volume%3D210%26spage%3D88%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Berry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span> </span><span class="NLM_article-title">Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=306-313&author=S.+Berryauthor=M.+Shahauthor=N.+Khanauthor=B.+Roth&title=Rapid+agonist-induced+internalization+of+the+5-hydroxytryptamine2A+receptor+occurs+via+the+endosome+pathway+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%26atitle%3DRapid%2520agonist-induced%2520internalization%2520of%2520the%25205-hydroxytryptamine2A%2520receptor%2520occurs%2520via%2520the%2520endosome%2520pathway%2520in%2520vitro%26jtitle%3DMol.%2520Pharmacol.%26date%3D1996%26volume%3D50%26spage%3D306%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Willins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsayegh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backstrom, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">861</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=861&publication_year=1998&pages=121-127&author=D.+L.+Willinsauthor=L.+Alsayeghauthor=S.+A.+Berryauthor=J.+R.+Backstromauthor=E.+Sanders-Bushauthor=L.+Friedmanauthor=N.+Khanauthor=B.+L.+Roth&title=Serotonergic+antagonist+effects+on+trafficking+of+serotonin+5-HT2A+receptors+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillins%26aufirst%3DD.%2BL.%26aulast%3DAlsayegh%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DS.%2BA.%26aulast%3DBackstrom%26aufirst%3DJ.%2BR.%26aulast%3DSanders-Bush%26aufirst%3DE.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DSerotonergic%2520antagonist%2520effects%2520on%2520trafficking%2520of%2520serotonin%25205-HT2A%2520receptors%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1998%26volume%3D861%26spage%3D121%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Willins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsayegh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span> </span><span class="NLM_article-title">Clozapine and other 5-hydroxytryptamine2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine2A receptors in vitro and in vivo</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=599-606&author=D.+Willinsauthor=S.+Berryauthor=L.+Alsayeghauthor=J.+Backstromauthor=E.+Sanders-Bushauthor=B.+Roth&title=Clozapine+and+other+5-hydroxytryptamine2A+receptor+antagonists+alter+the+subcellular+distribution+of+5-hydroxytryptamine2A+receptors+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillins%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DS.%26aulast%3DAlsayegh%26aufirst%3DL.%26aulast%3DBackstrom%26aufirst%3DJ.%26aulast%3DSanders-Bush%26aufirst%3DE.%26aulast%3DRoth%26aufirst%3DB.%26atitle%3DClozapine%2520and%2520other%25205-hydroxytryptamine2A%2520receptor%2520antagonists%2520alter%2520the%2520subcellular%2520distribution%2520of%25205-hydroxytryptamine2A%2520receptors%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DNeuroscience%26date%3D1999%26volume%3D91%26spage%3D599%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zastrow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity and classical concepts of quantitative pharmacology</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.106.104463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=16803859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1-13&author=J.+D.+Urbanauthor=W.+P.+Clarkeauthor=M.+von+Zastrowauthor=D.+E.+Nicholsauthor=B.+Kobilkaauthor=H.+Weinsteinauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=A.+Christopoulosauthor=P.+M.+Sextonauthor=K.+J.+Millerauthor=M.+Speddingauthor=R.+B.+Mailman&title=Functional+selectivity+and+classical+concepts+of+quantitative+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and classical concepts of quantitative pharmacology</span></div><div class="casAuthors">Urban, Jonathan D.; Clarke, William P.; von Zastrow, Mark; Nichols, David E.; Kobilka, Brian; Weinstein, Harel; Javitch, Jonathan A.; Roth, Bryan L.; Christopoulos, Arthur; Sexton, Patrick M.; Miller, Keith J.; Spedding, Michael; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The concept of intrinsic efficacy has been enshrined in pharmacol. for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy.  Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism.  At the extreme, functionally selective ligands may be both agonists and antagonists at different functions mediated by the same receptor.  Data illustrating this phenomenon are presented from serotonin, opioid, dopamine, vasopressin, and adrenergic receptor systems.  A variety of mechanisms may influence this apparently ubiquitous phenomenon.  It may be initiated by differences in ligand-induced intermediate conformational states, as shown for the β2-adrenergic receptor.  Subsequent mechanisms that may play a role include diversity of G proteins, scaffolding and signaling partners, and receptor oligomers.  Clearly, expanded research is needed to elucidate the proximal (e.g., how functionally selective ligands cause conformational changes that initiate differential signaling), intermediate (mechanisms that translate conformation changes into differential signaling), and distal mechanisms (differential effects on target tissue or organism).  Besides the heuristically interesting nature of functional selectivity, there is a clear impact on drug discovery, because this mechanism raises the possibility of selecting or designing novel ligands that differentially activate only a subset of functions of a single receptor, thereby optimizing therapeutic action.  It also may be timely to revise classic concepts in quant. pharmacol. and relevant pharmacol. conventions to incorporate these new concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5GzdtvWZRkbVg90H21EOLACvtfcHk0liHrj8-lZXQVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D&md5=54465473b5996d0755baeee89eeb0ba9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.104463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.104463%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DKobilka%26aufirst%3DB.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520and%2520classical%2520concepts%2520of%2520quantitative%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">GPCR functional selectivity has therapeutic impact</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=390-396&author=R.+B.+Mailman&title=GPCR+functional+selectivity+has+therapeutic+impact"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DGPCR%2520functional%2520selectivity%2520has%2520therapeutic%2520impact%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D390%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Luttrell, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maudsley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">Beta-arrestin-dependent formation of beta2 adrenergic receptor–Src protein kinase complexes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1999&pages=655-661&author=L.+M.+Luttrellauthor=S.+S.+Fergusonauthor=Y.+Daakaauthor=W.+E.+Millerauthor=S.+Maudsleyauthor=G.+J.+Della+Roccaauthor=F.+Linauthor=H.+Kawakatsuauthor=K.+Owadaauthor=D.+K.+Luttrellauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=Beta-arrestin-dependent+formation+of+beta2+adrenergic+receptor%E2%80%93Src+protein+kinase+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%26aulast%3DDaaka%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DMaudsley%26aufirst%3DS.%26aulast%3DDella%2BRocca%26aufirst%3DG.%2BJ.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DKawakatsu%26aufirst%3DH.%26aulast%3DOwada%26aufirst%3DK.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin-dependent%2520formation%2520of%2520beta2%2520adrenergic%2520receptor%25E2%2580%2593Src%2520protein%2520kinase%2520complexes%26jtitle%3DScience%26date%3D1999%26volume%3D283%26spage%3D655%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenoy, S. K.</span><span> </span><span class="NLM_article-title">Transduction of receptor signals by beta-arrestins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2005&pages=512-517&author=R.+J.+Lefkowitzauthor=S.+K.+Shenoy&title=Transduction+of+receptor+signals+by+beta-arrestins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DShenoy%26aufirst%3DS.%2BK.%26atitle%3DTransduction%2520of%2520receptor%2520signals%2520by%2520beta-arrestins%26jtitle%3DScience%26date%3D2005%26volume%3D308%26spage%3D512%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Abbas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Arresting serotonin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=831-832&author=A.+Abbasauthor=B.+L.+Roth&title=Arresting+serotonin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbas%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DArresting%2520serotonin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D2008%26volume%3D105%26spage%3D831%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zastrow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Violin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">[beta]-Arrestin-biased ligands at seven-transmembrane receptors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=416-422&author=J.+D.+Violinauthor=R.+J.+Lefkowitz&title=%5Bbeta%5D-Arrestin-biased+ligands+at+seven-transmembrane+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3D%255Bbeta%255D-Arrestin-biased%2520ligands%2520at%2520seven-transmembrane%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D416%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gesty-Palmer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flannery, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, L. M.</span><span> </span><span class="NLM_article-title">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1ra1</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1126%2Fscitranslmed.3000071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=20368153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1ra1&author=D.+Gesty-Palmerauthor=P.+Flanneryauthor=L.+Yuanauthor=L.+Corsinoauthor=R.+Spurneyauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=A+beta-arrestin-biased+agonist+of+the+parathyroid+hormone+receptor+%28PTH1R%29+promotes+bone+formation+independent+of+G+protein+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span></div><div class="casAuthors">Gesty-Palmer Diane; Flannery Pat; Yuan Ling; Corsino Leonor; Spurney Robert; Lefkowitz Robert J; Luttrell Louis M</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1ra1</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">About 40% of the therapeutic agents in use today exert their effects through seven-transmembrane receptors (7TMRs).  When activated by ligands, these receptors trigger two pathways that independently transduce signals to the cell: one through heterotrimeric GTP-binding proteins (G proteins) and one through beta-arrestins; so-called biased agonists can selectively activate these distinct pathways.  Here, we investigate selective activation of these pathways through the use of a biased agonist for the type 1 parathyroid hormone (PTH)-PTH-related protein receptor (PTH1R), (D-Trp(12),Tyr(34))-PTH(7-34) (PTH-betaarr), which activates beta-arrestin but not classic G protein signaling.  In mice, PTH-betaarr induces anabolic bone formation, as does the nonselective agonist PTH(1-34), which activates both mechanisms.  In beta-arrestin2-null mice, the increase in bone mineral density evoked by PTH(1-34) is attenuated and that stimulated by PTH-betaarr is ablated.  The beta-arrestin2-dependent pathway contributes primarily to trabecular bone formation and does not stimulate bone resorption.  These results show that a biased agonist selective for the beta-arrestin pathway can elicit a response in vivo distinct from that elicited by nonselective agonists.  Ligands with these properties may form the basis for improved 7TMR-directed pharmacologic agents with enhanced therapeutic specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmuM4aCIxthdXdcedVHT5tfW6udTcc2eZ_N_8_7pH2Prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D&md5=748e4367ded72b6b7e10fd759521ba62</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000071%26sid%3Dliteratum%253Aachs%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DFlannery%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DSpurney%26aufirst%3DR.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DA%2520beta-arrestin-biased%2520agonist%2520of%2520the%2520parathyroid%2520hormone%2520receptor%2520%2528PTH1R%2529%2520promotes%2520bone%2520formation%2520independent%2520of%2520G%2520protein%2520activation%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2009%26volume%3D1%26spage%3D1ra1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceres, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coccone, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandager-Nielsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheel-Kruger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span> </span><span class="NLM_article-title">Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800689g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=151-169&author=S.+Butiniauthor=S.+Gemmaauthor=G.+Campianiauthor=S.+Franceschiniauthor=F.+Trottaauthor=M.+Borrielloauthor=N.+Ceresauthor=S.+Rosauthor=S.+S.+Cocconeauthor=M.+Bernettiauthor=M.+De+Angelisauthor=M.+Brindisiauthor=V.+Nacciauthor=I.+Fioriniauthor=E.+Novellinoauthor=A.+Cagnottoauthor=T.+Menniniauthor=K.+Sandager-Nielsenauthor=J.+T.+Andreasenauthor=J.+Scheel-Krugerauthor=J.+D.+Mikkelsenauthor=C.+Fattorusso&title=Discovery+of+a+new+class+of+potential+multifunctional+atypical+antipsychotic+agents+targeting+dopamine+D3+and+serotonin+5-HT1A+and+5-HT2A+receptors%3A+design%2C+synthesis%2C+and+effects+on+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm800689g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800689g%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DCeres%26aufirst%3DN.%26aulast%3DRos%26aufirst%3DS.%26aulast%3DCoccone%26aufirst%3DS.%2BS.%26aulast%3DBernetti%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DNacci%26aufirst%3DV.%26aulast%3DFiorini%26aufirst%3DI.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DAndreasen%26aufirst%3DJ.%2BT.%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DFattorusso%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520potential%2520multifunctional%2520atypical%2520antipsychotic%2520agents%2520targeting%2520dopamine%2520D3%2520and%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%253A%2520design%252C%2520synthesis%252C%2520and%2520effects%2520on%2520behavior%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D151%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of Beta-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18488</span><span class="NLM_x">–</span> <span class="NLM_lpage">18493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=22025698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.-P.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+Beta-Arrestin-Biased+Dopamine+D2+Ligands+for+Probing+Signal+Transduction+Pathways+Essential+for+Antipsychotic+Efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span></div><div class="casAuthors">Allen, John A.; Yost, Julianne M.; Setola, Vincent; Chen, Xin; Sassano, Maria F.; Chen, Meng; Peterson, Sean; Yadav, Prem N.; Huang, Xi-Ping; Feng, Bo; Jensen, Niels H.; Che, Xin; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Caron, Marc G.; Javitch, Jonathan A.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18488-18493, S18488/1-S18488/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elucidating the key signal transduction pathways essential for both antipsychotic efficacy and side-effect profiles is essential for developing safer and more effective therapies.  Recent work has highlighted noncanonical modes of dopamine D2 receptor (D2R) signaling via β-arrestins as being important for the therapeutic actions of both antipsychotic and antimanic agents.  We thus sought to create unique D2R agonists that display signaling bias via β-arrestinergic signaling.  Through a robust diversity-oriented modification of the scaffold represented by aripiprazole (1), we discovered UNC9975 (2), UNC0006 (3); and UNC9994 (4) as unprecedented β-arrestin-biased D2R ligands.  These compds. also represent unprecedented β-arrestin-biased ligands for a Gi-coupled G protein-coupled receptor (GPCR).  Significantly, UNC9975, UNC0006, and UNC9994 are simultaneously antagonists of Gi-regulated cAMP prodn. and partial agonists for D2R/β-arrestin-2 interactions.  Importantly, VNC9975 displayed potent antipsychotic-like activity without inducing motoric side effects in inbred C57BL/6 mice in vivo.  Genetic deletion of β-arrestin-2 simultaneously attenuated the antipsychotic actions of UNC9975 and transformed it into a typical antipsychotic .drug with a high propensity to induce catalepsy.  Similarly, the antipsychotic-like activity displayed by UNC9994, an extremely β-arrestin-biased D2R agonist, in wild-type mice was completely abolished in β-arrestin-2 knockout mice.  Taken together, our results suggest that β-arrestin signaling and recruitment can be simultaneously a significant contributor to antipsychotic efficacy and protective against motoric side effects.  These functionally selective, β-arrestin-biased D2R ligands represent valuable chem. probes for further investigations of D2R signaling in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87mjP6jm447Vg90H21EOLACvtfcHk0lhGaAkXEMMpzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK&md5=d5b06e4ac4d2cc4cd04fd1de760ec628</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Beta-Arrestin-Biased%2520Dopamine%2520D2%2520Ligands%2520for%2520Probing%2520Signal%2520Transduction%2520Pathways%2520Essential%2520for%2520Antipsychotic%2520Efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prioleau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=612-627&author=C.+P.+Lawlerauthor=C.+Prioleauauthor=M.+M.+Lewisauthor=C.+Makauthor=D.+Jiangauthor=J.+A.+Schetzauthor=A.+M.+Gonzalezauthor=D.+R.+Sibleyauthor=R.+B.+Mailman&title=Interactions+of+the+novel+antipsychotic+aripiprazole+%28OPC-14597%29+with+dopamine+and+serotonin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DPrioleau%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DInteractions%2520of%2520the%2520novel%2520antipsychotic%2520aripiprazole%2520%2528OPC-14597%2529%2520with%2520dopamine%2520and%2520serotonin%2520receptor%2520subtypes%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D612%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Mailman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, V.</span><span> </span><span class="NLM_article-title">Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.2174%2F138161210790361461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=19909227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=488-501&author=R.+B.+Mailmanauthor=V.+Murthy&title=Third+generation+antipsychotic+drugs%3A+partial+agonism+or+receptor+functional+selectivity%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?</span></div><div class="casAuthors">Mailman, Richard B.; Murthy, Vishakantha</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">488-501</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Functional selectivity is the term that describes drugs that cause markedly different signaling through a single receptor (e.g., full agonist at one pathway and antagonist at a second).  It has been widely recognized recently that this phenomenon impacts the understanding of mechanism of action of some drugs, and has relevance to drug discovery.  One of the clin. areas where this mechanism has particular importance is in the treatment of schizophrenia.  Antipsychotic drugs have been grouped according to both pattern of clin. action and mechanism of action.  The original antipsychotic drugs such as chlorpromazine and haloperidol have been called typical or first generation.  They cause both antipsychotic actions and many side effects (extrapyramidal and endocrine) that are ascribed to their high affinity dopamine D2 receptor antagonism.  Drugs such as clozapine, olanzapine, risperidone and others were then developed that avoided the neurol. side effects (atypical or second generation antipsychotics).  These compds. are divided mechanistically into those that are high affinity D2 and 5-HT2A antagonists, and those that also bind with modest affinity to D2, 5-HT2A, and many other neuroreceptors.  There is one approved third generation drug, aripiprazole, whose actions have been ascribed alternately to either D2 partial agonism or D2 functional selectivity.  Although partial agonism has been the more widely accepted mechanism, the available data are inconsistent with this mechanism.  Conversely, the D2 functional selectivity hypothesis can accommodate all current data for aripiprazole, and also impacts on discovery compds. that are not pure D2 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxvYyphplbTrVg90H21EOLACvtfcHk0lhGaAkXEMMpzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbs%253D&md5=4f8bc018c55ee124e6d14016e90ddd6b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F138161210790361461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210790361461%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26aulast%3DMurthy%26aufirst%3DV.%26atitle%3DThird%2520generation%2520antipsychotic%2520drugs%253A%2520partial%2520agonism%2520or%2520receptor%2520functional%2520selectivity%253F%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D488%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mallikaarjun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramer, S. L.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1177%2F0091270003261901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=14747427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVGjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=179-187&author=S.+Mallikaarjunauthor=D.+E.+Salazarauthor=S.+L.+Bramer&title=Pharmacokinetics%2C+Tolerability%2C+and+Safety+of+Aripiprazole+following+Multiple+Oral+Dosing+in+Normal+Healthy+Volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers</span></div><div class="casAuthors">Mallikaarjun, Suresh; Salazar, Daniel E.; Bramer, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-187</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Two 14-day, placebo-controlled, double-blind studies evaluated the fasting pharmacokinetics, safety, and tolerability of aripiprazole, a new antipsychotic, in healthy male subjects.  In Study 1, 37 subjects were randomized to aripiprazole 5 mg, 10 mg, 15 mg, 20 mg, or placebo once daily.  In Study 2, 11 subjects were randomized to aripiprazole, titrated from 10 to 30 mg/day, or placebo.  Aripiprazole had linear pharmacokinetics over 5 to 30 mg/day, which were described by a two-compartment open model, with first-order absorption.  In Study 1, mean elimination half-life ranged from 47 to 68 h with aripiprazole, with apparent systemic clearance (CL/F) of approx. 3.45 L/h.  In Study 2, mean elimination half-life was 59 h (CL/F approx. 4.0 L/h).  Adverse events were generally mild to moderate, were transient in nature, and commonly occurred within the first 3 days of dosing.  Clin. lab. assessments, ECG, EEG, and prolactin levels showed no clin. significant changes during the studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRPBp42oMwLVg90H21EOLACvtfcHk0ljTC6Jl1uoIBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVGjtLc%253D&md5=df137c043fd2424748985b88a01543e6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1177%2F0091270003261901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270003261901%26sid%3Dliteratum%253Aachs%26aulast%3DMallikaarjun%26aufirst%3DS.%26aulast%3DSalazar%26aufirst%3DD.%2BE.%26aulast%3DBramer%26aufirst%3DS.%2BL.%26atitle%3DPharmacokinetics%252C%2520Tolerability%252C%2520and%2520Safety%2520of%2520Aripiprazole%2520following%2520Multiple%2520Oral%2520Dosing%2520in%2520Normal%2520Healthy%2520Volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D44%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favor, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akunne, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whetzel, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serpa, K. A.</span><span> </span><span class="NLM_article-title">Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2621</span><span class="NLM_x">–</span> <span class="NLM_lpage">2625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2621-2625&author=D.+S.+Johnsonauthor=C.+Choiauthor=L.+K.+Fayauthor=D.+A.+Favorauthor=J.+T.+Repineauthor=A.+D.+Whiteauthor=H.+C.+Akunneauthor=L.+Fitzgeraldauthor=K.+Nichollsauthor=B.+J.+Snyderauthor=S.+Z.+Whetzelauthor=L.+Zhangauthor=K.+A.+Serpa&title=Discovery+of+PF-00217830%3A+Aryl+piperazine+napthyridinones+as+D2+partial+agonists+for+schizophrenia+and+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DFavor%26aufirst%3DD.%2BA.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DWhite%26aufirst%3DA.%2BD.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DNicholls%26aufirst%3DK.%26aulast%3DSnyder%26aufirst%3DB.%2BJ.%26aulast%3DWhetzel%26aufirst%3DS.%2BZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSerpa%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520PF-00217830%253A%2520Aryl%2520piperazine%2520napthyridinones%2520as%2520D2%2520partial%2520agonists%2520for%2520schizophrenia%2520and%2520bipolar%2520disorder%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2621%26epage%3D2625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Oshiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uwahodo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, T.</span><span> </span><span class="NLM_article-title">Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1<i>H</i>)-quinolinone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm940608g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=658-667&author=Y.+Oshiroauthor=S.+Satoauthor=N.+Kurahashiauthor=T.+Tanakaauthor=T.+Kikuchiauthor=K.+Tottoriauthor=Y.+Uwahodoauthor=T.+Nishi&title=Novel+antipsychotic+agents+with+dopamine+autoreceptor+agonist+properties%3A+synthesis+and+pharmacology+of+7-%5B4-%284-phenyl-1-piperazinyl%29butoxy%5D-3%2C4-dihydro-2%281H%29-quinolinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm940608g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm940608g%26sid%3Dliteratum%253Aachs%26aulast%3DOshiro%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DKurahashi%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DTottori%26aufirst%3DK.%26aulast%3DUwahodo%26aufirst%3DY.%26aulast%3DNishi%26aufirst%3DT.%26atitle%3DNovel%2520antipsychotic%2520agents%2520with%2520dopamine%2520autoreceptor%2520agonist%2520properties%253A%2520synthesis%2520and%2520pharmacology%2520of%25207-%255B4-%25284-phenyl-1-piperazinyl%2529butoxy%255D-3%252C4-dihydro-2%25281H%2529-quinolinone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of selective dopamine D(2) receptor ligands using aripiprazole as the lead compound</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3502</span><span class="NLM_x">–</span> <span class="NLM_lpage">3511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3502-3511&author=S.+Vangveravongauthor=Z.+Zhangauthor=M.+Taylorauthor=M.+Beardenauthor=J.+Xuauthor=J.+Cuiauthor=W.+Wangauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+characterization+of+selective+dopamine+D%282%29+receptor+ligands+using+aripiprazole+as+the+lead+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DBearden%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520selective%2520dopamine%2520D%25282%2529%2520receptor%2520ligands%2520using%2520aripiprazole%2520as%2520the%2520lead%2520compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3502%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Martin, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elgin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiasen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesslick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldy, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shank, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. K.</span><span> </span><span class="NLM_article-title">Activity of Aromatic Substituted Phenylpiperazines Lacking Affinity for Dopamine Binding Sites in a Preclinical Test of Antipsychotic Efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00125a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1052-1056&author=G.+E.+Martinauthor=R.+J.+Elginauthor=J.+R.+Mathiasenauthor=C.+B.+Davisauthor=J.+M.+Kesslickauthor=W.+J.+Baldyauthor=R.+P.+Shankauthor=D.+L.+Distefanoauthor=C.+L.+Feddeauthor=M.+K.+Scott&title=Activity+of+Aromatic+Substituted+Phenylpiperazines+Lacking+Affinity+for+Dopamine+Binding+Sites+in+a+Preclinical+Test+of+Antipsychotic+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm00125a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00125a020%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DG.%2BE.%26aulast%3DElgin%26aufirst%3DR.%2BJ.%26aulast%3DMathiasen%26aufirst%3DJ.%2BR.%26aulast%3DDavis%26aufirst%3DC.%2BB.%26aulast%3DKesslick%26aufirst%3DJ.%2BM.%26aulast%3DBaldy%26aufirst%3DW.%2BJ.%26aulast%3DShank%26aufirst%3DR.%2BP.%26aulast%3DDistefano%26aufirst%3DD.%2BL.%26aulast%3DFedde%26aufirst%3DC.%2BL.%26aulast%3DScott%26aufirst%3DM.%2BK.%26atitle%3DActivity%2520of%2520Aromatic%2520Substituted%2520Phenylpiperazines%2520Lacking%2520Affinity%2520for%2520Dopamine%2520Binding%2520Sites%2520in%2520a%2520Preclinical%2520Test%2520of%2520Antipsychotic%2520Efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1052%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Elworthy, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A. P. D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgans, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozer, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repke, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talamas, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arredondo, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blue, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSousa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kava, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimont, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. E.</span><span> </span><span class="NLM_article-title"><i>N</i>-Arylpiperazinyl-<i>N</i>′-propylamino derivatives of heteroaryl amides as functional uroselective alpha(1)-adrenoceptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2687</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970166j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2674-2687&author=T.+R.+Elworthyauthor=A.+P.+D.+W.+Fordauthor=G.+W.+Bantleauthor=D.+J.+Morgansauthor=R.+S.+Ozerauthor=W.+S.+Palmerauthor=D.+B.+Repkeauthor=M.+Romeroauthor=L.+Sandovalauthor=E.+B.+Sjogrenauthor=F.+X.+Talamasauthor=A.+Vazquezauthor=H.+Wuauthor=N.+F.+Arredondoauthor=D.+R.+Blueauthor=A.+DeSousaauthor=L.+M.+Grossauthor=M.+S.+Kavaauthor=J.+D.+Lesnickauthor=R.+L.+Vimontauthor=T.+J.+Williamsauthor=Q.+M.+Zhuauthor=J.+R.+Pfisterauthor=D.+E.+Clarke&title=N-Arylpiperazinyl-N%E2%80%B2-propylamino+derivatives+of+heteroaryl+amides+as+functional+uroselective+alpha%281%29-adrenoceptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm970166j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970166j%26sid%3Dliteratum%253Aachs%26aulast%3DElworthy%26aufirst%3DT.%2BR.%26aulast%3DFord%26aufirst%3DA.%2BP.%2BD.%2BW.%26aulast%3DBantle%26aufirst%3DG.%2BW.%26aulast%3DMorgans%26aufirst%3DD.%2BJ.%26aulast%3DOzer%26aufirst%3DR.%2BS.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DRepke%26aufirst%3DD.%2BB.%26aulast%3DRomero%26aufirst%3DM.%26aulast%3DSandoval%26aufirst%3DL.%26aulast%3DSjogren%26aufirst%3DE.%2BB.%26aulast%3DTalamas%26aufirst%3DF.%2BX.%26aulast%3DVazquez%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DArredondo%26aufirst%3DN.%2BF.%26aulast%3DBlue%26aufirst%3DD.%2BR.%26aulast%3DDeSousa%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DL.%2BM.%26aulast%3DKava%26aufirst%3DM.%2BS.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DVimont%26aufirst%3DR.%2BL.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DZhu%26aufirst%3DQ.%2BM.%26aulast%3DPfister%26aufirst%3DJ.%2BR.%26aulast%3DClarke%26aufirst%3DD.%2BE.%26atitle%3DN-Arylpiperazinyl-N%25E2%2580%25B2-propylamino%2520derivatives%2520of%2520heteroaryl%2520amides%2520as%2520functional%2520uroselective%2520alpha%25281%2529-adrenoceptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2674%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fu, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span> </span><span class="NLM_article-title">Design, synthesis and vasorelaxant activity of <i>R</i>,<i>S</i>-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives</span> <span class="citation_source-journal">Yaoxue Xuebao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1eisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=735-740&author=X.+T.+Fuauthor=+Leiauthor=M.+Yuanauthor=J.+Shi&title=Design%2C+synthesis+and+vasorelaxant+activity+of+R%2CS-1-%28substituted+phenyl%29-4-%5B3-%28naphtha-1-yl-oxy%29-2-hydroxypropyl%5D-piperazine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives</span></div><div class="casAuthors">Fu, Xiaozhong; Tang, Lei; Yuan, Mu; Shi, Jingshan</div><div class="citationInfo"><span class="NLM_cas:title">Yaoxue Xuebao</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">735-740</span>CODEN:
                <span class="NLM_cas:coden">YHHPAL</span>;
        ISSN:<span class="NLM_cas:issn">0513-4870</span>.
    
            (<span class="NLM_cas:orgname">Yaoxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">According to the results of activity-structure relationship (SAR) studies of α1-adrenoceptor antagonists hydantoin-phenylpiperazine and benzimidazo-arypiperazine derivs., to design and synthesize a series of novel phenylpiperazine α1-adrenoceptor antagonists with more potent vasorelaxant activity, active metabolites of naftopidil were used as lead compds.  Ten novel R, S-1-substituted phenyl-4-[3-(naphthal-yl-oxy)-2-hydroxy propyl]-piperazine were designed and synthesized.  Their vasorelaxant activity was evaluated by calcg. inhibition rate of phenylephrine-induced vasocontraction of rabbit artery trips.  Five compds. exhibited vasorelaxant activity, and the o,p-di-OCH3 deriv. showed significant vasorelaxant activity in vitro.  At 0.01 and 1 μmol/L-1, its inhibition rates were 7.03% and 22.72%, resp.  This compd. possessed ideal vasorelaxant activity in vitro, and would be selected for further anti-hypertension evaluation in vivo.  Moreover, by analyzing the primary activity and structure relationship of these compds., it could be concluded that the SAR results of the reported phenylpiperazine α1-adrenoceptor antagonists could be used for ref. in designing novel derivs. of naftopidil with optimal pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQpBsu4X787Vg90H21EOLACvtfcHk0lhBOV41sHg0AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1eisQ%253D%253D&md5=d9d083e05933ae578ccb429d417db197</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%2BT.%26aulast%3DLei%26aulast%3DYuan%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520vasorelaxant%2520activity%2520of%2520R%252CS-1-%2528substituted%2520phenyl%2529-4-%255B3-%2528naphtha-1-yl-oxy%2529-2-hydroxypropyl%255D-piperazine%2520derivatives%26jtitle%3DYaoxue%2520Xuebao%26date%3D2007%26volume%3D42%26spage%3D735%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tsuruta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grewe, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskay, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebabian, J. W.</span><span> </span><span class="NLM_article-title">Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=1981&pages=463-465&author=K.+Tsurutaauthor=E.+A.+Freyauthor=C.+W.+Greweauthor=T.+E.+Coteauthor=R.+L.+Eskayauthor=J.+W.+Kebabian&title=Evidence+that+LY-141865+specifically+stimulates+the+D-2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuruta%26aufirst%3DK.%26aulast%3DFrey%26aufirst%3DE.%2BA.%26aulast%3DGrewe%26aufirst%3DC.%2BW.%26aulast%3DCote%26aufirst%3DT.%2BE.%26aulast%3DEskay%26aufirst%3DR.%2BL.%26aulast%3DKebabian%26aufirst%3DJ.%2BW.%26atitle%3DEvidence%2520that%2520LY-141865%2520specifically%2520stimulates%2520the%2520D-2%2520dopamine%2520receptor%26jtitle%3DNature%26date%3D1981%26volume%3D292%26spage%3D463%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Banno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span> </span><span class="NLM_article-title">Studies on 2(1<i>H</i>)-quinolinone derivatives as neuroleptic agents I. Synthesis and biological activities of (4-phenyl-1-piperazinyl)-propoxy-2(1<i>H</i>)-quinolinone derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1988&pages=4377-4388&author=K.+Bannoauthor=T.+Fujiokaauthor=T.+Kikuchiauthor=Y.+Oshiroauthor=T.+Hiyamaauthor=K.+Nakagawa&title=Studies+on+2%281H%29-quinolinone+derivatives+as+neuroleptic+agents+I.+Synthesis+and+biological+activities+of+%284-phenyl-1-piperazinyl%29-propoxy-2%281H%29-quinolinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanno%26aufirst%3DK.%26aulast%3DFujioka%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DOshiro%26aufirst%3DY.%26aulast%3DHiyama%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DK.%26atitle%3DStudies%2520on%25202%25281H%2529-quinolinone%2520derivatives%2520as%2520neuroleptic%2520agents%2520I.%2520Synthesis%2520and%2520biological%2520activities%2520of%2520%25284-phenyl-1-piperazinyl%2529-propoxy-2%25281H%2529-quinolinone%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1988%26volume%3D36%26spage%3D4377%26epage%3D4388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemethy, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugovics, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazekas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orosz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agai-Csongor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist–partial agonist antipsychotic candidate: in vitro and neurochemical profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horvathauthor=Z.+Nemethyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyertyanauthor=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+dopamine+D%283%29+receptor-preferring%2C+D%283%29%2FD%282%29+dopamine+receptor+antagonist%E2%80%93partial+agonist+antipsychotic+candidate%3A+in+vitro+and+neurochemical+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0lh-2IJ5elSp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DNemethy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520dopamine%2520D%25283%2529%2520receptor-preferring%252C%2520D%25283%2529%252FD%25282%2529%2520dopamine%2520receptor%2520antagonist%25E2%2580%2593partial%2520agonist%2520antipsychotic%2520candidate%253A%2520in%2520vitro%2520and%2520neurochemical%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">van Wijngaarden, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heyden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulp, M. T.</span><span> </span><span class="NLM_article-title">2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1934</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00118a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1934-1940&author=I.+van+Wijngaardenauthor=C.+G.+Kruseauthor=J.+A.+van+der+Heydenauthor=M.+T.+Tulp&title=2-Phenylpyrroles+as+conformationally+restricted+benzamide+analogues.+A+new+class+of+potential+antipsychotics.+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00118a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00118a011%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWijngaarden%26aufirst%3DI.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3Dvan%2Bder%2BHeyden%26aufirst%3DJ.%2BA.%26aulast%3DTulp%26aufirst%3DM.%2BT.%26atitle%3D2-Phenylpyrroles%2520as%2520conformationally%2520restricted%2520benzamide%2520analogues.%2520A%2520new%2520class%2520of%2520potential%2520antipsychotics.%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1934%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">van Wijngaarden, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heyden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulp, M. T.</span><span> </span><span class="NLM_article-title">2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2099</span><span class="NLM_x">–</span> <span class="NLM_lpage">2104</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00394a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=2099-2104&author=I.+van+Wijngaardenauthor=C.+G.+Kruseauthor=R.+van+Hesauthor=J.+A.+van+der+Heydenauthor=M.+T.+Tulp&title=2-Phenylpyrroles+as+conformationally+restricted+benzamide+analogues.+A+new+class+of+potential+antipsychotics.+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00394a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00394a028%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWijngaarden%26aufirst%3DI.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3Dvan%2BHes%26aufirst%3DR.%26aulast%3Dvan%2Bder%2BHeyden%26aufirst%3DJ.%2BA.%26aulast%3DTulp%26aufirst%3DM.%2BT.%26atitle%3D2-Phenylpyrroles%2520as%2520conformationally%2520restricted%2520benzamide%2520analogues.%2520A%2520new%2520class%2520of%2520potential%2520antipsychotics.%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D2099%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peppel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. T.</span><span> </span><span class="NLM_article-title">Enhanced morphine analgesia in mice lacking beta-arrestin 2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">2495</span><span class="NLM_x">–</span> <span class="NLM_lpage">2498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=2495-2498&author=L.+M.+Bohnauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=K.+Peppelauthor=M.+G.+Caronauthor=F.+T.+Lin&title=Enhanced+morphine+analgesia+in+mice+lacking+beta-arrestin+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DPeppel%26aufirst%3DK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.%2BT.%26atitle%3DEnhanced%2520morphine%2520analgesia%2520in%2520mice%2520lacking%2520beta-arrestin%25202%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D2495%26epage%3D2498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Nordquist, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risterucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kienlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunnecke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freichel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2008&pages=405-416&author=R.+E.+Nordquistauthor=C.+Risterucciauthor=J.+L.+Moreauauthor=M.+von+Kienlinauthor=B.+Kunneckeauthor=M.+Macoauthor=C.+Freichelauthor=C.+Riemerauthor=W.+Spooren&title=Effects+of+aripiprazole%2FOPC-14597+on+motor+activity%2C+pharmacological+models+of+psychosis%2C+and+brain+activity+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNordquist%26aufirst%3DR.%2BE.%26aulast%3DRisterucci%26aufirst%3DC.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3Dvon%2BKienlin%26aufirst%3DM.%26aulast%3DKunnecke%26aufirst%3DB.%26aulast%3DMaco%26aufirst%3DM.%26aulast%3DFreichel%26aufirst%3DC.%26aulast%3DRiemer%26aufirst%3DC.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DEffects%2520of%2520aripiprazole%252FOPC-14597%2520on%2520motor%2520activity%252C%2520pharmacological%2520models%2520of%2520psychosis%252C%2520and%2520brain%2520activity%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D54%26spage%3D405%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Gottlieb, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lh8G_juUgcWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Barnea, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strapps, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrada, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. J.</span><span> </span><span class="NLM_article-title">The genetic design of signaling cascades to record receptor activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1073%2Fpnas.0710487105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=18165312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvV2ktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=64-69&author=G.+Barneaauthor=W.+Strappsauthor=G.+Herradaauthor=Y.+Bermanauthor=J.+Ongauthor=B.+Klossauthor=R.+Axelauthor=K.+J.+Lee&title=The+genetic+design+of+signaling+cascades+to+record+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The genetic design of signaling cascades to record receptor activation</span></div><div class="casAuthors">Barnea, Gilad; Strapps, Walter; Herrada, Gilles; Berman, Yemiliya; Ong, Jane; Kloss, Brian; Axel, Richard; Lee, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-69</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors have developed an exptl. strategy to monitor protein interactions in a cell with a high degree of selectivity and sensitivity.  A transcription factor is tethered to a membrane-bound receptor with a linker that contains a cleavage site for a specific protease.  Activation of the receptor recruits a signaling protein fused to the protease that then cleaves and releases the transcription factor to activate reporter genes in the nucleus.  This strategy converts a transient interaction into a stable and amplifiable reporter gene signal to record the activation of a receptor without interference from endogenous signaling pathways.  The authors have developed this assay for three classes of receptors: G protein-coupled receptors, receptor tyrosine kinases, and steroid hormone receptors.  Finally, the authors use the assay to identify a ligand for the orphan receptor GPR1, suggesting a role for this receptor in the regulation of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ugB7pgEqlrVg90H21EOLACvtfcHk0lh8G_juUgcWuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvV2ktA%253D%253D&md5=3b49dfdb2949d947e145084ac87bb343</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710487105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710487105%26sid%3Dliteratum%253Aachs%26aulast%3DBarnea%26aufirst%3DG.%26aulast%3DStrapps%26aufirst%3DW.%26aulast%3DHerrada%26aufirst%3DG.%26aulast%3DBerman%26aufirst%3DY.%26aulast%3DOng%26aufirst%3DJ.%26aulast%3DKloss%26aufirst%3DB.%26aulast%3DAxel%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520genetic%2520design%2520of%2520signaling%2520cascades%2520to%2520record%2520receptor%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D64%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 92 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, Rafael Franco, Aitor García-Rey, Maria Majellaro, Darío Miranda-Pastoriza, Xerardo García-Mera, Willem Jespers, Hugo Gutiérrez-de-Terán, Gemma Navarro, <span class="NLM_string-name hlFld-ContribAuthor">Eddy Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8710-8726. <a href="https://doi.org/10.1021/acs.jmedchem.1c00704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSubtype-Selective%252BDopamine%252BD2%252BReceptor%252BBiased%252BPartial%252BAgonists%252BDiscovered%252Bvia%252Ban%252BUgi-Based%252BApproach%26aulast%3DMallo-Abreu%26aufirst%3DAna%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8710%26epage%3D8726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wenlong Sun, Cho-Hon Ling, Chi-Ming Au, <span class="NLM_string-name hlFld-ContribAuthor">Wing-Yiu Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed Intramolecular Arene C(sp2)–H Amidation for Synthesis of 3,4-Dihydroquinolin-2(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (9)
                                     , 3310-3314. <a href="https://doi.org/10.1021/acs.orglett.1c00781" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00781%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRuthenium-Catalyzed%252BIntramolecular%252BArene%252BC%252528sp2%252529%2525E2%252580%252593H%252BAmidation%252Bfor%252BSynthesis%252Bof%252B3%25252C4-Dihydroquinolin-2%2525281H%252529-ones%26aulast%3DSun%26aufirst%3DWenlong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05032021%26date%3D26042021%26volume%3D23%26issue%3D9%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
L. Martini, Caroline Ray, Xufen Yu, Jing Liu, Vladimir M. Pogorelov, William C. Wetsel, Xi-Ping Huang, John D. McCorvy, Marc G. Caron, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4160-4182. <a href="https://doi.org/10.1021/acschemneuro.9b00410" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesigning%252BFunctionally%252BSelective%252BNoncatechol%252BDopamine%252BD1%252BReceptor%252BAgonists%252Bwith%252BPotent%252BIn%252BVivo%252BAntiparkinsonian%252BActivity%26aulast%3DMartini%26aufirst%3DMichael%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D06082019%26date%3D20082019%26date%3D06082019%26volume%3D10%26issue%3D9%26spage%3D4160%26epage%3D4182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francisco
O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, Anver Basha Shaik, Jenny Lam, Rana Rais, Barbara S. Slusher, Jeffery R. Deschamps, Greg H. Imler, Amy Hauck Newman, <span class="NLM_string-name hlFld-ContribAuthor">Alessandro Bonifazi</span>. </span><span class="cited-content_cbyCitation_article-title">The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (13)
                                     , 6287-6314. <a href="https://doi.org/10.1021/acs.jmedchem.9b00702" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00702%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BSignificance%252Bof%252BChirality%252Bin%252BDrug%252BDesign%252Band%252BSynthesis%252Bof%252BBitopic%252BLigands%252Bas%252BD3%252BReceptor%252B%252528D3R%252529%252BSelective%252BAgonists%26aulast%3DBattiti%26aufirst%3DFrancisco%2BO.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29042019%26date%3D01072019%26date%3D19062019%26volume%3D62%26issue%3D13%26spage%3D6287%26epage%3D6314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yudao Shen, John D. McCorvy, Michael L. Martini, Ramona M. Rodriguiz, Vladimir M. Pogorelov, Karen M. Ward, William C. Wetsel, Jing Liu, Bryan L. Roth, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4755-4771. <a href="https://doi.org/10.1021/acs.jmedchem.9b00508" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00508%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DD2%252BDopamine%252BReceptor%252BG%252BProtein-Biased%252BPartial%252BAgonists%252BBased%252Bon%252BCariprazine%26aulast%3DShen%26aufirst%3DYudao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22032019%26date%3D18042019%26date%3D09042019%26volume%3D62%26issue%3D9%26spage%3D4755%26epage%3D4771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, Vivek Kumar, Alexander F. Hoffman, Carl R. Lupica, Lei Shi, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     , 52-65. <a href="https://doi.org/10.1021/acsptsci.8b00060" title="DOI URL">https://doi.org/10.1021/acsptsci.8b00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.8b00060%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DNovel%252Band%252BPotent%252BDopamine%252BD2%252BReceptor%252BGo-Protein%252BBiased%252BAgonists%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21122018%26date%3D28012019%26date%3D14012019%26volume%3D2%26issue%3D1%26spage%3D52%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Wenzhong Yan, John D. McCorvy, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9841-9878. <a href="https://doi.org/10.1021/acs.jmedchem.8b00435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiased%252BLigands%252Bof%252BG%252BProtein-Coupled%252BReceptors%252B%252528GPCRs%252529%25253A%252BStructure%2525E2%252580%252593Functional%252BSelectivity%252BRelationships%252B%252528SFSRs%252529%252Band%252BTherapeutic%252BPotential%26aulast%3DTan%26aufirst%3DLiang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19032018%26date%3D10072018%26date%3D25062018%26volume%3D61%26issue%3D22%26spage%3D9841%26epage%3D9878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rahul Tyagi, Harnam Singh, Jagat Singh, Himanshu Arora, Vijayalaxmi Yelmeli, Mohit Jain, Sathyanarayana Girigani, <span class="NLM_string-name hlFld-ContribAuthor">Pramod Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Identification, Synthesis, and Control of Process-Related Impurities in the Antipsychotic Drug Substance Brexpiprazole. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2018,</strong> <em>22 </em>
                                    (11)
                                     , 1471-1480. <a href="https://doi.org/10.1021/acs.oprd.8b00074" title="DOI URL">https://doi.org/10.1021/acs.oprd.8b00074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.8b00074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.8b00074%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DIdentification%25252C%252BSynthesis%25252C%252Band%252BControl%252Bof%252BProcess-Related%252BImpurities%252Bin%252Bthe%252BAntipsychotic%252BDrug%252BSubstance%252BBrexpiprazole%26aulast%3DTyagi%26aufirst%3DRahul%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23032018%26date%3D22102018%26date%3D05102018%26volume%3D22%26issue%3D11%26spage%3D1471%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Mariama  Jaiteh</span>, <span class="hlFld-ContribAuthor ">Alexey  Zeifman</span>, <span class="hlFld-ContribAuthor ">Alena  Randakova</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, and <span class="hlFld-ContribAuthor ">Jens  Carlsson</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (10)
                                     , 2652-2661. <a href="https://doi.org/10.1021/acschembio.7b00493" title="DOI URL">https://doi.org/10.1021/acschembio.7b00493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00493%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructure-Guided%252BScreening%252Bfor%252BFunctionally%252BSelective%252BD2%252BDopamine%252BReceptor%252BLigands%252Bfrom%252Ba%252BVirtual%252BChemical%252BLibrary%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15062017%26date%3D28082017%26date%3D19092017%26date%3D20102017%26date%3D28082017%26volume%3D12%26issue%3D10%26spage%3D2652%26epage%3D2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Daniela  Dengler</span>, <span class="hlFld-ContribAuthor ">Jeremy  Shonberg</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D2R Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (11)
                                     , 4693-4713. <a href="https://doi.org/10.1021/acs.jmedchem.7b00363" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00363%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHydroxy-Substituted%252BHeteroarylpiperazines%25253A%252BNovel%252BScaffolds%252Bfor%252B%2525CE%2525B2-Arrestin-Biased%252BD2R%252BAgonists%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07032017%26date%3D18052017%26date%3D08062017%26date%3D10052017%26volume%3D60%26issue%3D11%26spage%3D4693%26epage%3D4713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Banerjee</span>, <span class="hlFld-ContribAuthor ">Taygun C.  Uzuneser</span>, <span class="hlFld-ContribAuthor ">Marika  Skultety</span>, <span class="hlFld-ContribAuthor ">Tobias  Huth</span>, <span class="hlFld-ContribAuthor ">Bianca  Plouffe</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Christian  Alzheimer</span>, <span class="hlFld-ContribAuthor ">Kristina  Friedland</span>, <span class="hlFld-ContribAuthor ">Christian P.  Müller</span>, <span class="hlFld-ContribAuthor ">Michel  Bouvier</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2908-2929. <a href="https://doi.org/10.1021/acs.jmedchem.6b01857" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BG%252BProtein-Biased%252BDopaminergics%252Bwith%252Ba%252BPyrazolo%25255B1%25252C5-a%25255Dpyridine%252BSubstructure%26aulast%3DM%25C3%25B6ller%26aufirst%3DDorothee%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21122016%26date%3D22032017%26date%3D13042017%26date%3D01032017%26volume%3D60%26issue%3D7%26spage%3D2908%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Ludovic  Muller</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Mu-Fa  Zou</span>, <span class="hlFld-ContribAuthor ">Ning Sheng  Cai</span>, <span class="hlFld-ContribAuthor ">Adrian M.  Guerrero</span>, <span class="hlFld-ContribAuthor ">Amina S.  Woods</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2890-2907. <a href="https://doi.org/10.1021/acs.jmedchem.6b01875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BBivalent%252BLigands%252BBased%252Bon%252Bthe%252BSumanirole%252BPharmacophore%252BReveal%252BDopamine%252BD2%252BReceptor%252B%252528D2R%252529%252BBiased%252BAgonism%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D16032017%26date%3D13042017%26volume%3D60%26issue%3D7%26spage%3D2890%26epage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaozhao  Wang</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Tocker</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Lee-Yuan  Liu-Chen</span>, <span class="hlFld-ContribAuthor ">Amos B.  Smith, III</span>, and <span class="hlFld-ContribAuthor ">Sandhya  Kortagere</span>  . </span><span class="cited-content_cbyCitation_article-title">Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 486-500. <a href="https://doi.org/10.1021/acschemneuro.6b00221" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00221%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DFunctional%252BCharacterization%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BBiased%252BSignaling%252BDopamine%252BD3%252BReceptor%252BAgonists%26aulast%3DXu%26aufirst%3DWei%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29072016%26date%3D01112016%26date%3D23112016%26date%3D15032017%26date%3D01112016%26volume%3D8%26issue%3D3%26spage%3D486%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Buonerba</span>, <span class="hlFld-ContribAuthor ">Susan  Lepri</span>, <span class="hlFld-ContribAuthor ">Laura  Goracci</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Schindler</span>, <span class="hlFld-ContribAuthor ">Susan M.  Seo</span>, <span class="hlFld-ContribAuthor ">Glenn W.  Kaatz</span>, and <span class="hlFld-ContribAuthor ">Gabriele  Cruciani</span>  . </span><span class="cited-content_cbyCitation_article-title">Improved Potency of Indole-Based NorA Efflux Pump Inhibitors: From Serendipity toward Rational Design and Development. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 517-523. <a href="https://doi.org/10.1021/acs.jmedchem.6b01281" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01281%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImproved%252BPotency%252Bof%252BIndole-Based%252BNorA%252BEfflux%252BPump%252BInhibitors%25253A%252BFrom%252BSerendipity%252Btoward%252BRational%252BDesign%252Band%252BDevelopment%26aulast%3DBuonerba%26aufirst%3DFederica%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D07092016%26date%3D15122016%26date%3D12012017%26date%3D02122016%26volume%3D60%26issue%3D1%26spage%3D517%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Fischer</span>, <span class="hlFld-ContribAuthor ">Kyle V.  Butler</span>, <span class="hlFld-ContribAuthor ">Yudao  Shen</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Jian  Jin</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10601-10618. <a href="https://doi.org/10.1021/acs.jmedchem.6b01208" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BG%252BProtein-Biased%252BD2%252BDopamine%252BReceptor%252BPartial%252BAgonists%26aulast%3DChen%26aufirst%3DXin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10082016%26date%3D16112016%26date%3D08122016%26date%3D02112016%26volume%3D59%26issue%3D23%26spage%3D10601%26epage%3D10618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seiji  Ogawa</span>, <span class="hlFld-ContribAuthor ">Toshihide  Watanabe</span>, <span class="hlFld-ContribAuthor ">Isamu  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Kazumi  Moriyuki</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Goto</span>, <span class="hlFld-ContribAuthor ">Shinsaku  Yamane</span>, <span class="hlFld-ContribAuthor ">Akio  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kazuma  Tsuboi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Hideo  Kigoshi</span>, <span class="hlFld-ContribAuthor ">Kousuke  Tani</span>, and <span class="hlFld-ContribAuthor ">Toru  Maruyama</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of G Protein-Biased EP2 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 306-311. <a href="https://doi.org/10.1021/acsmedchemlett.5b00455" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00455%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BG%252BProtein-Biased%252BEP2%252BReceptor%252BAgonists%26aulast%3DOgawa%26aufirst%3DSeiji%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D26112015%26date%3D03012016%26date%3D05012016%26date%3D10032016%26date%3D04012016%26volume%3D7%26issue%3D3%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Lepri</span>, <span class="hlFld-ContribAuthor ">Federica  Buonerba</span>, <span class="hlFld-ContribAuthor ">Laura  Goracci</span>, <span class="hlFld-ContribAuthor ">Irene  Velilla</span>, <span class="hlFld-ContribAuthor ">Renzo  Ruzziconi</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Schindler</span>, <span class="hlFld-ContribAuthor ">Susan M.  Seo</span>, <span class="hlFld-ContribAuthor ">Glenn W.  Kaatz</span>, and <span class="hlFld-ContribAuthor ">Gabriele  Cruciani</span>  . </span><span class="cited-content_cbyCitation_article-title">Indole Based Weapons to Fight Antibiotic Resistance: A Structure–Activity Relationship Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 867-891. <a href="https://doi.org/10.1021/acs.jmedchem.5b01219" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01219</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01219%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndole%252BBased%252BWeapons%252Bto%252BFight%252BAntibiotic%252BResistance%25253A%252BA%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%26aulast%3DLepri%26aufirst%3DSusan%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D02082015%26date%3D26012016%26date%3D11022016%26date%3D12012016%26volume%3D59%26issue%3D3%26spage%3D867%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennie L.  Conroy</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, and <span class="hlFld-ContribAuthor ">David R.  Sibley</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of G Protein-Biased Agonists That Fail To Recruit β-Arrestin or Promote Internalization of the D1 Dopamine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 681-692. <a href="https://doi.org/10.1021/acschemneuro.5b00020" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00020%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Bof%252BG%252BProtein-Biased%252BAgonists%252BThat%252BFail%252BTo%252BRecruit%252B%2525CE%2525B2-Arrestin%252Bor%252BPromote%252BInternalization%252Bof%252Bthe%252BD1%252BDopamine%252BReceptor%26aulast%3DConroy%26aufirst%3DJennie%2BL.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13012015%26date%3D08022015%26date%3D20022015%26date%3D15042015%26date%3D08022015%26volume%3D6%26issue%3D4%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dietmar  Weichert</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Banerjee</span>, <span class="hlFld-ContribAuthor ">Christine  Hiller</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Kling</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2703-2717. <a href="https://doi.org/10.1021/jm501889t" title="DOI URL">https://doi.org/10.1021/jm501889t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501889t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501889t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BDeterminants%252Bof%252BBiased%252BAgonism%252Bat%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DWeichert%26aufirst%3DDietmar%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D12032015%26date%3D26032015%26date%3D03032015%26volume%3D58%26issue%3D6%26spage%3D2703%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig C.  Correll</span> and <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>  . </span><span class="cited-content_cbyCitation_article-title">Biased Ligand Modulation of Seven Transmembrane Receptors (7TMRs): Functional Implications for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (16)
                                     , 6887-6896. <a href="https://doi.org/10.1021/jm401677g" title="DOI URL">https://doi.org/10.1021/jm401677g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401677g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401677g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiased%252BLigand%252BModulation%252Bof%252BSeven%252BTransmembrane%252BReceptors%252B%2525287TMRs%252529%25253A%252BFunctional%252BImplications%252Bfor%252BDrug%252BDiscovery%26aulast%3DCorrell%26aufirst%3DCraig%2BC.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D29102013%26date%3D29042014%26date%3D28082014%26date%3D03042014%26volume%3D57%26issue%3D16%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subramaniam  Ananthan</span>, <span class="hlFld-ContribAuthor ">Surendra K.  Saini</span>, <span class="hlFld-ContribAuthor ">Guangyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Judith V.  Hobrath</span>, <span class="hlFld-ContribAuthor ">Indira  Padmalayam</span>, <span class="hlFld-ContribAuthor ">Ling  Zhai</span>, <span class="hlFld-ContribAuthor ">J. Robert  Bostwick</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Shea  McDowell</span>, <span class="hlFld-ContribAuthor ">Eunie  Cho</span>, <span class="hlFld-ContribAuthor ">Leah  McAleer</span>, <span class="hlFld-ContribAuthor ">Michelle  Taylor</span>, and <span class="hlFld-ContribAuthor ">Robert R.  Luedtke</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Structure–Activity Relationship Studies of a Series of [4-(4-Carboxamidobutyl)]-1-arylpiperazines: Insights into Structural Features Contributing to Dopamine D3 versus D2 Receptor Subtype Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (16)
                                     , 7042-7060. <a href="https://doi.org/10.1021/jm500801r" title="DOI URL">https://doi.org/10.1021/jm500801r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500801r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500801r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252Ba%252BSeries%252Bof%252B%25255B4-%2525284-Carboxamidobutyl%252529%25255D-1-arylpiperazines%25253A%252BInsights%252Binto%252BStructural%252BFeatures%252BContributing%252Bto%252BDopamine%252BD3%252Bversus%252BD2%252BReceptor%252BSubtype%252BSelectivity%26aulast%3DAnanthan%26aufirst%3DSubramaniam%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23052014%26date%3D15082014%26date%3D28082014%26volume%3D57%26issue%3D16%26spage%3D7042%26epage%3D7060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Kling</span>, <span class="hlFld-ContribAuthor ">Marika  Skultety</span>, <span class="hlFld-ContribAuthor ">Kristina  Leuner</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Functionally Selective Dopamine D2, D3 Receptor Partial Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4861-4875. <a href="https://doi.org/10.1021/jm5004039" title="DOI URL">https://doi.org/10.1021/jm5004039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5004039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5004039%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFunctionally%252BSelective%252BDopamine%252BD2%25252C%252BD3%252BReceptor%252BPartial%252BAgonists%26aulast%3DM%25C3%25B6ller%26aufirst%3DDorothee%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D14032014%26date%3D23052014%26date%3D12062014%26date%3D15052014%26volume%3D57%26issue%3D11%26spage%3D4861%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Szabo</span>, <span class="hlFld-ContribAuthor ">Carmen  Klein Herenbrink</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, and <span class="hlFld-ContribAuthor ">Ben  Capuano</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4924-4939. <a href="https://doi.org/10.1021/jm500457x" title="DOI URL">https://doi.org/10.1021/jm500457x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500457x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500457x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BPrivileged%252BStructures%252BLead%252Bto%252Bthe%252BDiscovery%252Bof%252BNovel%252BBiased%252BLigands%252Bat%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DSzabo%26aufirst%3DMonika%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24032014%26date%3D30052014%26date%3D12062014%26date%3D14052014%26volume%3D57%26issue%3D11%26spage%3D4924%26epage%3D4939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy  Shonberg</span>, <span class="hlFld-ContribAuthor ">Carmen Klein  Herenbrink</span>, <span class="hlFld-ContribAuthor ">Laura  López</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, and <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>  . </span><span class="cited-content_cbyCitation_article-title">A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (22)
                                     , 9199-9221. <a href="https://doi.org/10.1021/jm401318w" title="DOI URL">https://doi.org/10.1021/jm401318w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401318w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BStructure%2525E2%252580%252593Activity%252BAnalysis%252Bof%252BBiased%252BAgonism%252Bat%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DShonberg%26aufirst%3DJeremy%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D26082013%26date%3D08112013%26date%3D27112013%26date%3D19102013%26volume%3D56%26issue%3D22%26spage%3D9199%26epage%3D9221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles E.  Hendrick</span>, <span class="hlFld-ContribAuthor ">Stacey L.  McDonald</span>, and <span class="hlFld-ContribAuthor ">Qiu  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Insertion of Arynes into N-Halo Bonds: A Direct Approach to o-Haloaminoarenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (13)
                                     , 3444-3447. <a href="https://doi.org/10.1021/ol401518c" title="DOI URL">https://doi.org/10.1021/ol401518c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol401518c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol401518c%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DInsertion%252Bof%252BArynes%252Binto%252BN-Halo%252BBonds%25253A%252BA%252BDirect%252BApproach%252Bto%252Bo-Haloaminoarenes%26aulast%3DHendrick%26aufirst%3DCharles%2BE.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D29052013%26date%3D24062013%26date%3D05072013%26volume%3D15%26issue%3D13%26spage%3D3444%26epage%3D3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Hiller</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Kling</span>, <span class="hlFld-ContribAuthor ">Frank W.  Heinemann</span>, <span class="hlFld-ContribAuthor ">Karsten  Meyer</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Functionally Selective Dopamine D2/D3 Receptor Agonists Comprising an Enyne Moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (12)
                                     , 5130-5141. <a href="https://doi.org/10.1021/jm400520c" title="DOI URL">https://doi.org/10.1021/jm400520c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400520c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400520c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFunctionally%252BSelective%252BDopamine%252BD2%25252FD3%252BReceptor%252BAgonists%252BComprising%252Ban%252BEnyne%252BMoiety%26aulast%3DHiller%26aufirst%3DChristine%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D09042013%26date%3D17062013%26date%3D27062013%26date%3D03062013%26volume%3D56%26issue%3D12%26spage%3D5130%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahlia R.  Weiss</span>, <span class="hlFld-ContribAuthor ">SeungKirl  Ahn</span>, <span class="hlFld-ContribAuthor ">Maria F.  Sassano</span>, <span class="hlFld-ContribAuthor ">Andrew  Kleist</span>, <span class="hlFld-ContribAuthor ">Xiao  Zhu</span>, <span class="hlFld-ContribAuthor ">Ryan  Strachan</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Robert J.  Lefkowitz</span>, and <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (5)
                                     , 1018-1026. <a href="https://doi.org/10.1021/cb400103f" title="DOI URL">https://doi.org/10.1021/cb400103f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400103f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400103f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DConformation%252BGuides%252BMolecular%252BEfficacy%252Bin%252BDocking%252BScreens%252Bof%252BActivated%252B%2525CE%2525B2-2%252BAdrenergic%252BG%252BProtein%252BCoupled%252BReceptor%26aulast%3DWeiss%26aufirst%3DDahlia%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D13022013%26date%3D13032013%26date%3D21032013%26date%3D17052013%26date%3D13032013%26volume%3D8%26issue%3D5%26spage%3D1018%26epage%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria F.  Sassano</span>, <span class="hlFld-ContribAuthor ">Allison K.  Doak</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Brian K.  Shoichet</span>  . </span><span class="cited-content_cbyCitation_article-title">Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2406-2414. <a href="https://doi.org/10.1021/jm301749y" title="DOI URL">https://doi.org/10.1021/jm301749y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301749y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301749y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DColloidal%252BAggregation%252BCauses%252BInhibition%252Bof%252BG%252BProtein-Coupled%252BReceptors%26aulast%3DSassano%26aufirst%3DMaria%2BF.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D27112012%26date%3D12032013%26date%3D28032013%26date%3D25022013%26volume%3D56%26issue%3D6%26spage%3D2406%26epage%3D2414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah  Wenk</span>, <span class="hlFld-ContribAuthor ">Vladimir  Ignatchenko</span>, <span class="hlFld-ContribAuthor ">Andrew  Macklin</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, <span class="hlFld-ContribAuthor ">Dorothée  Weikert</span>, <span class="hlFld-ContribAuthor ">Monika  Pischetsrieder</span>, <span class="hlFld-ContribAuthor ">Thomas  Kislinger</span>. </span><span class="cited-content_cbyCitation_article-title">Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-83038-x" title="DOI URL">https://doi.org/10.1038/s41598-021-83038-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-83038-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-83038-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFunctionally%252Bselective%252Bactivation%252Bof%252Bthe%252Bdopamine%252Breceptor%252BD2%252Bis%252Bmirrored%252Bby%252Bthe%252Bprotein%252Bexpression%252Bprofiles%26aulast%3DWenk%26aufirst%3DDeborah%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seth  Ablordeppey</span>, <span class="hlFld-ContribAuthor ">Edward  Ofori</span>. </span><span class="cited-content_cbyCitation_article-title">Antipsychotic Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-69. <a href="https://doi.org/10.1002/0471266949.bmc103.pub3" title="DOI URL">https://doi.org/10.1002/0471266949.bmc103.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc103.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc103.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DAntipsychotic%252BAgents%26aulast%3DAblordeppey%26aufirst%3DSeth%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D69%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aldineia P.  da Silva</span>, <span class="hlFld-ContribAuthor ">Laise P. A.  Chiari</span>, <span class="hlFld-ContribAuthor ">Amanda R.  Guimarães</span>, <span class="hlFld-ContribAuthor ">Kathia M.  Honorio</span>, <span class="hlFld-ContribAuthor ">Albérico B. F.  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">New D2R partial agonist candidates: an in silico approach from statistical models, molecular docking, and ADME/Tox properties. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2021,</strong> <em>392 </em><a href="https://doi.org/10.1007/s11224-021-01742-w" title="DOI URL">https://doi.org/10.1007/s11224-021-01742-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-021-01742-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-021-01742-w%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DNew%252BD2R%252Bpartial%252Bagonist%252Bcandidates%25253A%252Ban%252Bin%252Bsilico%252Bapproach%252Bfrom%252Bstatistical%252Bmodels%25252C%252Bmolecular%252Bdocking%25252C%252Band%252BADME%25252FTox%252Bproperties%26aulast%3Dda%2BSilva%26aufirst%3DAldineia%2BP.%26date%3D2021%26date%3D2021%26volume%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pramisha  Adhikari</span>, <span class="hlFld-ContribAuthor ">Bing  Xie</span>, <span class="hlFld-ContribAuthor ">Ana  Semeano</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Francisco O.  Battiti</span>, <span class="hlFld-ContribAuthor ">Amy H.  Newman</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 570. <a href="https://doi.org/10.3390/biom11040570" title="DOI URL">https://doi.org/10.3390/biom11040570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11040570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11040570%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DChirality%252Bof%252BNovel%252BBitopic%252BAgonists%252BDetermines%252BUnique%252BPharmacology%252Bat%252Bthe%252BDopamine%252BD3%252BReceptor%26aulast%3DAdhikari%26aufirst%3DPramisha%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sam R. J.  Hoare</span>, <span class="hlFld-ContribAuthor ">Paul H.  Tewson</span>, <span class="hlFld-ContribAuthor ">Anne Marie  Quinn</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis framework. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-58421-9" title="DOI URL">https://doi.org/10.1038/s41598-020-58421-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-58421-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-58421-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DA%252Bkinetic%252Bmethod%252Bfor%252Bmeasuring%252Bagonist%252Befficacy%252Band%252Bligand%252Bbias%252Busing%252Bhigh%252Bresolution%252Bbiosensors%252Band%252Ba%252Bkinetic%252Bdata%252Banalysis%252Bframework%26aulast%3DHoare%26aufirst%3DSam%2BR.%2BJ.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Attila  Egyed</span>, <span class="hlFld-ContribAuthor ">Katalin  Domány-Kovács</span>, <span class="hlFld-ContribAuthor ">Bence  Koványi</span>, <span class="hlFld-ContribAuthor ">Ferenc  Horti</span>, <span class="hlFld-ContribAuthor ">Dalma  Kurkó</span>, <span class="hlFld-ContribAuthor ">Dóra Judit  Kiss</span>, <span class="hlFld-ContribAuthor ">Gáspár  Pándy-Szekeres</span>, <span class="hlFld-ContribAuthor ">István  Greiner</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling receptor function from the extracellular vestibule of G-protein coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (91)
                                     , 14167-14170. <a href="https://doi.org/10.1039/D0CC05532H" title="DOI URL">https://doi.org/10.1039/D0CC05532H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC05532H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC05532H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DControlling%252Breceptor%252Bfunction%252Bfrom%252Bthe%252Bextracellular%252Bvestibule%252Bof%252BG-protein%252Bcoupled%252Breceptors%26aulast%3DEgyed%26aufirst%3DAttila%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D91%26spage%3D14167%26epage%3D14170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jialei  Zhu</span>, <span class="hlFld-ContribAuthor ">Ting  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Dongshuo  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Zhu</span>, <span class="hlFld-ContribAuthor ">Hang  Yao</span>, <span class="hlFld-ContribAuthor ">Jianhua  Ding</span>, <span class="hlFld-ContribAuthor ">Gang  Hu</span>, <span class="hlFld-ContribAuthor ">Ming  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson’s disease model via a β-arrestin2-biased mechanism. </span><span class="cited-content_cbyCitation_journal-name">Brain, Behavior, and Immunity</span><span> <strong>2020,</strong> <em>90 </em>, 259-271. <a href="https://doi.org/10.1016/j.bbi.2020.08.025" title="DOI URL">https://doi.org/10.1016/j.bbi.2020.08.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbi.2020.08.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbi.2020.08.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%252C%2520Behavior%252C%2520and%2520Immunity%26atitle%3DDrd2%252Bbiased%252Bagonist%252Bprevents%252Bneurodegeneration%252Bagainst%252BNLRP3%252Binflammasome%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%252Bmodel%252Bvia%252Ba%252B%2525CE%2525B2-arrestin2-biased%252Bmechanism%26aulast%3DZhu%26aufirst%3DJialei%26date%3D2020%26volume%3D90%26spage%3D259%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashant  Donthamsetti</span>, <span class="hlFld-ContribAuthor ">Eduardo F.  Gallo</span>, <span class="hlFld-ContribAuthor ">David C.  Buck</span>, <span class="hlFld-ContribAuthor ">Edward L.  Stahl</span>, <span class="hlFld-ContribAuthor ">Ying  Zhu</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, <span class="hlFld-ContribAuthor ">Laura M.  Bohn</span>, <span class="hlFld-ContribAuthor ">Kim A.  Neve</span>, <span class="hlFld-ContribAuthor ">Christoph  Kellendonk</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>. </span><span class="cited-content_cbyCitation_article-title">Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2086-2100. <a href="https://doi.org/10.1038/s41380-018-0212-4" title="DOI URL">https://doi.org/10.1038/s41380-018-0212-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41380-018-0212-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41380-018-0212-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DArrestin%252Brecruitment%252Bto%252Bdopamine%252BD2%252Breceptor%252Bmediates%252Blocomotion%252Bbut%252Bnot%252Bincentive%252Bmotivation%26aulast%3DDonthamsetti%26aufirst%3DPrashant%26date%3D2020%26date%3D2018%26volume%3D25%26issue%3D9%26spage%3D2086%26epage%3D2100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Yuna  Qian</span>, <span class="hlFld-ContribAuthor ">Huixia  Jia</span>, <span class="hlFld-ContribAuthor ">Yuzhong  Yu</span>, <span class="hlFld-ContribAuthor ">Haibo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianliang  Shen</span>, <span class="hlFld-ContribAuthor ">Shanchao  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of naftopidil-based arylpiperazine derivatives containing the bromophenol moiety. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reports</span><span> <strong>2020,</strong> <em>72 </em>
                                    (4)
                                     , 1058-1068. <a href="https://doi.org/10.1007/s43440-019-00041-w" title="DOI URL">https://doi.org/10.1007/s43440-019-00041-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43440-019-00041-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43440-019-00041-w%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reports%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bnaftopidil-based%252Barylpiperazine%252Bderivatives%252Bcontaining%252Bthe%252Bbromophenol%252Bmoiety%26aulast%3DChen%26aufirst%3DHong%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D4%26spage%3D1058%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Soave</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Briddon</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Hill</span>, <span class="hlFld-ContribAuthor ">Leigh A.  Stoddart</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent ligands: Bringing light to emerging GPCR paradigms. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (5)
                                     , 978-991. <a href="https://doi.org/10.1111/bph.14953" title="DOI URL">https://doi.org/10.1111/bph.14953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14953%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DFluorescent%252Bligands%25253A%252BBringing%252Blight%252Bto%252Bemerging%252BGPCR%252Bparadigms%26aulast%3DSoave%26aufirst%3DMark%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D5%26spage%3D978%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marlene  Jacobson</span>, <span class="hlFld-ContribAuthor ">Wayne  Childers</span>, <span class="hlFld-ContribAuthor ">Magid  Abou‐Gharbia</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D
              2
              Partial Agonists – Discovery, Evolution, and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 83-130. <a href="https://doi.org/10.1002/9783527814695.ch4" title="DOI URL">https://doi.org/10.1002/9783527814695.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527814695.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527814695.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DDopamine%252BD%252B2%252BPartial%252BAgonists%252B%2525E2%252580%252593%252BDiscovery%25252C%252BEvolution%25252C%252Band%252BTherapeutic%252BPotential%26aulast%3DJacobson%26aufirst%3DMarlene%26date%3D2019%26date%3D2019%26spage%3D83%26epage%3D130%26pub%3DWiley%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2019%26date%3D2019%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Jingxiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Peixin  Hu</span>, <span class="hlFld-ContribAuthor ">Yuna  Qian</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Jianliang  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (20)
                                     , 115081. <a href="https://doi.org/10.1016/j.bmc.2019.115081" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115081%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bof%252B4-Amino-2H-benzo%25255Bh%25255Dchromen-2-one%252B%252528ABO%252529%252Banalogs%252Bcontaining%252Bthe%252Bpiperazine%252Bmoiety%26aulast%3DChen%26aufirst%3DHong%26date%3D2019%26volume%3D27%26issue%3D20%26spage%3D115081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Montgomery</span>, <span class="hlFld-ContribAuthor ">Alexandra  Campbell</span>, <span class="hlFld-ContribAuthor ">Holli-Joi  Sullivan</span>, <span class="hlFld-ContribAuthor ">Chun  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (12)
                                     , 3206-3225. <a href="https://doi.org/10.1080/07391102.2018.1513378" title="DOI URL">https://doi.org/10.1080/07391102.2018.1513378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1513378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1513378%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Bof%252Bbiased%252Bagonists%252Bat%252Bthe%252Bdopamine%252BD2%252Breceptor%252Bsuggests%252Bthe%252Bmechanism%252Bof%252Breceptor%252Bfunctional%252Bselectivity%26aulast%3DMontgomery%26aufirst%3DDavid%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D12%26spage%3D3206%26epage%3D3225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Seyedabadi</span>, <span class="hlFld-ContribAuthor ">Mohammad Hossein  Ghahremani</span>, <span class="hlFld-ContribAuthor ">Paul R.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>200 </em>, 148-178. <a href="https://doi.org/10.1016/j.pharmthera.2019.05.006" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DBiased%252Bsignaling%252Bof%252BG%252Bprotein%252Bcoupled%252Breceptors%252B%252528GPCRs%252529%25253A%252BMolecular%252Bdeterminants%252Bof%252BGPCR%25252Ftransducer%252Bselectivity%252Band%252Btherapeutic%252Bpotential%26aulast%3DSeyedabadi%26aufirst%3DMohammad%26date%3D2019%26volume%3D200%26spage%3D148%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara A.  Bricker</span>, <span class="hlFld-ContribAuthor ">Kwame  Peprah</span>, <span class="hlFld-ContribAuthor ">Hye J.  Kang</span>, <span class="hlFld-ContribAuthor ">S.Y.  Ablordeppey</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2019,</strong> <em>179 </em>, 55-62. <a href="https://doi.org/10.1016/j.pbb.2019.02.003" title="DOI URL">https://doi.org/10.1016/j.pbb.2019.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2019.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2019.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DEvaluation%252Bof%252BSYA16263%252Bas%252Ba%252Bnew%252Bpotential%252Bantipsychotic%252Bagent%252Bwithout%252Bcatalepsy%26aulast%3DBricker%26aufirst%3DBarbara%2BA.%26date%3D2019%26volume%3D179%26spage%3D55%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>, . </span><span class="cited-content_cbyCitation_article-title">Biased Receptor Signaling in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2019,</strong> <em>71 </em>
                                    (2)
                                     , 267-315. <a href="https://doi.org/10.1124/pr.118.016790" title="DOI URL">https://doi.org/10.1124/pr.118.016790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.016790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.016790%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DBiased%252BReceptor%252BSignaling%252Bin%252BDrug%252BDiscovery%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2019%26date%3D2019%26volume%3D71%26issue%3D2%26spage%3D267%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-Zhong  Yu</span>, <span class="hlFld-ContribAuthor ">Xiu-Mei  Tian</span>, <span class="hlFld-ContribAuthor ">Cai-Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Na  Qian</span>, <span class="hlFld-ContribAuthor ">Zai-An  Deng</span>, <span class="hlFld-ContribAuthor ">Jing-Xiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Dao-Jun  Lv</span>, <span class="hlFld-ContribAuthor ">Hai-Bo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian-Liang  Shen</span>, <span class="hlFld-ContribAuthor ">Mu  Yuan</span>, <span class="hlFld-ContribAuthor ">Shan-Chao  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (1)
                                     , 133-143. <a href="https://doi.org/10.1016/j.bmc.2018.11.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Barylpiperazine%252Bderivatives%252Bas%252Bpotential%252Banti-prostate%252Bcancer%252Bagents%26aulast%3DChen%26aufirst%3DHong%26date%3D2019%26volume%3D27%26issue%3D1%26spage%3D133%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christiane  Mendre</span>, <span class="hlFld-ContribAuthor ">Bernard  Mouillac</span>. </span><span class="cited-content_cbyCitation_article-title">Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 249-272. <a href="https://doi.org/10.1016/bs.apcsb.2019.07.002" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2019.07.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2019.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2019.07.002%26sid%3Dliteratum%253Aachs%26atitle%3DMisfolding%252Bof%252Bvasopressin%252Breceptors%25253A%252Bbiased%252Bagonist%252Bpharmacochaperones%252Bas%252Bpotential%252Btherapeutics%26aulast%3DMendre%26aufirst%3DChristiane%26date%3D2019%26spage%3D249%26epage%3D272%26pub%3DElsevier%26atitle%3DProtein%252BMisfolding%26date%3D2019%26volume%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelly A  Berg</span>, <span class="hlFld-ContribAuthor ">William P  Clarke</span>. </span><span class="cited-content_cbyCitation_article-title">Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>21 </em>
                                    (10)
                                     , 962-977. <a href="https://doi.org/10.1093/ijnp/pyy071" title="DOI URL">https://doi.org/10.1093/ijnp/pyy071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ijnp/pyy071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fijnp%2Fpyy071%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DMaking%252BSense%252Bof%252BPharmacology%25253A%252BInverse%252BAgonism%252Band%252BFunctional%252BSelectivity%26aulast%3DBerg%26aufirst%3DKelly%2BA%26date%3D2018%26date%3D2018%26volume%3D21%26issue%3D10%26spage%3D962%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Xue  Liang</span>, <span class="hlFld-ContribAuthor ">Tao  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Qiao</span>, <span class="hlFld-ContribAuthor ">Zhou  Zhan</span>, <span class="hlFld-ContribAuthor ">Ziyong  Li</span>, <span class="hlFld-ContribAuthor ">Chaojun  He</span>, <span class="hlFld-ContribAuthor ">Huiyuan  Ya</span>, <span class="hlFld-ContribAuthor ">Mu  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of estrone 3- O -ether derivatives containing the piperazine moiety. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2018,</strong> <em>134 </em>, 101-109. <a href="https://doi.org/10.1016/j.steroids.2018.02.002" title="DOI URL">https://doi.org/10.1016/j.steroids.2018.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2018.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bestrone%252B3-%252BO%252B-ether%252Bderivatives%252Bcontaining%252Bthe%252Bpiperazine%252Bmoiety%26aulast%3DChen%26aufirst%3DHong%26date%3D2018%26volume%3D134%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey S.  Smith</span>, <span class="hlFld-ContribAuthor ">Robert J.  Lefkowitz</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Rajagopal</span>. </span><span class="cited-content_cbyCitation_article-title">Biased signalling: from simple switches to allosteric microprocessors. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2018,</strong> <em>17 </em>
                                    (4)
                                     , 243-260. <a href="https://doi.org/10.1038/nrd.2017.229" title="DOI URL">https://doi.org/10.1038/nrd.2017.229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd.2017.229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd.2017.229%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBiased%252Bsignalling%25253A%252Bfrom%252Bsimple%252Bswitches%252Bto%252Ballosteric%252Bmicroprocessors%26aulast%3DSmith%26aufirst%3DJeffrey%2BS.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D4%26spage%3D243%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Flori  Sassano</span>, <span class="hlFld-ContribAuthor ">Eric S.  Davis</span>, <span class="hlFld-ContribAuthor ">James E.  Keating</span>, <span class="hlFld-ContribAuthor ">Bryan T.  Zorn</span>, <span class="hlFld-ContribAuthor ">Tavleen K.  Kochar</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Wolfgang</span>, <span class="hlFld-ContribAuthor ">Gary L.  Glish</span>, <span class="hlFld-ContribAuthor ">Robert  Tarran</span>, . </span><span class="cited-content_cbyCitation_article-title">Evaluation of e-liquid toxicity using an open-source high-throughput screening assay. </span><span class="cited-content_cbyCitation_journal-name">PLOS Biology</span><span> <strong>2018,</strong> <em>16 </em>
                                    (3)
                                     , e2003904. <a href="https://doi.org/10.1371/journal.pbio.2003904" title="DOI URL">https://doi.org/10.1371/journal.pbio.2003904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pbio.2003904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pbio.2003904%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Biology%26atitle%3DEvaluation%252Bof%252Be-liquid%252Btoxicity%252Busing%252Ban%252Bopen-source%252Bhigh-throughput%252Bscreening%252Bassay%26aulast%3DSassano%26aufirst%3DM.%2BFlori%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D3%26spage%3De2003904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lani S.  Chun</span>, <span class="hlFld-ContribAuthor ">Rakesh H.  Vekariya</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Yun  Li</span>, <span class="hlFld-ContribAuthor ">Da-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Ping  Su</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Yoon  Namkung</span>, <span class="hlFld-ContribAuthor ">Stephane A.  Laporte</span>, <span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Aubé</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Frankowski</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Synaptic Neuroscience</span><span> <strong>2018,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnsyn.2018.00002" title="DOI URL">https://doi.org/10.3389/fnsyn.2018.00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnsyn.2018.00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnsyn.2018.00002%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Synaptic%2520Neuroscience%26atitle%3DStructure-Activity%252BInvestigation%252Bof%252Ba%252BG%252BProtein-Biased%252BAgonist%252BReveals%252BMolecular%252BDeterminants%252Bfor%252BBiased%252BSignaling%252Bof%252Bthe%252BD2%252BDopamine%252BReceptor%26aulast%3DChun%26aufirst%3DLani%2BS.%26date%3D2018%26date%3D2018%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D  McCorvy</span>, <span class="hlFld-ContribAuthor ">Kyle V  Butler</span>, <span class="hlFld-ContribAuthor ">Brendan  Kelly</span>, <span class="hlFld-ContribAuthor ">Katie  Rechsteiner</span>, <span class="hlFld-ContribAuthor ">Joel  Karpiak</span>, <span class="hlFld-ContribAuthor ">Robin M  Betz</span>, <span class="hlFld-ContribAuthor ">Bethany L  Kormos</span>, <span class="hlFld-ContribAuthor ">Brian K  Shoichet</span>, <span class="hlFld-ContribAuthor ">Ron O  Dror</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Bryan L  Roth</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (2)
                                     , 126-134. <a href="https://doi.org/10.1038/nchembio.2527" title="DOI URL">https://doi.org/10.1038/nchembio.2527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.2527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.2527%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DStructure-inspired%252Bdesign%252Bof%252B%2525CE%2525B2-arrestin-biased%252Bligands%252Bfor%252Baminergic%252BGPCRs%26aulast%3DMcCorvy%26aufirst%3DJohn%2BD%26date%3D2018%26date%3D2017%26volume%3D14%26issue%3D2%26spage%3D126%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2018,</strong> <em>41 </em>, 75-81. <a href="https://doi.org/10.1016/j.cellsig.2017.07.003" title="DOI URL">https://doi.org/10.1016/j.cellsig.2017.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2017.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2017.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DAdvances%252Band%252Bchallenges%252Bin%252Bthe%252Bsearch%252Bfor%252BD2%252Band%252BD3%252Bdopamine%252Breceptor-selective%252Bcompounds%26aulast%3DMoritz%26aufirst%3DAmy%2BE.%26date%3D2018%26volume%3D41%26spage%3D75%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan L  Roth</span>, <span class="hlFld-ContribAuthor ">John J  Irwin</span>, <span class="hlFld-ContribAuthor ">Brian K  Shoichet</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new GPCR ligands to illuminate new biology. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (11)
                                     , 1143-1151. <a href="https://doi.org/10.1038/nchembio.2490" title="DOI URL">https://doi.org/10.1038/nchembio.2490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.2490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.2490%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Bnew%252BGPCR%252Bligands%252Bto%252Billuminate%252Bnew%252Bbiology%26aulast%3DRoth%26aufirst%3DBryan%2BL%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D11%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Dorothée  Möller</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5613-5628. <a href="https://doi.org/10.1016/j.bmc.2017.08.037" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.08.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.08.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Arrestin%252Bbiased%252Bdopamine%252BD2%252Breceptor%252Bpartial%252Bagonists%25253A%252BSynthesis%252Band%252Bpharmacological%252Bevaluation%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5613%26epage%3D5628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zheng</span>, <span class="hlFld-ContribAuthor ">Yong-Ming  Yan</span>, <span class="hlFld-ContribAuthor ">Zheng-Chao  Tu</span>, <span class="hlFld-ContribAuthor ">Qi  Luo</span>, <span class="hlFld-ContribAuthor ">Fu-Rong  Xu</span>, <span class="hlFld-ContribAuthor ">Yong-Xian  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Phenolic derivatives from Blaps japanensis and their biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2017,</strong> <em>120 </em>, 58-60. <a href="https://doi.org/10.1016/j.fitote.2017.05.010" title="DOI URL">https://doi.org/10.1016/j.fitote.2017.05.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2017.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2017.05.010%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DPhenolic%252Bderivatives%252Bfrom%252BBlaps%252Bjapanensis%252Band%252Btheir%252Bbiological%252Bevaluation%26aulast%3DZheng%26aufirst%3DTao%26date%3D2017%26volume%3D120%26spage%3D58%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Mouillac</span>, <span class="hlFld-ContribAuthor ">Christiane  Mendre</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 63-83. <a href="https://doi.org/10.1007/164_2017_50" title="DOI URL">https://doi.org/10.1007/164_2017_50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2017_50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2017_50%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacological%252BChaperones%252Bas%252BPotential%252BTherapeutic%252BStrategies%252Bfor%252BMisfolded%252BMutant%252BVasopressin%252BReceptors%26aulast%3DMouillac%26aufirst%3DBernard%26date%3D2017%26spage%3D63%26epage%3D83%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTargeting%252BTrafficking%252Bin%252BDrug%252BDevelopment%26aulast%3DUlloa-Aguirre%26aufirst%3DAlfredo%26date%3D2018%26volume%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Mouillac</span>, <span class="hlFld-ContribAuthor ">Christiane  Mendre</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 163-180. <a href="https://doi.org/10.1007/7355_2017_14" title="DOI URL">https://doi.org/10.1007/7355_2017_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_14%26sid%3Dliteratum%253Aachs%26atitle%3DBiased%252BAgonist%252BPharmacochaperones%25253A%252BSmall%252BMolecules%252Bin%252Bthe%252BToolbox%252Bfor%252BSelectively%252BModulating%252BGPCR%252BActivity%26aulast%3DMouillac%26aufirst%3DBernard%26date%3D2017%26date%3D2017%26spage%3D163%26epage%3D180%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DStructure%252Band%252BFunction%252Bof%252BGPCRs%26aulast%3DLebon%26aufirst%3DGuillaume%26date%3D2019%26volume%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil M.  Urs</span>, <span class="hlFld-ContribAuthor ">Sean M.  Peterson</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>. </span><span class="cited-content_cbyCitation_article-title">New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy. </span><span class="cited-content_cbyCitation_journal-name">Biological Psychiatry</span><span> <strong>2017,</strong> <em>81 </em>
                                    (1)
                                     , 78-85. <a href="https://doi.org/10.1016/j.biopsych.2016.10.011" title="DOI URL">https://doi.org/10.1016/j.biopsych.2016.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopsych.2016.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopsych.2016.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520Psychiatry%26atitle%3DNew%252BConcepts%252Bin%252BDopamine%252BD2%252BReceptor%252BBiased%252BSignaling%252Band%252BImplications%252Bfor%252BSchizophrenia%252BTherapy%26aulast%3DUrs%26aufirst%3DNikhil%2BM.%26date%3D2017%26volume%3D81%26issue%3D1%26spage%3D78%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuzana  Bologna</span>, <span class="hlFld-ContribAuthor ">Jian-peng  Teoh</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Bayoumi</span>, <span class="hlFld-ContribAuthor ">Yaoliang  Tang</span>, <span class="hlFld-ContribAuthor ">Il-man  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Biased G Protein-Coupled Receptor Signaling: New Player in Modulating Physiology and Pathology. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules & Therapeutics</span><span> <strong>2017,</strong> <em>25 </em>
                                    (1)
                                     , 12-25. <a href="https://doi.org/10.4062/biomolther.2016.165" title="DOI URL">https://doi.org/10.4062/biomolther.2016.165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4062/biomolther.2016.165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4062%2Fbiomolther.2016.165%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%2520%2526%2520Therapeutics%26atitle%3DBiased%252BG%252BProtein-Coupled%252BReceptor%252BSignaling%25253A%252BNew%252BPlayer%252Bin%252BModulating%252BPhysiology%252Band%252BPathology%26aulast%3DBologna%26aufirst%3DZuzana%26date%3D2017%26volume%3D25%26issue%3D1%26spage%3D12%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil M.  Urs</span>, <span class="hlFld-ContribAuthor ">Steven M.  Gee</span>, <span class="hlFld-ContribAuthor ">Thomas F.  Pack</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Tama  Evron</span>, <span class="hlFld-ContribAuthor ">Joshua C.  Snyder</span>, <span class="hlFld-ContribAuthor ">Xiaobao  Yang</span>, <span class="hlFld-ContribAuthor ">Ramona M.  Rodriguiz</span>, <span class="hlFld-ContribAuthor ">Emiliana  Borrelli</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Patricio  O’Donnell</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>. </span><span class="cited-content_cbyCitation_article-title">Distinct cortical and striatal actions of a β-arrestin–biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2016,</strong> <em>113 </em>
                                    (50)
                                     , E8178-E8186. <a href="https://doi.org/10.1073/pnas.1614347113" title="DOI URL">https://doi.org/10.1073/pnas.1614347113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1614347113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1614347113%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDistinct%252Bcortical%252Band%252Bstriatal%252Bactions%252Bof%252Ba%252B%2525CE%2525B2-arrestin%2525E2%252580%252593biased%252Bdopamine%252BD2%252Breceptor%252Bligand%252Breveal%252Bunique%252Bantipsychotic-like%252Bproperties%26aulast%3DUrs%26aufirst%3DNikhil%2BM.%26date%3D2016%26date%3D2016%26volume%3D113%26issue%3D50%26spage%3DE8178%26epage%3DE8186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sungchil  Yang</span>, <span class="hlFld-ContribAuthor ">Roy  Ben-Shalom</span>, <span class="hlFld-ContribAuthor ">Misol  Ahn</span>, <span class="hlFld-ContribAuthor ">Alayna T.  Liptak</span>, <span class="hlFld-ContribAuthor ">Richard M.  van Rijn</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Whistler</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Bender</span>. </span><span class="cited-content_cbyCitation_article-title">β-Arrestin-Dependent Dopaminergic Regulation of Calcium Channel Activity in the Axon Initial Segment. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2016,</strong> <em>16 </em>
                                    (6)
                                     , 1518-1526. <a href="https://doi.org/10.1016/j.celrep.2016.06.098" title="DOI URL">https://doi.org/10.1016/j.celrep.2016.06.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2016.06.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2016.06.098%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3D%2525CE%2525B2-Arrestin-Dependent%252BDopaminergic%252BRegulation%252Bof%252BCalcium%252BChannel%252BActivity%252Bin%252Bthe%252BAxon%252BInitial%252BSegment%26aulast%3DYang%26aufirst%3DSungchil%26date%3D2016%26volume%3D16%26issue%3D6%26spage%3D1518%26epage%3D1526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jo-Anne  Baltos</span>, <span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Anh T. N.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Dilip K.  Tosh</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Lauren T.  May</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Analysis of Biased Agonism at the Human Adenosine A
              3
              Receptor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2016,</strong> <em>90 </em>
                                    (1)
                                     , 12-22. <a href="https://doi.org/10.1124/mol.116.103283" title="DOI URL">https://doi.org/10.1124/mol.116.103283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.116.103283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.116.103283%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DStructure-Activity%252BAnalysis%252Bof%252BBiased%252BAgonism%252Bat%252Bthe%252BHuman%252BAdenosine%252BA%252B3%252BReceptor%26aulast%3DBaltos%26aufirst%3DJo-Anne%26date%3D2016%26date%3D2016%26volume%3D90%26issue%3D1%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anitha  Kopinathan</span>, <span class="hlFld-ContribAuthor ">Peter J  Scammells</span>, <span class="hlFld-ContribAuthor ">J Robert  Lane</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>. </span><span class="cited-content_cbyCitation_article-title">Multivalent approaches and beyond: novel tools for the investigation of dopamine D
              2
              receptor pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (11)
                                     , 1349-1372. <a href="https://doi.org/10.4155/fmc-2016-0010" title="DOI URL">https://doi.org/10.4155/fmc-2016-0010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0010%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultivalent%252Bapproaches%252Band%252Bbeyond%25253A%252Bnovel%252Btools%252Bfor%252Bthe%252Binvestigation%252Bof%252Bdopamine%252BD%252B2%252Breceptor%252Bpharmacology%26aulast%3DKopinathan%26aufirst%3DAnitha%26date%3D2016%26volume%3D8%26issue%3D11%26spage%3D1349%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seiji  Ogawa</span>, <span class="hlFld-ContribAuthor ">Toshihide  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kazumi  Moriyuki</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Goto</span>, <span class="hlFld-ContribAuthor ">Shinsaku  Yamane</span>, <span class="hlFld-ContribAuthor ">Akio  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kazuma  Tsuboi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Takuya  Okada</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Takeda</span>, <span class="hlFld-ContribAuthor ">Kousuke  Tani</span>, <span class="hlFld-ContribAuthor ">Toru  Maruyama</span>. </span><span class="cited-content_cbyCitation_article-title">Structural optimization and structure–functional selectivity relationship studies of G protein-biased EP2 receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (10)
                                     , 2446-2449. <a href="https://doi.org/10.1016/j.bmcl.2016.03.110" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Boptimization%252Band%252Bstructure%2525E2%252580%252593functional%252Bselectivity%252Brelationship%252Bstudies%252Bof%252BG%252Bprotein-biased%252BEP2%252Breceptor%252Bagonists%26aulast%3DOgawa%26aufirst%3DSeiji%26date%3D2016%26volume%3D26%26issue%3D10%26spage%3D2446%26epage%3D2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>, <span class="hlFld-ContribAuthor ">Tarsis F.  Brust</span>, <span class="hlFld-ContribAuthor ">Laura M.  Bohn</span>. </span><span class="cited-content_cbyCitation_article-title">Biased agonism: An emerging paradigm in GPCR drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 241-250. <a href="https://doi.org/10.1016/j.bmcl.2015.12.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiased%252Bagonism%25253A%252BAn%252Bemerging%252Bparadigm%252Bin%252BGPCR%252Bdrug%252Bdiscovery%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D241%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyeong-Min  Lee</span>, <span class="hlFld-ContribAuthor ">Yuna  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders. </span><span class="cited-content_cbyCitation_journal-name">Schizophrenia Research and Treatment</span><span> <strong>2016,</strong> <em>2016 </em>, 1-12. <a href="https://doi.org/10.1155/2016/6378137" title="DOI URL">https://doi.org/10.1155/2016/6378137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2016/6378137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2016%2F6378137%26sid%3Dliteratum%253Aachs%26jtitle%3DSchizophrenia%2520Research%2520and%2520Treatment%26atitle%3DDrug%252BRepurposing%252BIs%252Ba%252BNew%252BOpportunity%252Bfor%252BDeveloping%252BDrugs%252Bagainst%252BNeuropsychiatric%252BDisorders%26aulast%3DLee%26aufirst%3DHyeong-Min%26date%3D2016%26volume%3D2016%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony Yiu-Ho  Woo</span>, <span class="hlFld-ContribAuthor ">Ying  Song</span>, <span class="hlFld-ContribAuthor ">Weizhong  Zhu</span>, <span class="hlFld-ContribAuthor ">Rui-Ping  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β
              2
              -adrenoceptor. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2015,</strong> <em>172 </em>
                                    (23)
                                     , 5477-5488. <a href="https://doi.org/10.1111/bph.13049" title="DOI URL">https://doi.org/10.1111/bph.13049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13049%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DAdvances%252Bin%252Breceptor%252Bconformation%252Bresearch%25253A%252Bthe%252Bquest%252Bfor%252Bfunctionally%252Bselective%252Bconformations%252Bfocusing%252Bon%252Bthe%252B%2525CE%2525B2%252B2%252B-adrenoceptor%26aulast%3DWoo%26aufirst%3DAnthony%2BYiu-Ho%26date%3D2015%26date%3D2015%26volume%3D172%26issue%3D23%26spage%3D5477%26epage%3D5488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Ismail  Salama</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Kling</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (18)
                                     , 6195-6209. <a href="https://doi.org/10.1016/j.bmc.2015.07.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1%25252C4-Disubstituted%252Baromatic%252Bpiperazines%252Bwith%252Bhigh%252B5-HT2A%25252FD2%252Bselectivity%25253A%252BQuantitative%252Bstructure-selectivity%252Binvestigations%25252C%252Bdocking%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DM%25C3%25B6ller%26aufirst%3DDorothee%26date%3D2015%26volume%3D23%26issue%3D18%26spage%3D6195%26epage%3D6209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Richard  Ward</span>, <span class="hlFld-ContribAuthor ">Su  An</span>, <span class="hlFld-ContribAuthor ">Xiao-Xi  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Tian-Rui  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2015,</strong> <em>470 </em>
                                    (2)
                                     , 155-167. <a href="https://doi.org/10.1042/BJ20150358" title="DOI URL">https://doi.org/10.1042/BJ20150358</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20150358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20150358%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DBiased%252Bsignalling%25253A%252Bthe%252Binstinctive%252Bskill%252Bof%252Bthe%252Bcell%252Bin%252Bthe%252Bselection%252Bof%252Bappropriate%252Bsignalling%252Bpathways%26aulast%3DLiu%26aufirst%3DYing%26date%3D2015%26date%3D2015%26volume%3D470%26issue%3D2%26spage%3D155%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolas  Stroth</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Nicola A.  Colabufo</span>, <span class="hlFld-ContribAuthor ">Roberto  Perrone</span>, <span class="hlFld-ContribAuthor ">Per  Svenningsson</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>. </span><span class="cited-content_cbyCitation_article-title">Arylpiperazine agonists of the serotonin 5-HT1A receptor preferentially activate cAMP signaling versus recruitment of β-arrestin-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4824-4830. <a href="https://doi.org/10.1016/j.bmc.2015.05.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DArylpiperazine%252Bagonists%252Bof%252Bthe%252Bserotonin%252B5-HT1A%252Breceptor%252Bpreferentially%252Bactivate%252BcAMP%252Bsignaling%252Bversus%252Brecruitment%252Bof%252B%2525CE%2525B2-arrestin-2%26aulast%3DStroth%26aufirst%3DNikolas%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4824%26epage%3D4830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin C.  Michel</span>, <span class="hlFld-ContribAuthor ">Roland  Seifert</span>. </span><span class="cited-content_cbyCitation_article-title">Selectivity of pharmacological tools: implications for use in cell physiology. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Cell Physiology</span><span> <strong>2015,</strong> <em>308 </em>
                                    (7)
                                     , C505-C520. <a href="https://doi.org/10.1152/ajpcell.00389.2014" title="DOI URL">https://doi.org/10.1152/ajpcell.00389.2014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpcell.00389.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpcell.00389.2014%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Cell%2520Physiology%26atitle%3DSelectivity%252Bof%252Bpharmacological%252Btools%25253A%252Bimplications%252Bfor%252Buse%252Bin%252Bcell%252Bphysiology.%252BA%252BReview%252Bin%252Bthe%252BTheme%25253A%252BCell%252BSignaling%25253A%252BProteins%25252C%252BPathways%252Band%252BMechanisms%26aulast%3DMichel%26aufirst%3DMartin%2BC.%26date%3D2015%26volume%3D308%26issue%3D7%26spage%3DC505%26epage%3DC520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie A.  Meade</span>, <span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Nicole R.  Miller</span>, <span class="hlFld-ContribAuthor ">Lani S.  Chun</span>, <span class="hlFld-ContribAuthor ">Trevor B.  Doyle</span>, <span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Jennie L.  Conroy</span>, <span class="hlFld-ContribAuthor ">Val J.  Watts</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling. </span><span class="cited-content_cbyCitation_journal-name">Psychopharmacology</span><span> <strong>2015,</strong> <em>232 </em>
                                    (5)
                                     , 917-930. <a href="https://doi.org/10.1007/s00213-014-3726-8" title="DOI URL">https://doi.org/10.1007/s00213-014-3726-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00213-014-3726-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00213-014-3726-8%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychopharmacology%26atitle%3D%252528-%252529-Stepholidine%252Bis%252Ba%252Bpotent%252Bpan-dopamine%252Breceptor%252Bantagonist%252Bof%252Bboth%252BG%252Bprotein-%252Band%252B%2525CE%2525B2-arrestin-mediated%252Bsignaling%26aulast%3DMeade%26aufirst%3DJulie%2BA.%26date%3D2015%26date%3D2014%26volume%3D232%26issue%3D5%26spage%3D917%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Reinartz</span>, <span class="hlFld-ContribAuthor ">Solveig  Kälble</span>, <span class="hlFld-ContribAuthor ">Timo  Littmann</span>, <span class="hlFld-ContribAuthor ">Takeaki  Ozawa</span>, <span class="hlFld-ContribAuthor ">Stefan  Dove</span>, <span class="hlFld-ContribAuthor ">Volkhard  Kaever</span>, <span class="hlFld-ContribAuthor ">Irving W.  Wainer</span>, <span class="hlFld-ContribAuthor ">Roland  Seifert</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor. </span><span class="cited-content_cbyCitation_journal-name">Naunyn-Schmiedeberg's Archives of Pharmacology</span><span> <strong>2015,</strong> <em>388 </em>
                                    (1)
                                     , 51-65. <a href="https://doi.org/10.1007/s00210-014-1054-5" title="DOI URL">https://doi.org/10.1007/s00210-014-1054-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00210-014-1054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00210-014-1054-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Archives%2520of%2520Pharmacology%26atitle%3DStructure-bias%252Brelationships%252Bfor%252Bfenoterol%252Bstereoisomers%252Bin%252Bsix%252Bmolecular%252Band%252Bcellular%252Bassays%252Bat%252Bthe%252B%2525CE%2525B22-adrenoceptor%26aulast%3DReinartz%26aufirst%3DMichael%2BT.%26date%3D2015%26date%3D2014%26volume%3D388%26issue%3D1%26spage%3D51%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarsis F.  Brust</span>, <span class="hlFld-ContribAuthor ">Michael P.  Hayes</span>, <span class="hlFld-ContribAuthor ">David L.  Roman</span>, <span class="hlFld-ContribAuthor ">Val J.  Watts</span>. </span><span class="cited-content_cbyCitation_article-title">New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>93 </em>
                                    (1)
                                     , 85-91. <a href="https://doi.org/10.1016/j.bcp.2014.10.014" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DNew%252Bfunctional%252Bactivity%252Bof%252Baripiprazole%252Brevealed%25253A%252BRobust%252Bantagonism%252Bof%252BD2%252Bdopamine%252Breceptor-stimulated%252BG%2525CE%2525B2%2525CE%2525B3%252Bsignaling%26aulast%3DBrust%26aufirst%3DTarsis%2BF.%26date%3D2015%26volume%3D93%26issue%3D1%26spage%3D85%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Fang  Xu</span>, <span class="hlFld-ContribAuthor ">Xue  Liang</span>, <span class="hlFld-ContribAuthor ">Bing-Bing  Xu</span>, <span class="hlFld-ContribAuthor ">Zong-Lin  Yang</span>, <span class="hlFld-ContribAuthor ">Xue-Lan  He</span>, <span class="hlFld-ContribAuthor ">Bi-Yun  Huang</span>, <span class="hlFld-ContribAuthor ">Mu  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (2)
                                     , 285-287. <a href="https://doi.org/10.1016/j.bmcl.2014.11.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Barylpiperazine%252Bderivatives%252Bon%252Bhuman%252Bprostate%252Bcancer%252Bcell%252Blines%26aulast%3DChen%26aufirst%3DHong%26date%3D2015%26volume%3D25%26issue%3D2%26spage%3D285%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Mahadeo R.  Patil</span>, <span class="hlFld-ContribAuthor ">Siddappa A.  Patil</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 207-251. <a href="https://doi.org/10.1016/j.ejmech.2014.10.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bin%252Bcurrent%252Bdevelopments%252Bof%252Bbenzothiazole-based%252Bmolecules%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2015%26volume%3D89%26spage%3D207%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Martin  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Stefano  Espinoza</span>, <span class="hlFld-ContribAuthor ">Raul R  Gainetdinov</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine receptors - IUPHAR Review 13. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2015,</strong> <em>172 </em>
                                    (1)
                                     , 1-23. <a href="https://doi.org/10.1111/bph.12906" title="DOI URL">https://doi.org/10.1111/bph.12906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12906%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DDopamine%252Breceptors%252B-%252BIUPHAR%252BReview%252B13%26aulast%3DBeaulieu%26aufirst%3DJean-Martin%26date%3D2015%26date%3D2014%26volume%3D172%26issue%3D1%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan-Peter  van Wieringen</span>, <span class="hlFld-ContribAuthor ">Martin C  Michel</span>, <span class="hlFld-ContribAuthor ">Henk M  Janssen</span>, <span class="hlFld-ContribAuthor ">Anton G  Janssen</span>, <span class="hlFld-ContribAuthor ">Philip H  Elsinga</span>, <span class="hlFld-ContribAuthor ">Jan  Booij</span>. </span><span class="cited-content_cbyCitation_article-title">Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2014,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-014-0053-3" title="DOI URL">https://doi.org/10.1186/s13550-014-0053-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-014-0053-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-014-0053-3%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DAgonist%252Bsignalling%252Bproperties%252Bof%252Bradiotracers%252Bused%252Bfor%252Bimaging%252Bof%252Bdopamine%252BD2%25252F3%252Breceptors%26aulast%3Dvan%2BWieringen%26aufirst%3DJan-Peter%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy  Shonberg</span>, <span class="hlFld-ContribAuthor ">Laura  Lopez</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2014,</strong> <em>34 </em>
                                    (6)
                                     , 1286-1330. <a href="https://doi.org/10.1002/med.21318" title="DOI URL">https://doi.org/10.1002/med.21318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21318%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DBiased%252BAgonism%252Bat%252BG%252BProtein-Coupled%252BReceptors%25253A%252BThe%252BPromise%252Band%252Bthe%252BChallenges-A%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DShonberg%26aufirst%3DJeremy%26date%3D2014%26date%3D2014%26volume%3D34%26issue%3D6%26spage%3D1286%26epage%3D1330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Xue  Liang</span>, <span class="hlFld-ContribAuthor ">Fang  Xu</span>, <span class="hlFld-ContribAuthor ">Bingbing  Xu</span>, <span class="hlFld-ContribAuthor ">Xuelan  He</span>, <span class="hlFld-ContribAuthor ">Biyun  Huang</span>, <span class="hlFld-ContribAuthor ">Mu  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic Activity Evaluation of Novel Arylpiperazine Derivatives on Human Prostate Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (8)
                                     , 12048-12064. <a href="https://doi.org/10.3390/molecules190812048" title="DOI URL">https://doi.org/10.3390/molecules190812048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules190812048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules190812048%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BCytotoxic%252BActivity%252BEvaluation%252Bof%252BNovel%252BArylpiperazine%252BDerivatives%252Bon%252BHuman%252BProstate%252BCancer%252BCell%252BLines%26aulast%3DChen%26aufirst%3DHong%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D8%26spage%3D12048%26epage%3D12064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Benjamin  Free</span>, <span class="hlFld-ContribAuthor ">Lani S.  Chun</span>, <span class="hlFld-ContribAuthor ">Amy E.  Moritz</span>, <span class="hlFld-ContribAuthor ">Brittney N.  Miller</span>, <span class="hlFld-ContribAuthor ">Trevor B.  Doyle</span>, <span class="hlFld-ContribAuthor ">Jennie L.  Conroy</span>, <span class="hlFld-ContribAuthor ">Adrian  Padron</span>, <span class="hlFld-ContribAuthor ">Julie A.  Meade</span>, <span class="hlFld-ContribAuthor ">Jingbo  Xiao</span>, <span class="hlFld-ContribAuthor ">Xin  Hu</span>, <span class="hlFld-ContribAuthor ">Andrés E.  Dulcey</span>, <span class="hlFld-ContribAuthor ">Yang  Han</span>, <span class="hlFld-ContribAuthor ">Lihua  Duan</span>, <span class="hlFld-ContribAuthor ">Steve  Titus</span>, <span class="hlFld-ContribAuthor ">Melanie  Bryant-Genevier</span>, <span class="hlFld-ContribAuthor ">Elena  Barnaeva</span>, <span class="hlFld-ContribAuthor ">Marc  Ferrer</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Thijs  Beuming</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Noel T.  Southall</span>, <span class="hlFld-ContribAuthor ">Juan J.  Marugan</span>, <span class="hlFld-ContribAuthor ">David R.  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of a G Protein–Biased Agonist That Inhibits
              β
              -Arrestin Recruitment to the D2 Dopamine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2014,</strong> <em>86 </em>
                                    (1)
                                     , 96-105. <a href="https://doi.org/10.1124/mol.113.090563" title="DOI URL">https://doi.org/10.1124/mol.113.090563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.113.090563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.113.090563%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252Ba%252BG%252BProtein%2525E2%252580%252593Biased%252BAgonist%252BThat%252BInhibits%252B%2525CE%2525B2%252B-Arrestin%252BRecruitment%252Bto%252Bthe%252BD2%252BDopamine%252BReceptor%26aulast%3DFree%26aufirst%3DR.%2BBenjamin%26date%3D2014%26date%3D2014%26volume%3D86%26issue%3D1%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyeong-Min  Lee</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Giguere</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>. </span><span class="cited-content_cbyCitation_article-title">DREADDs: novel tools for drug discovery and development. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (4)
                                     , 469-473. <a href="https://doi.org/10.1016/j.drudis.2013.10.018" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DDREADDs%25253A%252Bnovel%252Btools%252Bfor%252Bdrug%252Bdiscovery%252Band%252Bdevelopment%26aulast%3DLee%26aufirst%3DHyeong-Min%26date%3D2014%26volume%3D19%26issue%3D4%26spage%3D469%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Reinartz</span>, <span class="hlFld-ContribAuthor ">Roland  Seifert</span>. </span><span class="cited-content_cbyCitation_article-title">Funktionelle Selektivität am Beispiel des β2-Adrenozeptors. </span><span class="cited-content_cbyCitation_journal-name">BIOspektrum</span><span> <strong>2014,</strong> <em>20 </em>
                                    (2)
                                     , 130-135. <a href="https://doi.org/10.1007/s12268-014-0415-4" title="DOI URL">https://doi.org/10.1007/s12268-014-0415-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12268-014-0415-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12268-014-0415-4%26sid%3Dliteratum%253Aachs%26jtitle%3DBIOspektrum%26atitle%3DFunktionelle%252BSelektivit%2525C3%2525A4t%252Bam%252BBeispiel%252Bdes%252B%2525CE%2525B22-Adrenozeptors%26aulast%3DReinartz%26aufirst%3DMichael%2BT.%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D2%26spage%3D130%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">Quantifying Biased β-Arrestin Signaling. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 57-83. <a href="https://doi.org/10.1007/978-3-642-41199-1_3" title="DOI URL">https://doi.org/10.1007/978-3-642-41199-1_3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-642-41199-1_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-642-41199-1_3%26sid%3Dliteratum%253Aachs%26atitle%3DQuantifying%252BBiased%252B%2525CE%2525B2-Arrestin%252BSignaling%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2014%26date%3D2013%26spage%3D57%26epage%3D83%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DArrestins%252B-%252BPharmacology%252Band%252BTherapeutic%252BPotential%26aulast%3DGurevich%26aufirst%3DVsevolod%2BV.%26date%3D2014%26volume%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry  Kenakin</span>. </span><span class="cited-content_cbyCitation_article-title">The Application of Signaling Bias to New Therapeutic Drug Therapy for Seven Transmembrane (G Protein-coupled) Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 81-102. <a href="https://doi.org/10.1016/B978-0-12-411460-9.00003-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-411460-9.00003-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411460-9.00003-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411460-9.00003-3%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BApplication%252Bof%252BSignaling%252BBias%252Bto%252BNew%252BTherapeutic%252BDrug%252BTherapy%252Bfor%252BSeven%252BTransmembrane%252B%252528G%252BProtein-coupled%252529%252BReceptors%26aulast%3DKenakin%26aufirst%3DTerry%26date%3D2014%26spage%3D81%26epage%3D102%26pub%3DElsevier%26atitle%3DBiased%252BSignaling%252Bin%252BPhysiology%25252C%252BPharmacology%252Band%252BTherapeutics%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Bosier</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Hermans</span>. </span><span class="cited-content_cbyCitation_article-title">Promises of Biased Signaling in the Development of Improved Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 251-292. <a href="https://doi.org/10.1016/B978-0-12-411460-9.00008-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-411460-9.00008-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411460-9.00008-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411460-9.00008-2%26sid%3Dliteratum%253Aachs%26atitle%3DPromises%252Bof%252BBiased%252BSignaling%252Bin%252Bthe%252BDevelopment%252Bof%252BImproved%252BTherapeutics%26aulast%3DBosier%26aufirst%3DBarbara%26date%3D2014%26spage%3D251%26epage%3D292%26pub%3DElsevier%26atitle%3DBiased%252BSignaling%252Bin%252BPhysiology%25252C%252BPharmacology%252Band%252BTherapeutics%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kate L.  White</span>, <span class="hlFld-ContribAuthor ">Alex P.  Scopton</span>, <span class="hlFld-ContribAuthor ">Marie-Laure  Rives</span>, <span class="hlFld-ContribAuthor ">Ruslan V.  Bikbulatov</span>, <span class="hlFld-ContribAuthor ">Prabhakar R.  Polepally</span>, <span class="hlFld-ContribAuthor ">Peter J.  Brown</span>, <span class="hlFld-ContribAuthor ">Terrance  Kenakin</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Jordan K.  Zjawiony</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Functionally Selective
              κ
              -Opioid Receptor Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2014,</strong> <em>85 </em>
                                    (1)
                                     , 83-90. <a href="https://doi.org/10.1124/mol.113.089649" title="DOI URL">https://doi.org/10.1124/mol.113.089649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.113.089649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.113.089649%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DIdentification%252Bof%252BNovel%252BFunctionally%252BSelective%252B%2525CE%2525BA%252B-Opioid%252BReceptor%252BScaffolds%26aulast%3DWhite%26aufirst%3DKate%2BL.%26date%3D2014%26date%3D2013%26volume%3D85%26issue%3D1%26spage%3D83%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayako  Michino</span>, <span class="hlFld-ContribAuthor ">Prashant  Donthamsetti</span>, <span class="hlFld-ContribAuthor ">Thijs  Beuming</span>, <span class="hlFld-ContribAuthor ">Ashwini  Banala</span>, <span class="hlFld-ContribAuthor ">Lihua  Duan</span>, <span class="hlFld-ContribAuthor ">Thomas  Roux</span>, <span class="hlFld-ContribAuthor ">Yang  Han</span>, <span class="hlFld-ContribAuthor ">Eric  Trinquet</span>, <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A Single Glycine in Extracellular Loop 1 Is the Critical Determinant for Pharmacological Specificity of Dopamine D2 and D3 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2013,</strong> <em>84 </em>
                                    (6)
                                     , 854-864. <a href="https://doi.org/10.1124/mol.113.087833" title="DOI URL">https://doi.org/10.1124/mol.113.087833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.113.087833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.113.087833%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DA%252BSingle%252BGlycine%252Bin%252BExtracellular%252BLoop%252B1%252BIs%252Bthe%252BCritical%252BDeterminant%252Bfor%252BPharmacological%252BSpecificity%252Bof%252BDopamine%252BD2%252Band%252BD3%252BReceptors%26aulast%3DMichino%26aufirst%3DMayako%26date%3D2013%26date%3D2013%26volume%3D84%26issue%3D6%26spage%3D854%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica Hoyos  Flight</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery: Structure-led design. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2013,</strong> <em>502 </em>
                                    (7471)
                                     , S50-S52. <a href="https://doi.org/10.1038/502S50a" title="DOI URL">https://doi.org/10.1038/502S50a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/502S50a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2F502S50a%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DDrug%252BDiscovery%25253A%252BStructure-led%252Bdesign%26aulast%3DFlight%26aufirst%3DMonica%2BHoyos%26date%3D2013%26date%3D2013%26volume%3D502%26issue%3D7471%26spage%3DS50%26epage%3DS52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heike  Anderson-Schmidt</span>, <span class="hlFld-ContribAuthor ">Olga  Beltcheva</span>, <span class="hlFld-ContribAuthor ">Mariko D.  Brandon</span>, <span class="hlFld-ContribAuthor ">Enda M.  Byrne</span>, <span class="hlFld-ContribAuthor ">Eric J.  Diehl</span>, <span class="hlFld-ContribAuthor ">Laramie  Duncan</span>, <span class="hlFld-ContribAuthor ">Suzanne D.  Gonzalez</span>, <span class="hlFld-ContribAuthor ">Eilis  Hannon</span>, <span class="hlFld-ContribAuthor ">Katri  Kantojärvi</span>, <span class="hlFld-ContribAuthor ">Iordanis  Karagiannidis</span>, <span class="hlFld-ContribAuthor ">Mark Z.  Kos</span>, <span class="hlFld-ContribAuthor ">Eszter  Kotyuk</span>, <span class="hlFld-ContribAuthor ">Benjamin I.  Laufer</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Mantha</span>, <span class="hlFld-ContribAuthor ">Nathaniel W.  McGregor</span>, <span class="hlFld-ContribAuthor ">Sandra  Meier</span>, <span class="hlFld-ContribAuthor ">Vanessa  Nieratschker</span>, <span class="hlFld-ContribAuthor ">Helen  Spiers</span>, <span class="hlFld-ContribAuthor ">Alessio  Squassina</span>, <span class="hlFld-ContribAuthor ">Geeta A.  Thakur</span>, <span class="hlFld-ContribAuthor ">Yash  Tiwari</span>, <span class="hlFld-ContribAuthor ">Biju  Viswanath</span>, <span class="hlFld-ContribAuthor ">Michael J.  Way</span>, <span class="hlFld-ContribAuthor ">Cybele C.P.  Wong</span>, <span class="hlFld-ContribAuthor ">Anne  O'Shea</span>, <span class="hlFld-ContribAuthor ">Lynn E.  DeLisi</span>. </span><span class="cited-content_cbyCitation_article-title">Selected rapporteur summaries from the XX world congress of psychiatric genetics, Hamburg, Germany, october 14-18, 2012. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</span><span> <strong>2013,</strong> <em>162 </em>
                                    (2)
                                     , 96-121. <a href="https://doi.org/10.1002/ajmg.b.32132" title="DOI URL">https://doi.org/10.1002/ajmg.b.32132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajmg.b.32132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajmg.b.32132%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Medical%2520Genetics%2520Part%2520B%253A%2520Neuropsychiatric%2520Genetics%26atitle%3DSelected%252Brapporteur%252Bsummaries%252Bfrom%252Bthe%252BXX%252Bworld%252Bcongress%252Bof%252Bpsychiatric%252Bgenetics%25252C%252BHamburg%25252C%252BGermany%25252C%252Boctober%252B14-18%25252C%252B2012%26aulast%3DAnderson-Schmidt%26aufirst%3DHeike%26date%3D2013%26date%3D2013%26volume%3D162%26issue%3D2%26spage%3D96%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Henry  Lin</span>, <span class="hlFld-ContribAuthor ">Maria F  Sassano</span>, <span class="hlFld-ContribAuthor ">Bryan L  Roth</span>, <span class="hlFld-ContribAuthor ">Brian K  Shoichet</span>. </span><span class="cited-content_cbyCitation_article-title">A pharmacological organization of G protein–coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">Nature Methods</span><span> <strong>2013,</strong> <em>10 </em>
                                    (2)
                                     , 140-146. <a href="https://doi.org/10.1038/nmeth.2324" title="DOI URL">https://doi.org/10.1038/nmeth.2324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nmeth.2324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnmeth.2324%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Methods%26atitle%3DA%252Bpharmacological%252Borganization%252Bof%252BG%252Bprotein%2525E2%252580%252593coupled%252Breceptors%26aulast%3DLin%26aufirst%3DHenry%26date%3D2013%26date%3D2013%26volume%3D10%26issue%3D2%26spage%3D140%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Four regions of compound <b>1</b> investigated for SFSR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds designed to explore the LHS phenyl moiety.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds with Various Substituents on the LHS Phenyl Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds for Exploring the Middle Amino Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClCOOCH<sub>2</sub>Ph, CuI, THF, −10 °C; (b) <i>i</i>-PrMgCl, THF, −20 °C, 76%; (c) H<sub>2</sub>, RhCl(PPh<sub>3</sub>)<sub>3</sub>, toluene, 70 °C, 4 d, 95%; (d) 6 N HCl, reflux, 93%; (e) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 60% for <b>18</b>, 62% for <b>19</b>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds for Exploring the Central Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, EtOH, reflux, overnight, 35–80%; (b) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%; (c) Et<sub>3</sub>N, CH<sub>3</sub>CN, reflux, 4 h, 70–75%; (d) CuCl, Cs<sub>2</sub>CO<sub>3</sub>, TMHD, NMP, 120 °C, 7.5 h, 40–50%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0008.jpeg" id="rightTab-GRAPHIC-d168e1379-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds with Various RHS Bicyclic Aromatic Groups<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3,</sub> EtOH, reflux, 6 h, 30–80%; (b) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0019.jpeg" id="rightTab-GRAPHIC-d168e1521-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Combination Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3,</sub> EtOH, reflux, 6 h, 30–80%; (b) NaI/K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux, 6 h, 40–70%.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/medium/jm-2012-00603y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compounds <b>19</b> and <b>35</b> exhibit potent antipsychotic-like activities in mouse hyperlocomotion studies, which are completely abolished or significantly attenuated in β-arrestin-2 knockout mice. Locomotor activities shown as 5 min binned intervals for wild-type (WT) or β-arrestin-2 knockout (β-ARR2 KO) littermate mice given vehicle or 2.0 mg/kg <b>19</b> or <b>35</b> (ip), followed 30 min later with 6 mg/kg phencyclidine (PCP, ip). <i>n</i> = 8–13 WT and β-ARR2 KO pairs/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-16/jm300603y/production/images/large/jm-2012-00603y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300603y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Furchgott, R. F.</span><span> </span><span class="NLM_article-title">The use of haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of agonist-receptor complexes</span>. In  <span class="citation_source-book">Advances in Drug Research</span>; <span class="NLM_contrib-group">Harper, N.; Simmonds, A.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1966</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">3</span>, pp  <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1966&pages=21-55&author=R.+F.+Furchgottauthor=N.+Harper&author=A.+Simmonds&title=Advances+in+Drug+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFurchgott%26aufirst%3DR.%2BF.%26atitle%3DThe%2520use%2520of%2520haloalkylamines%2520in%2520the%2520differentiation%2520of%2520receptors%2520and%2520in%2520the%2520determination%2520of%2520dissociation%2520constants%2520of%2520agonist-receptor%2520complexes%26btitle%3DAdvances%2520in%2520Drug%2520Research%26aulast%3DHarper%26aufirst%3DN.%26pub%3DAcademic%2520Press%26date%3D1966%26volume%3D3%26spage%3D21%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, D. M.</span><span> </span><span class="NLM_article-title">Multiple mechanisms of serotonergic signal transduction</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1987&pages=1051-1064&author=B.+L.+Rothauthor=D.+M.+Chuang&title=Multiple+mechanisms+of+serotonergic+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChuang%26aufirst%3DD.%2BM.%26atitle%3DMultiple%2520mechanisms%2520of%2520serotonergic%2520signal%2520transduction%26jtitle%3DLife%2520Sci.%26date%3D1987%26volume%3D41%26spage%3D1051%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Berg, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maayani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfarb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaramellini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W. P.</span><span> </span><span class="NLM_article-title">Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fmol.54.1.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=9658194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVKqt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1998&pages=94-104&author=K.+A.+Bergauthor=S.+Maayaniauthor=J.+Goldfarbauthor=C.+Scaramelliniauthor=P.+Leffauthor=W.+P.+Clarke&title=Effector+pathway-dependent+relative+efficacy+at+serotonin+type+2A+and+2C+receptors%3A+evidence+for+agonist-directed+trafficking+of+receptor+stimulus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus</span></div><div class="casAuthors">Berg, Kelly A.; Maayani, Saul; Goldfarb, Joseph; Scaramellini, Clare; Leff, Paul; Clarke, William P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-104</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">There are many examples of a single receptor coupling directly to more than one cellular signal transduction pathway.  Although traditional receptor theory allows for activation of multiple cellular effectors by agonists, it predicts that the relative degree of activation of each effector pathway by an agonist (relative efficacy) must be the same.  In the current expts., we demonstrate that agonists at the human serotonin2A (5-HT2A) and 5-HT2C receptors activate differentially two signal transduction pathways independently coupled to the receptors [phospholipase C (PLC)-mediated inositol phosphate (IP) accumulation and phospholipase A2 (PLA2)-mediated arachidonic acid (AA) release].  The relative efficacies of agonists differed depending on which signal transduction pathway was measured.  Moreover, relative to 5-HT, some 5-HT2C agonists (e.g., 3-trifluoromethylphenyl-piperazine) preferentially activated the PLC-IP pathway, whereas others (e.g., lysergic acid diethylamide) favored the PLA2-AA pathway.  In contrast, when two dependent responses were measured (IP accumulation and calcium mobilization), agonist relative efficacies were not different.  These data strongly support the hypothesis termed "agonist-directed trafficking of receptor stimulus" recently proposed by Kenakin [Trends Pharmacol Sci 16:232-238 (1995)].  Concn.-response curves to 5-HT2C agonists were fit well by a three-state model of receptor activation, suggesting that two active receptor states may be sufficient to explain pathway-dependent agonist efficacy.  Rational drug design that optimizes preferential effector activity within a group of receptor-selective drugs holds the promise of increased selectivity in clin. useful agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpidEqbbZNg07Vg90H21EOLACvtfcHk0lhJDWHrmulgow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVKqt7w%253D&md5=99239b54cc498d1254aad42298ea5684</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fmol.54.1.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.54.1.94%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DMaayani%26aufirst%3DS.%26aulast%3DGoldfarb%26aufirst%3DJ.%26aulast%3DScaramellini%26aufirst%3DC.%26aulast%3DLeff%26aufirst%3DP.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26atitle%3DEffector%2520pathway-dependent%2520relative%2520efficacy%2520at%2520serotonin%2520type%25202A%2520and%25202C%2520receptors%253A%2520evidence%2520for%2520agonist-directed%2520trafficking%2520of%2520receptor%2520stimulus%26jtitle%3DMol.%2520Pharmacol.%26date%3D1998%26volume%3D54%26spage%3D94%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Parrish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">1575</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1111%2Fj.1471-4159.2005.03477.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=16277614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=1575-1584&author=J.+Parrishauthor=M.+Bradenauthor=E.+Gundyauthor=D.+E.+Nichols&title=Differential+phospholipase+C+activation+by+phenylalkylamine+serotonin+5-HT2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists</span></div><div class="casAuthors">Parrish, Jason C.; Braden, Michael R.; Gundy, Emily; Nichols, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1575-1584</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Expts. compared a series of phenethylamine hallucinogens with their phenylisopropylamine analogs for binding affinity and ability to stimulate serotonin 5-HT2A receptor-mediated hydrolysis of phosphatidyl inositol in cells expressing cloned rat and human 5-HT2A receptors.  The (±) phenylisopropylamine analogs had significantly higher intrinsic activities for 5-HT2A receptor-mediated hydrolysis of phosphatidyl inositol compared to their phenethylamine analogs.  With respect to the effects of the stereochem. of the phenylisopropylamines, those with the (R) abs. configuration at the alpha carbon had higher intrinsic activities for hydrolysis of phosphatidyl inositol in a cell line expressing the human 5-HT2A receptor compared to those with the (S) abs. configuration.  In virtual docking studies comparing the (R)- and (S)-phenylisopropylamines with their phenethylamine analogs, there were distinct differences in the orientations of key ligand binding domain residues that have been identified as important by previous mutagenesis studies.  In conclusion, our data support the hypothesis that phenylisopropylamines have higher hallucinogenic potency than their phenethylamine analogs primarily because they have higher intrinsic activities at 5-HT2A receptors.  Although virtual ligand binding led to significant perturbations of certain key residues, our results emphasize the conclusion reached by others that overall three-dimensional structural microdomains within the receptor must be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3fvZj2WkH7Vg90H21EOLACvtfcHk0lhJDWHrmulgow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVKisw%253D%253D&md5=fcba4d293061d292c540919af92f956f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03477.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03477.x%26sid%3Dliteratum%253Aachs%26aulast%3DParrish%26aufirst%3DJ.%26aulast%3DBraden%26aufirst%3DM.%26aulast%3DGundy%26aufirst%3DE.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3DDifferential%2520phospholipase%2520C%2520activation%2520by%2520phenylalkylamine%2520serotonin%25205-HT2A%2520receptor%2520agonists%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26spage%3D1575%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span> </span><span class="NLM_article-title">9-Dihydroxy-2,3,7,11b-tetrahydro-1<i>H</i>-naph[1,2,3-<i>de</i>]isoquinoline: a potent full dopamine D1 agonist containing a rigid beta-phenyldopamine pharmacophore</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950707%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=549-555&author=D.+Ghoshauthor=S.+E.+Snyderauthor=V.+J.+Wattsauthor=R.+B.+Mailmanauthor=D.+E.+Nichols&title=9-Dihydroxy-2%2C3%2C7%2C11b-tetrahydro-1H-naph%5B1%2C2%2C3-de%5Disoquinoline%3A+a+potent+full+dopamine+D1+agonist+containing+a+rigid+beta-phenyldopamine+pharmacophore"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm950707%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950707%252B%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DS.%2BE.%26aulast%3DWatts%26aufirst%3DV.%2BJ.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26atitle%3D9-Dihydroxy-2%252C3%252C7%252C11b-tetrahydro-1H-naph%255B1%252C2%252C3-de%255Disoquinoline%253A%2520a%2520potent%2520full%2520dopamine%2520D1%2520agonist%2520containing%2520a%2520rigid%2520beta-phenyldopamine%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D549%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kilts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connery, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.301.3.1179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=12023553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1179-1189&author=J.+D.+Kiltsauthor=H.+S.+Conneryauthor=E.+G.+Arringtonauthor=M.+M.+Lewisauthor=C.+P.+Lawlerauthor=G.+S.+Oxfordauthor=K.+L.+O%E2%80%99Malleyauthor=R.+D.+Toddauthor=B.+L.+Blakeauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+II.+Actions+of+dihydrexidine+in+D2L+receptor-transfected+MN9D+cells+and+pituitary+lactotrophs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs</span></div><div class="casAuthors">Kilts, Jason D.; Connery, Hilary S.; Arrington, Elaine G.; Lewis, Mechelle M.; Lawler, Cindy P.; Oxford, Gerry S.; O'Malley, Karen L.; Todd, Richard D.; Blake, Bonita L.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1179-1189</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">D2-like dopamine receptors mediate functional changes via activation of inhibitory G proteins, including those that affect adenylate cyclase activity, and potassium and calcium channels.  Although it is assumed that the binding of a drug to a single isoform of a D2-like receptor will cause similar changes in all receptor-mediated functions, it has been demonstrated in brain that the dopamine agonists dihydrexidine (DHX) and N-n-propyl-DHX are "functionally selective".  The current study explores the underlying mechanism using transfected MN9D cells and D2-producing anterior pituitary lactotrophs.  Both dopamine and DHX inhibited adenylate cyclase activity in a concn.-dependent manner in both systems, effects blocked by D2, but not D1, antagonists.  In the MN9D cells, quinpirole and R-(-)-N-propylnorapomorphine (NPA) also inhibited the K+-stimulated release of [3H]dopamine in a concn.-responsive, antagonist-reversible manner.  Conversely, neither DHX, nor its analogs, inhibited K+-stimulated [3H]dopamine release, although they antagonized the effects of quinpirole.  S-(+)-NPA actually had the reverse functional selectivity profile from DHX (i.e., it was a full agonist at D2L receptors coupled to inhibition of dopamine release, but a weak partial agonist at D2L receptor-mediated inhibition of adenylate cyclase).  In lactotrophs, DHX had little intrinsic activity at D2 receptors coupled to G protein-coupled inwardly rectifying potassium channels, and actually antagonized the effects of dopamine at these D2 receptors.  Together, these findings provide compelling evidence for agonist-induced functional selectivity with the D2L receptor.  Although the underlying mol. mechanism is controversial (e.g., "conformational induction" vs. "drug-active state selection"), such data are irreconcilable with the widely held view that drugs have "intrinsic efficacy".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxKyo-BPUi-LVg90H21EOLACvtfcHk0lgx5uHd3eH3pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrc%253D&md5=6686ca6fae277969b216781088d74a87</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1179%26sid%3Dliteratum%253Aachs%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DArrington%26aufirst%3DE.%2BG.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DK.%2BL.%26aulast%3DTodd%26aufirst%3DR.%2BD.%26aulast%3DBlake%26aufirst%3DB.%2BL.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520II.%2520Actions%2520of%2520dihydrexidine%2520in%2520D2L%2520receptor-transfected%2520MN9D%2520cells%2520and%2520pituitary%2520lactotrophs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1179%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mottola, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connery, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyslop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wightman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.301.3.1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=12023552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1166-1178&author=D.+M.+Mottolaauthor=J.+D.+Kiltsauthor=M.+M.+Lewisauthor=H.+S.+Conneryauthor=Q.+D.+Walkerauthor=S.+R.+Jonesauthor=R.+G.+Boothauthor=D.+K.+Hyslopauthor=M.+Pierceyauthor=R.+M.+Wightmanauthor=C.+P.+Lawlerauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+I.+Selective+activation+of+postsynaptic+dopamine+D2+receptors+linked+to+adenylate+cyclase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span></div><div class="casAuthors">Mottola, David M.; Kilts, Jason D.; Lewis, Mechelle M.; Connory, Hilary S.; Walker, Q. David; Jones, Sara R.; Booth, Raymond G.; Hyslop, Deborah K.; Piercey, Monford; Wightman, R. Mark; Lawler, Cindy P.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1166-1179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydrexidine (DHX), the first high-affinity D1 dopamine receptor full agonist, is only 10-fold selective for D1 vs. D2 receptors, having D2 affinity similar to the prototypical agonist quinpirole.  The D2 functional properties of DHX and its more D2 selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary.  DHX and PrDHX had binding characteristics to D2 receptors in rat striatum typical of D2 agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides.  Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equiv. to that of quinpirole.  Unexpectedly, however, DHX and PrDHX had little functional effect at D2 receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis.  Quant. receptor competition autoradiog. demonstrated that DHX bound to D2 receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D2 sites in the substantia nigra (autoreceptor sites).  The data from these expts., coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D2L and D2S receptors, causes agonist-typical functional changes only at some of these receptors.  This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at sep. functions mediated by a single isoform, yielding novel approaches to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpif5JbU-Rs9bVg90H21EOLACvtfcHk0lgx5uHd3eH3pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D&md5=b1d65ec3f66b3652deb9f9a4c76b70a3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1166%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DWalker%26aufirst%3DQ.%2BD.%26aulast%3DJones%26aufirst%3DS.%2BR.%26aulast%3DBooth%26aufirst%3DR.%2BG.%26aulast%3DHyslop%26aufirst%3DD.%2BK.%26aulast%3DPiercey%26aufirst%3DM.%26aulast%3DWightman%26aufirst%3DR.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520I.%2520Selective%2520activation%2520of%2520postsynaptic%2520dopamine%2520D2%2520receptors%2520linked%2520to%2520adenylate%2520cyclase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1166%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirotta, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotnikova, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salahpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1523%2FJNEUROSCI.5074-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=17251429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1Wrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=881-885&author=J.+M.+Beaulieuauthor=E.+Tirottaauthor=T.+D.+Sotnikovaauthor=B.+Masriauthor=A.+Salahpourauthor=R.+R.+Gainetdinovauthor=E.+Borrelliauthor=M.+G.+Caron&title=Regulation+of+Akt+signaling+by+D2+and+D3+dopamine+receptors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo</span></div><div class="casAuthors">Beaulieu, Jean-Martin; Tirotta, Emanuele; Sotnikova, Tatyana D.; Masri, Bernard; Salahpour, Ali; Gainetdinov, Raul R.; Borrelli, Emiliana; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-885</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The serine/threonine kinase Akt is a downstream target of dopamine receptor signaling that is inhibited/dephosphorylated in response to direct and indirect dopamine receptor agonists.  Although pharmacol. studies uncovered the involvement of D2-class dopamine receptors in Akt regulation, they did not identify the role of individual receptor subtypes in this process.  Here we used knock-out mice lacking the D1, D2, D2 long, or D3 dopamine receptors as well as a D4 receptor-selective antagonist to address the function of each of these receptors in the regulation of Akt in vivo.  Under basal conditions, D2, D2 long, and D3 knock-out mice display enhanced striatal Akt activation, whereas D1 knock-out mice and mice treated with the D4 receptor antagonist L 745870 have phospho-Akt levels comparable with those of normal control animals.  Furthermore, both amphetamine and apomorphine lose their ability to inhibit Akt in D2 knock-out mice but retain their normal effect on this signaling mol. in D1 knock-out animals.  Finally, D3 knock-out mice show a reduced sensitivity of Akt-mediated signaling to dopaminergic drugs but retain the action of these drugs on Akt at high dose regimens.  These results indicate that D2 receptors are essential for the inhibition of Akt by dopamine and that D3 receptors also participate in this signaling potentially by enhancing D2 receptor response.  Identification of the functions of individual dopamine receptor subtypes in Akt regulation may help the development of new pharmaceutical approaches for mental disorders related to abnormal dopamine transmission such as bipolar disorder and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgXxur8ijCxLVg90H21EOLACvtfcHk0lhlbiDLDZr3iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1Wrtrc%253D&md5=9d1c1f4ad5388e4e68ce70b5fddaddf0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5074-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5074-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DTirotta%26aufirst%3DE.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26aulast%3DMasri%26aufirst%3DB.%26aulast%3DSalahpour%26aufirst%3DA.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DBorrelli%26aufirst%3DE.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DRegulation%2520of%2520Akt%2520signaling%2520by%2520D2%2520and%2520D3%2520dopamine%2520receptors%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D881%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotnikova, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2005&pages=261-273&author=J.+M.+Beaulieuauthor=T.+D.+Sotnikovaauthor=S.+Marionauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=M.+G.+Caron&title=An+Akt%2Fbeta-arrestin+2%2FPP2A+signaling+complex+mediates+dopaminergic+neurotransmission+and+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26aulast%3DMarion%26aufirst%3DS.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DAn%2520Akt%252Fbeta-arrestin%25202%252FPP2A%2520signaling%2520complex%2520mediates%2520dopaminergic%2520neurotransmission%2520and%2520behavior%26jtitle%3DCell%26date%3D2005%26volume%3D122%26spage%3D261%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chidiac, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hebert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valiquette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Inverse agonist activity of beta-adrenergic antagonists</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=490-499&author=P.+Chidiacauthor=T.+Hebertauthor=M.+Valiquetteauthor=M.+Dennisauthor=M.+Bouvier&title=Inverse+agonist+activity+of+beta-adrenergic+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChidiac%26aufirst%3DP.%26aulast%3DHebert%26aufirst%3DT.%26aulast%3DValiquette%26aufirst%3DM.%26aulast%3DDennis%26aufirst%3DM.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DInverse%2520agonist%2520activity%2520of%2520beta-adrenergic%2520antagonists%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D45%26spage%3D490%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Barker, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westphal, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span> </span><span class="NLM_article-title">Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">11687</span><span class="NLM_x">–</span> <span class="NLM_lpage">11690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=11687-11690&author=E.+L.+Barkerauthor=R.+S.+Westphalauthor=D.+Schmidtauthor=E.+Sanders-Bush&title=Constitutively+active+5-hydroxytryptamine2C+receptors+reveal+novel+inverse+agonist+activity+of+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarker%26aufirst%3DE.%2BL.%26aulast%3DWestphal%26aufirst%3DR.%2BS.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DSanders-Bush%26aufirst%3DE.%26atitle%3DConstitutively%2520active%25205-hydroxytryptamine2C%2520receptors%2520reveal%2520novel%2520inverse%2520agonist%2520activity%2520of%2520receptor%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D11687%26epage%3D11690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Rauser, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=11561066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=83-89&author=L.+Rauserauthor=J.+E.+Savageauthor=H.+Y.+Meltzerauthor=B.+L.+Roth&title=Inverse+agonist+actions+of+typical+and+atypical+antipsychotic+drugs+at+the+human+5-hydroxytryptamine%282C%29+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine2C receptor</span></div><div class="casAuthors">Rauser, Laura; Savage, Jason E.; Meltzer, Herbert Y.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-89</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Atypical antipsychotic drugs, which are distinguished from typical antipsychotic drugs by a lower incidence of extra-pyramidal side effects and less propensity to elevate serum prolactin levels (e.g., clozapine, olanzapine, risperidone, quetiapine, ziprasidone), have become the most widely used treatments for schizophrenia, although their precise mechanism of action remains controversial.  It has been suggested that this group of atypical antipsychotic drugs is characterized by preferentially high affinities for 5-hydroxytryptamine (5-HT)2A serotonin receptors and relatively low affinities for D2-dopamine receptors.  It has recently been proposed that these atypical antipsychotic drugs may also be distinguished from typical antipsychotic drugs (e.g., haloperidol, fluphenazine, chlorpromazine, and so on) by inverse agonist actions at the 5-HT2C-INI RNA edited isoform of the human 5-HT2C receptor transiently expressed in COS-7 cells.  We have examd. the relation among 5-HT2C inverse agonist potency, efficacy, and atypical antipsychotic drug status in HEK-293 cells of a large no. of typical and atypical antipsychotic drugs using human embryonic kidney (HEK)-293 cells stably transfected with the h5-HT2C-INI receptor.  Inverse agonist actions at h5-HT2C-INI receptors were measured for both typical and atypical antipsychotic drugs.  Thus, some typical antipsychotic drugs (chlorpromazine, mesoridazine, fluphenazine, and loxapine) were efficient inverse agonists, whereas several clin. effective atypical antipsychotic drugs (remoxipride, quetiapine, sulpiride, melperone, amperozide) were not.  Addnl., several drugs without significant antipsychotic actions (M100907, ketanserin, mianserin, ritanserin, and amitriptyline) were potent inverse agonists at the 5-HT2C-INI isoform expressed in HEK-293 cells.  Taken together, these results demonstrate that both typical and atypical antipsychotic drugs may exhibit inverse agonist effects at the 5-HT2C-INI isoform of the human 5-HT2C receptor and that no relation exists between inverse agonist actions and atypicality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQYyIwLMQ1z7Vg90H21EOLACvtfcHk0lhhcbbpJgO3yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltrY%253D&md5=1a4485604f512006fcb46a49ec2c2cf4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRauser%26aufirst%3DL.%26aulast%3DSavage%26aufirst%3DJ.%2BE.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DInverse%2520agonist%2520actions%2520of%2520typical%2520and%2520atypical%2520antipsychotic%2520drugs%2520at%2520the%2520human%25205-hydroxytryptamine%25282C%2529%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D83%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gilliland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alper, R. H.</span><span> </span><span class="NLM_article-title">Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays</span> <span class="citation_source-journal">Naunyn Schmiedebergs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2000&pages=498-504&author=S.+L.+Gillilandauthor=R.+H.+Alper&title=Characterization+of+dopaminergic+compounds+at+hD2short%2C+hD4.2+and+hD4.7+receptors+in+agonist-stimulated+%5B35S%5DGTPgammaS+binding+assays"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilliland%26aufirst%3DS.%2BL.%26aulast%3DAlper%26aufirst%3DR.%2BH.%26atitle%3DCharacterization%2520of%2520dopaminergic%2520compounds%2520at%2520hD2short%252C%2520hD4.2%2520and%2520hD4.7%2520receptors%2520in%2520agonist-stimulated%2520%255B35S%255DGTPgammaS%2520binding%2520assays%26jtitle%3DNaunyn%2520Schmiedebergs%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D361%26spage%3D498%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Burstein, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brann, M. R.</span><span> </span><span class="NLM_article-title">Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite <i>N</i>-desmethylclozapine as a D2/D3 partial agonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.105.092155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=16135699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlalurnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=1278-1287&author=E.+S.+Bursteinauthor=J.+Maauthor=S.+Wongauthor=Y.+Gaoauthor=E.+Phamauthor=A.+E.+Knappauthor=N.+R.+Nashauthor=R.+Olssonauthor=R.+E.+Davisauthor=U.+Hacksellauthor=D.+M.+Weinerauthor=M.+R.+Brann&title=Intrinsic+efficacy+of+antipsychotics+at+human+D2%2C+D3%2C+and+D4+dopamine+receptors%3A+identification+of+the+clozapine+metabolite+N-desmethylclozapine+as+a+D2%2FD3+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist</span></div><div class="casAuthors">Burstein, E. S.; Ma, J.; Wong, S.; Gao, Y.; Pham, E.; Knapp, A. E.; Nash, N. R.; Olsson, R.; Davis, R. E.; Hacksell, U.; Weiner, D. M.; Brann, M. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1278-1287</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Drugs that antagonize D2-like receptors are effective antipsychotics, but the debilitating movement disorder side effects assocd. with these drugs cannot be dissocd. from dopamine receptor blockade.  The "atypical" antipsychotics have a lower propensity to cause extrapyramidal symptoms (EPS), but the mol. basis for this is not fully understood nor is the impact of inverse agonism upon their clin. properties.  Using a cell-based functional assay, we demonstrate that overexpression of Gαo induces constitutive activity in the human D2-like receptors (D2, D3, and D4).  A large collection of typical and atypical antipsychotics was profiled for activity at these receptors.  Virtually all were D2 and D3 inverse agonists, whereas none was D4 inverse agonist, although many were potent D4 antagonists.  The inverse agonist activity of haloperidol at D2 and D3 receptors could be reversed by mesoridazine demonstrating that there were significant differences in the degrees of inverse agonism among the compds. tested.  Aripiprazole and the principle active metabolite of clozapine NDMC [8-chloro-11-(1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine] were identified as partial agonists at D2 and D3 receptors, although clozapine itself was an inverse agonist at these receptors.  NDMC-induced functional responses could be reversed by clozapine.  It is proposed that the low incidence of EPS assocd. with clozapine and aripiprazole used may be due, in part, to these partial agonist properties of NDMC and aripiprazole and that bypassing clozapine blockade through direct administration of NDMC to patients may provide superior antipsychotic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJpq7vgFnG8rVg90H21EOLACvtfcHk0lgeKuAPaaVbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlalurnL&md5=327fe47435bf8fa5215af0d2af4b3b40</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.092155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.092155%26sid%3Dliteratum%253Aachs%26aulast%3DBurstein%26aufirst%3DE.%2BS.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DPham%26aufirst%3DE.%26aulast%3DKnapp%26aufirst%3DA.%2BE.%26aulast%3DNash%26aufirst%3DN.%2BR.%26aulast%3DOlsson%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DWeiner%26aufirst%3DD.%2BM.%26aulast%3DBrann%26aufirst%3DM.%2BR.%26atitle%3DIntrinsic%2520efficacy%2520of%2520antipsychotics%2520at%2520human%2520D2%252C%2520D3%252C%2520and%2520D4%2520dopamine%2520receptors%253A%2520identification%2520of%2520the%2520clozapine%2520metabolite%2520N-desmethylclozapine%2520as%2520a%2520D2%252FD3%2520partial%2520agonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D1278%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Peroutka, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=1980&pages=88-90&author=S.+J.+Peroutkaauthor=S.+H.+Snyder&title=Long-term+antidepressant+treatment+decreases+spiroperidol-labeled+serotonin+receptor+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeroutka%26aufirst%3DS.%2BJ.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DLong-term%2520antidepressant%2520treatment%2520decreases%2520spiroperidol-labeled%2520serotonin%2520receptor%2520binding%26jtitle%3DScience%26date%3D1980%26volume%3D210%26spage%3D88%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Berry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span> </span><span class="NLM_article-title">Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1996&pages=306-313&author=S.+Berryauthor=M.+Shahauthor=N.+Khanauthor=B.+Roth&title=Rapid+agonist-induced+internalization+of+the+5-hydroxytryptamine2A+receptor+occurs+via+the+endosome+pathway+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%26atitle%3DRapid%2520agonist-induced%2520internalization%2520of%2520the%25205-hydroxytryptamine2A%2520receptor%2520occurs%2520via%2520the%2520endosome%2520pathway%2520in%2520vitro%26jtitle%3DMol.%2520Pharmacol.%26date%3D1996%26volume%3D50%26spage%3D306%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Willins, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsayegh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backstrom, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">861</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=861&publication_year=1998&pages=121-127&author=D.+L.+Willinsauthor=L.+Alsayeghauthor=S.+A.+Berryauthor=J.+R.+Backstromauthor=E.+Sanders-Bushauthor=L.+Friedmanauthor=N.+Khanauthor=B.+L.+Roth&title=Serotonergic+antagonist+effects+on+trafficking+of+serotonin+5-HT2A+receptors+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillins%26aufirst%3DD.%2BL.%26aulast%3DAlsayegh%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DS.%2BA.%26aulast%3DBackstrom%26aufirst%3DJ.%2BR.%26aulast%3DSanders-Bush%26aufirst%3DE.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DSerotonergic%2520antagonist%2520effects%2520on%2520trafficking%2520of%2520serotonin%25205-HT2A%2520receptors%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D1998%26volume%3D861%26spage%3D121%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Willins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsayegh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Backstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span> </span><span class="NLM_article-title">Clozapine and other 5-hydroxytryptamine2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine2A receptors in vitro and in vivo</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=599-606&author=D.+Willinsauthor=S.+Berryauthor=L.+Alsayeghauthor=J.+Backstromauthor=E.+Sanders-Bushauthor=B.+Roth&title=Clozapine+and+other+5-hydroxytryptamine2A+receptor+antagonists+alter+the+subcellular+distribution+of+5-hydroxytryptamine2A+receptors+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillins%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DS.%26aulast%3DAlsayegh%26aufirst%3DL.%26aulast%3DBackstrom%26aufirst%3DJ.%26aulast%3DSanders-Bush%26aufirst%3DE.%26aulast%3DRoth%26aufirst%3DB.%26atitle%3DClozapine%2520and%2520other%25205-hydroxytryptamine2A%2520receptor%2520antagonists%2520alter%2520the%2520subcellular%2520distribution%2520of%25205-hydroxytryptamine2A%2520receptors%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DNeuroscience%26date%3D1999%26volume%3D91%26spage%3D599%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zastrow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sexton, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity and classical concepts of quantitative pharmacology</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">320</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.106.104463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=16803859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=320&publication_year=2007&pages=1-13&author=J.+D.+Urbanauthor=W.+P.+Clarkeauthor=M.+von+Zastrowauthor=D.+E.+Nicholsauthor=B.+Kobilkaauthor=H.+Weinsteinauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=A.+Christopoulosauthor=P.+M.+Sextonauthor=K.+J.+Millerauthor=M.+Speddingauthor=R.+B.+Mailman&title=Functional+selectivity+and+classical+concepts+of+quantitative+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and classical concepts of quantitative pharmacology</span></div><div class="casAuthors">Urban, Jonathan D.; Clarke, William P.; von Zastrow, Mark; Nichols, David E.; Kobilka, Brian; Weinstein, Harel; Javitch, Jonathan A.; Roth, Bryan L.; Christopoulos, Arthur; Sexton, Patrick M.; Miller, Keith J.; Spedding, Michael; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">320</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The concept of intrinsic efficacy has been enshrined in pharmacol. for half of a century, yet recent data have revealed that many ligands can differentially activate signaling pathways mediated via a single G protein-coupled receptor in a manner that challenges the traditional definition of intrinsic efficacy.  Some terms for this phenomenon include functional selectivity, agonist-directed trafficking, and biased agonism.  At the extreme, functionally selective ligands may be both agonists and antagonists at different functions mediated by the same receptor.  Data illustrating this phenomenon are presented from serotonin, opioid, dopamine, vasopressin, and adrenergic receptor systems.  A variety of mechanisms may influence this apparently ubiquitous phenomenon.  It may be initiated by differences in ligand-induced intermediate conformational states, as shown for the β2-adrenergic receptor.  Subsequent mechanisms that may play a role include diversity of G proteins, scaffolding and signaling partners, and receptor oligomers.  Clearly, expanded research is needed to elucidate the proximal (e.g., how functionally selective ligands cause conformational changes that initiate differential signaling), intermediate (mechanisms that translate conformation changes into differential signaling), and distal mechanisms (differential effects on target tissue or organism).  Besides the heuristically interesting nature of functional selectivity, there is a clear impact on drug discovery, because this mechanism raises the possibility of selecting or designing novel ligands that differentially activate only a subset of functions of a single receptor, thereby optimizing therapeutic action.  It also may be timely to revise classic concepts in quant. pharmacol. and relevant pharmacol. conventions to incorporate these new concepts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5GzdtvWZRkbVg90H21EOLACvtfcHk0lgeKuAPaaVbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFersw%253D%253D&md5=54465473b5996d0755baeee89eeb0ba9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.104463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.104463%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DKobilka%26aufirst%3DB.%26aulast%3DWeinstein%26aufirst%3DH.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520and%2520classical%2520concepts%2520of%2520quantitative%2520pharmacology%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D320%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">GPCR functional selectivity has therapeutic impact</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=390-396&author=R.+B.+Mailman&title=GPCR+functional+selectivity+has+therapeutic+impact"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DGPCR%2520functional%2520selectivity%2520has%2520therapeutic%2520impact%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D390%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Luttrell, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maudsley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">Beta-arrestin-dependent formation of beta2 adrenergic receptor–Src protein kinase complexes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1999&pages=655-661&author=L.+M.+Luttrellauthor=S.+S.+Fergusonauthor=Y.+Daakaauthor=W.+E.+Millerauthor=S.+Maudsleyauthor=G.+J.+Della+Roccaauthor=F.+Linauthor=H.+Kawakatsuauthor=K.+Owadaauthor=D.+K.+Luttrellauthor=M.+G.+Caronauthor=R.+J.+Lefkowitz&title=Beta-arrestin-dependent+formation+of+beta2+adrenergic+receptor%E2%80%93Src+protein+kinase+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%26aulast%3DDaaka%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DW.%2BE.%26aulast%3DMaudsley%26aufirst%3DS.%26aulast%3DDella%2BRocca%26aufirst%3DG.%2BJ.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DKawakatsu%26aufirst%3DH.%26aulast%3DOwada%26aufirst%3DK.%26aulast%3DLuttrell%26aufirst%3DD.%2BK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3DBeta-arrestin-dependent%2520formation%2520of%2520beta2%2520adrenergic%2520receptor%25E2%2580%2593Src%2520protein%2520kinase%2520complexes%26jtitle%3DScience%26date%3D1999%26volume%3D283%26spage%3D655%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenoy, S. K.</span><span> </span><span class="NLM_article-title">Transduction of receptor signals by beta-arrestins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2005&pages=512-517&author=R.+J.+Lefkowitzauthor=S.+K.+Shenoy&title=Transduction+of+receptor+signals+by+beta-arrestins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DShenoy%26aufirst%3DS.%2BK.%26atitle%3DTransduction%2520of%2520receptor%2520signals%2520by%2520beta-arrestins%26jtitle%3DScience%26date%3D2005%26volume%3D308%26spage%3D512%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Abbas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Arresting serotonin</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">832</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=831-832&author=A.+Abbasauthor=B.+L.+Roth&title=Arresting+serotonin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbas%26aufirst%3DA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DArresting%2520serotonin%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A%26date%3D2008%26volume%3D105%26spage%3D831%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zastrow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Violin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span> </span><span class="NLM_article-title">[beta]-Arrestin-biased ligands at seven-transmembrane receptors</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=416-422&author=J.+D.+Violinauthor=R.+J.+Lefkowitz&title=%5Bbeta%5D-Arrestin-biased+ligands+at+seven-transmembrane+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26atitle%3D%255Bbeta%255D-Arrestin-biased%2520ligands%2520at%2520seven-transmembrane%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D416%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gesty-Palmer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flannery, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttrell, L. M.</span><span> </span><span class="NLM_article-title">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1ra1</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1126%2Fscitranslmed.3000071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=20368153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1ra1&author=D.+Gesty-Palmerauthor=P.+Flanneryauthor=L.+Yuanauthor=L.+Corsinoauthor=R.+Spurneyauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=A+beta-arrestin-biased+agonist+of+the+parathyroid+hormone+receptor+%28PTH1R%29+promotes+bone+formation+independent+of+G+protein+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span></div><div class="casAuthors">Gesty-Palmer Diane; Flannery Pat; Yuan Ling; Corsino Leonor; Spurney Robert; Lefkowitz Robert J; Luttrell Louis M</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1ra1</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">About 40% of the therapeutic agents in use today exert their effects through seven-transmembrane receptors (7TMRs).  When activated by ligands, these receptors trigger two pathways that independently transduce signals to the cell: one through heterotrimeric GTP-binding proteins (G proteins) and one through beta-arrestins; so-called biased agonists can selectively activate these distinct pathways.  Here, we investigate selective activation of these pathways through the use of a biased agonist for the type 1 parathyroid hormone (PTH)-PTH-related protein receptor (PTH1R), (D-Trp(12),Tyr(34))-PTH(7-34) (PTH-betaarr), which activates beta-arrestin but not classic G protein signaling.  In mice, PTH-betaarr induces anabolic bone formation, as does the nonselective agonist PTH(1-34), which activates both mechanisms.  In beta-arrestin2-null mice, the increase in bone mineral density evoked by PTH(1-34) is attenuated and that stimulated by PTH-betaarr is ablated.  The beta-arrestin2-dependent pathway contributes primarily to trabecular bone formation and does not stimulate bone resorption.  These results show that a biased agonist selective for the beta-arrestin pathway can elicit a response in vivo distinct from that elicited by nonselective agonists.  Ligands with these properties may form the basis for improved 7TMR-directed pharmacologic agents with enhanced therapeutic specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmuM4aCIxthdXdcedVHT5tfW6udTcc2eaiHhlsIgV8P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D&md5=748e4367ded72b6b7e10fd759521ba62</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000071%26sid%3Dliteratum%253Aachs%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DFlannery%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DSpurney%26aufirst%3DR.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DA%2520beta-arrestin-biased%2520agonist%2520of%2520the%2520parathyroid%2520hormone%2520receptor%2520%2528PTH1R%2529%2520promotes%2520bone%2520formation%2520independent%2520of%2520G%2520protein%2520activation%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2009%26volume%3D1%26spage%3D1ra1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceres, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ros, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coccone, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnotto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandager-Nielsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheel-Kruger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span> </span><span class="NLM_article-title">Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800689g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=151-169&author=S.+Butiniauthor=S.+Gemmaauthor=G.+Campianiauthor=S.+Franceschiniauthor=F.+Trottaauthor=M.+Borrielloauthor=N.+Ceresauthor=S.+Rosauthor=S.+S.+Cocconeauthor=M.+Bernettiauthor=M.+De+Angelisauthor=M.+Brindisiauthor=V.+Nacciauthor=I.+Fioriniauthor=E.+Novellinoauthor=A.+Cagnottoauthor=T.+Menniniauthor=K.+Sandager-Nielsenauthor=J.+T.+Andreasenauthor=J.+Scheel-Krugerauthor=J.+D.+Mikkelsenauthor=C.+Fattorusso&title=Discovery+of+a+new+class+of+potential+multifunctional+atypical+antipsychotic+agents+targeting+dopamine+D3+and+serotonin+5-HT1A+and+5-HT2A+receptors%3A+design%2C+synthesis%2C+and+effects+on+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm800689g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800689g%26sid%3Dliteratum%253Aachs%26aulast%3DButini%26aufirst%3DS.%26aulast%3DGemma%26aufirst%3DS.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DFranceschini%26aufirst%3DS.%26aulast%3DTrotta%26aufirst%3DF.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DCeres%26aufirst%3DN.%26aulast%3DRos%26aufirst%3DS.%26aulast%3DCoccone%26aufirst%3DS.%2BS.%26aulast%3DBernetti%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DNacci%26aufirst%3DV.%26aulast%3DFiorini%26aufirst%3DI.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCagnotto%26aufirst%3DA.%26aulast%3DMennini%26aufirst%3DT.%26aulast%3DSandager-Nielsen%26aufirst%3DK.%26aulast%3DAndreasen%26aufirst%3DJ.%2BT.%26aulast%3DScheel-Kruger%26aufirst%3DJ.%26aulast%3DMikkelsen%26aufirst%3DJ.%2BD.%26aulast%3DFattorusso%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520a%2520new%2520class%2520of%2520potential%2520multifunctional%2520atypical%2520antipsychotic%2520agents%2520targeting%2520dopamine%2520D3%2520and%2520serotonin%25205-HT1A%2520and%25205-HT2A%2520receptors%253A%2520design%252C%2520synthesis%252C%2520and%2520effects%2520on%2520behavior%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D151%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of Beta-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18488</span><span class="NLM_x">–</span> <span class="NLM_lpage">18493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1073%2Fpnas.1104807108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=22025698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.-P.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+Beta-Arrestin-Biased+Dopamine+D2+Ligands+for+Probing+Signal+Transduction+Pathways+Essential+for+Antipsychotic+Efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span></div><div class="casAuthors">Allen, John A.; Yost, Julianne M.; Setola, Vincent; Chen, Xin; Sassano, Maria F.; Chen, Meng; Peterson, Sean; Yadav, Prem N.; Huang, Xi-Ping; Feng, Bo; Jensen, Niels H.; Che, Xin; Bai, Xu; Frye, Stephen V.; Wetsel, William C.; Caron, Marc G.; Javitch, Jonathan A.; Roth, Bryan L.; Jin, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">18488-18493, S18488/1-S18488/15</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Elucidating the key signal transduction pathways essential for both antipsychotic efficacy and side-effect profiles is essential for developing safer and more effective therapies.  Recent work has highlighted noncanonical modes of dopamine D2 receptor (D2R) signaling via β-arrestins as being important for the therapeutic actions of both antipsychotic and antimanic agents.  We thus sought to create unique D2R agonists that display signaling bias via β-arrestinergic signaling.  Through a robust diversity-oriented modification of the scaffold represented by aripiprazole (1), we discovered UNC9975 (2), UNC0006 (3); and UNC9994 (4) as unprecedented β-arrestin-biased D2R ligands.  These compds. also represent unprecedented β-arrestin-biased ligands for a Gi-coupled G protein-coupled receptor (GPCR).  Significantly, UNC9975, UNC0006, and UNC9994 are simultaneously antagonists of Gi-regulated cAMP prodn. and partial agonists for D2R/β-arrestin-2 interactions.  Importantly, VNC9975 displayed potent antipsychotic-like activity without inducing motoric side effects in inbred C57BL/6 mice in vivo.  Genetic deletion of β-arrestin-2 simultaneously attenuated the antipsychotic actions of UNC9975 and transformed it into a typical antipsychotic .drug with a high propensity to induce catalepsy.  Similarly, the antipsychotic-like activity displayed by UNC9994, an extremely β-arrestin-biased D2R agonist, in wild-type mice was completely abolished in β-arrestin-2 knockout mice.  Taken together, our results suggest that β-arrestin signaling and recruitment can be simultaneously a significant contributor to antipsychotic efficacy and protective against motoric side effects.  These functionally selective, β-arrestin-biased D2R ligands represent valuable chem. probes for further investigations of D2R signaling in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr87mjP6jm447Vg90H21EOLACvtfcHk0liVDan9Cd1J7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFymtLzK&md5=d5b06e4ac4d2cc4cd04fd1de760ec628</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1104807108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1104807108%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Beta-Arrestin-Biased%2520Dopamine%2520D2%2520Ligands%2520for%2520Probing%2520Signal%2520Transduction%2520Pathways%2520Essential%2520for%2520Antipsychotic%2520Efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prioleau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=612-627&author=C.+P.+Lawlerauthor=C.+Prioleauauthor=M.+M.+Lewisauthor=C.+Makauthor=D.+Jiangauthor=J.+A.+Schetzauthor=A.+M.+Gonzalezauthor=D.+R.+Sibleyauthor=R.+B.+Mailman&title=Interactions+of+the+novel+antipsychotic+aripiprazole+%28OPC-14597%29+with+dopamine+and+serotonin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DPrioleau%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DInteractions%2520of%2520the%2520novel%2520antipsychotic%2520aripiprazole%2520%2528OPC-14597%2529%2520with%2520dopamine%2520and%2520serotonin%2520receptor%2520subtypes%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D612%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Mailman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, V.</span><span> </span><span class="NLM_article-title">Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.2174%2F138161210790361461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=19909227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=488-501&author=R.+B.+Mailmanauthor=V.+Murthy&title=Third+generation+antipsychotic+drugs%3A+partial+agonism+or+receptor+functional+selectivity%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?</span></div><div class="casAuthors">Mailman, Richard B.; Murthy, Vishakantha</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">488-501</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Functional selectivity is the term that describes drugs that cause markedly different signaling through a single receptor (e.g., full agonist at one pathway and antagonist at a second).  It has been widely recognized recently that this phenomenon impacts the understanding of mechanism of action of some drugs, and has relevance to drug discovery.  One of the clin. areas where this mechanism has particular importance is in the treatment of schizophrenia.  Antipsychotic drugs have been grouped according to both pattern of clin. action and mechanism of action.  The original antipsychotic drugs such as chlorpromazine and haloperidol have been called typical or first generation.  They cause both antipsychotic actions and many side effects (extrapyramidal and endocrine) that are ascribed to their high affinity dopamine D2 receptor antagonism.  Drugs such as clozapine, olanzapine, risperidone and others were then developed that avoided the neurol. side effects (atypical or second generation antipsychotics).  These compds. are divided mechanistically into those that are high affinity D2 and 5-HT2A antagonists, and those that also bind with modest affinity to D2, 5-HT2A, and many other neuroreceptors.  There is one approved third generation drug, aripiprazole, whose actions have been ascribed alternately to either D2 partial agonism or D2 functional selectivity.  Although partial agonism has been the more widely accepted mechanism, the available data are inconsistent with this mechanism.  Conversely, the D2 functional selectivity hypothesis can accommodate all current data for aripiprazole, and also impacts on discovery compds. that are not pure D2 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxvYyphplbTrVg90H21EOLACvtfcHk0lhBVivAWknXXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVKjtbs%253D&md5=4f8bc018c55ee124e6d14016e90ddd6b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F138161210790361461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210790361461%26sid%3Dliteratum%253Aachs%26aulast%3DMailman%26aufirst%3DR.%2BB.%26aulast%3DMurthy%26aufirst%3DV.%26atitle%3DThird%2520generation%2520antipsychotic%2520drugs%253A%2520partial%2520agonism%2520or%2520receptor%2520functional%2520selectivity%253F%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D488%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mallikaarjun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramer, S. L.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1177%2F0091270003261901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=14747427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsVGjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=179-187&author=S.+Mallikaarjunauthor=D.+E.+Salazarauthor=S.+L.+Bramer&title=Pharmacokinetics%2C+Tolerability%2C+and+Safety+of+Aripiprazole+following+Multiple+Oral+Dosing+in+Normal+Healthy+Volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers</span></div><div class="casAuthors">Mallikaarjun, Suresh; Salazar, Daniel E.; Bramer, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-187</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Two 14-day, placebo-controlled, double-blind studies evaluated the fasting pharmacokinetics, safety, and tolerability of aripiprazole, a new antipsychotic, in healthy male subjects.  In Study 1, 37 subjects were randomized to aripiprazole 5 mg, 10 mg, 15 mg, 20 mg, or placebo once daily.  In Study 2, 11 subjects were randomized to aripiprazole, titrated from 10 to 30 mg/day, or placebo.  Aripiprazole had linear pharmacokinetics over 5 to 30 mg/day, which were described by a two-compartment open model, with first-order absorption.  In Study 1, mean elimination half-life ranged from 47 to 68 h with aripiprazole, with apparent systemic clearance (CL/F) of approx. 3.45 L/h.  In Study 2, mean elimination half-life was 59 h (CL/F approx. 4.0 L/h).  Adverse events were generally mild to moderate, were transient in nature, and commonly occurred within the first 3 days of dosing.  Clin. lab. assessments, ECG, EEG, and prolactin levels showed no clin. significant changes during the studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRPBp42oMwLVg90H21EOLACvtfcHk0lhBVivAWknXXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsVGjtLc%253D&md5=df137c043fd2424748985b88a01543e6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1177%2F0091270003261901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270003261901%26sid%3Dliteratum%253Aachs%26aulast%3DMallikaarjun%26aufirst%3DS.%26aulast%3DSalazar%26aufirst%3DD.%2BE.%26aulast%3DBramer%26aufirst%3DS.%2BL.%26atitle%3DPharmacokinetics%252C%2520Tolerability%252C%2520and%2520Safety%2520of%2520Aripiprazole%2520following%2520Multiple%2520Oral%2520Dosing%2520in%2520Normal%2520Healthy%2520Volunteers%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2004%26volume%3D44%26spage%3D179%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favor, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akunne, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whetzel, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serpa, K. A.</span><span> </span><span class="NLM_article-title">Discovery of PF-00217830: Aryl piperazine napthyridinones as D2 partial agonists for schizophrenia and bipolar disorder</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2621</span><span class="NLM_x">–</span> <span class="NLM_lpage">2625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2621-2625&author=D.+S.+Johnsonauthor=C.+Choiauthor=L.+K.+Fayauthor=D.+A.+Favorauthor=J.+T.+Repineauthor=A.+D.+Whiteauthor=H.+C.+Akunneauthor=L.+Fitzgeraldauthor=K.+Nichollsauthor=B.+J.+Snyderauthor=S.+Z.+Whetzelauthor=L.+Zhangauthor=K.+A.+Serpa&title=Discovery+of+PF-00217830%3A+Aryl+piperazine+napthyridinones+as+D2+partial+agonists+for+schizophrenia+and+bipolar+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DFavor%26aufirst%3DD.%2BA.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DWhite%26aufirst%3DA.%2BD.%26aulast%3DAkunne%26aufirst%3DH.%2BC.%26aulast%3DFitzgerald%26aufirst%3DL.%26aulast%3DNicholls%26aufirst%3DK.%26aulast%3DSnyder%26aufirst%3DB.%2BJ.%26aulast%3DWhetzel%26aufirst%3DS.%2BZ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSerpa%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520PF-00217830%253A%2520Aryl%2520piperazine%2520napthyridinones%2520as%2520D2%2520partial%2520agonists%2520for%2520schizophrenia%2520and%2520bipolar%2520disorder%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2621%26epage%3D2625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Oshiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uwahodo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishi, T.</span><span> </span><span class="NLM_article-title">Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1<i>H</i>)-quinolinone derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm940608g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=658-667&author=Y.+Oshiroauthor=S.+Satoauthor=N.+Kurahashiauthor=T.+Tanakaauthor=T.+Kikuchiauthor=K.+Tottoriauthor=Y.+Uwahodoauthor=T.+Nishi&title=Novel+antipsychotic+agents+with+dopamine+autoreceptor+agonist+properties%3A+synthesis+and+pharmacology+of+7-%5B4-%284-phenyl-1-piperazinyl%29butoxy%5D-3%2C4-dihydro-2%281H%29-quinolinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm940608g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm940608g%26sid%3Dliteratum%253Aachs%26aulast%3DOshiro%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DKurahashi%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DTottori%26aufirst%3DK.%26aulast%3DUwahodo%26aufirst%3DY.%26aulast%3DNishi%26aufirst%3DT.%26atitle%3DNovel%2520antipsychotic%2520agents%2520with%2520dopamine%2520autoreceptor%2520agonist%2520properties%253A%2520synthesis%2520and%2520pharmacology%2520of%25207-%255B4-%25284-phenyl-1-piperazinyl%2529butoxy%255D-3%252C4-dihydro-2%25281H%2529-quinolinone%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D658%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of selective dopamine D(2) receptor ligands using aripiprazole as the lead compound</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3502</span><span class="NLM_x">–</span> <span class="NLM_lpage">3511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3502-3511&author=S.+Vangveravongauthor=Z.+Zhangauthor=M.+Taylorauthor=M.+Beardenauthor=J.+Xuauthor=J.+Cuiauthor=W.+Wangauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+characterization+of+selective+dopamine+D%282%29+receptor+ligands+using+aripiprazole+as+the+lead+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DBearden%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520selective%2520dopamine%2520D%25282%2529%2520receptor%2520ligands%2520using%2520aripiprazole%2520as%2520the%2520lead%2520compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3502%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Martin, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elgin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathiasen, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesslick, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldy, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shank, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distefano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedde, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. K.</span><span> </span><span class="NLM_article-title">Activity of Aromatic Substituted Phenylpiperazines Lacking Affinity for Dopamine Binding Sites in a Preclinical Test of Antipsychotic Efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1056</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00125a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1052-1056&author=G.+E.+Martinauthor=R.+J.+Elginauthor=J.+R.+Mathiasenauthor=C.+B.+Davisauthor=J.+M.+Kesslickauthor=W.+J.+Baldyauthor=R.+P.+Shankauthor=D.+L.+Distefanoauthor=C.+L.+Feddeauthor=M.+K.+Scott&title=Activity+of+Aromatic+Substituted+Phenylpiperazines+Lacking+Affinity+for+Dopamine+Binding+Sites+in+a+Preclinical+Test+of+Antipsychotic+Efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm00125a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00125a020%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DG.%2BE.%26aulast%3DElgin%26aufirst%3DR.%2BJ.%26aulast%3DMathiasen%26aufirst%3DJ.%2BR.%26aulast%3DDavis%26aufirst%3DC.%2BB.%26aulast%3DKesslick%26aufirst%3DJ.%2BM.%26aulast%3DBaldy%26aufirst%3DW.%2BJ.%26aulast%3DShank%26aufirst%3DR.%2BP.%26aulast%3DDistefano%26aufirst%3DD.%2BL.%26aulast%3DFedde%26aufirst%3DC.%2BL.%26aulast%3DScott%26aufirst%3DM.%2BK.%26atitle%3DActivity%2520of%2520Aromatic%2520Substituted%2520Phenylpiperazines%2520Lacking%2520Affinity%2520for%2520Dopamine%2520Binding%2520Sites%2520in%2520a%2520Preclinical%2520Test%2520of%2520Antipsychotic%2520Efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1052%26epage%3D1056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Elworthy, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, A. P. D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgans, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozer, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repke, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talamas, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arredondo, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blue, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSousa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kava, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vimont, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, D. E.</span><span> </span><span class="NLM_article-title"><i>N</i>-Arylpiperazinyl-<i>N</i>′-propylamino derivatives of heteroaryl amides as functional uroselective alpha(1)-adrenoceptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2687</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970166j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2674-2687&author=T.+R.+Elworthyauthor=A.+P.+D.+W.+Fordauthor=G.+W.+Bantleauthor=D.+J.+Morgansauthor=R.+S.+Ozerauthor=W.+S.+Palmerauthor=D.+B.+Repkeauthor=M.+Romeroauthor=L.+Sandovalauthor=E.+B.+Sjogrenauthor=F.+X.+Talamasauthor=A.+Vazquezauthor=H.+Wuauthor=N.+F.+Arredondoauthor=D.+R.+Blueauthor=A.+DeSousaauthor=L.+M.+Grossauthor=M.+S.+Kavaauthor=J.+D.+Lesnickauthor=R.+L.+Vimontauthor=T.+J.+Williamsauthor=Q.+M.+Zhuauthor=J.+R.+Pfisterauthor=D.+E.+Clarke&title=N-Arylpiperazinyl-N%E2%80%B2-propylamino+derivatives+of+heteroaryl+amides+as+functional+uroselective+alpha%281%29-adrenoceptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm970166j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970166j%26sid%3Dliteratum%253Aachs%26aulast%3DElworthy%26aufirst%3DT.%2BR.%26aulast%3DFord%26aufirst%3DA.%2BP.%2BD.%2BW.%26aulast%3DBantle%26aufirst%3DG.%2BW.%26aulast%3DMorgans%26aufirst%3DD.%2BJ.%26aulast%3DOzer%26aufirst%3DR.%2BS.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DRepke%26aufirst%3DD.%2BB.%26aulast%3DRomero%26aufirst%3DM.%26aulast%3DSandoval%26aufirst%3DL.%26aulast%3DSjogren%26aufirst%3DE.%2BB.%26aulast%3DTalamas%26aufirst%3DF.%2BX.%26aulast%3DVazquez%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DArredondo%26aufirst%3DN.%2BF.%26aulast%3DBlue%26aufirst%3DD.%2BR.%26aulast%3DDeSousa%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DL.%2BM.%26aulast%3DKava%26aufirst%3DM.%2BS.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DVimont%26aufirst%3DR.%2BL.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DZhu%26aufirst%3DQ.%2BM.%26aulast%3DPfister%26aufirst%3DJ.%2BR.%26aulast%3DClarke%26aufirst%3DD.%2BE.%26atitle%3DN-Arylpiperazinyl-N%25E2%2580%25B2-propylamino%2520derivatives%2520of%2520heteroaryl%2520amides%2520as%2520functional%2520uroselective%2520alpha%25281%2529-adrenoceptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2674%26epage%3D2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fu, X. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span> </span><span class="NLM_article-title">Design, synthesis and vasorelaxant activity of <i>R</i>,<i>S</i>-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives</span> <span class="citation_source-journal">Yaoxue Xuebao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">740</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1eisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=735-740&author=X.+T.+Fuauthor=+Leiauthor=M.+Yuanauthor=J.+Shi&title=Design%2C+synthesis+and+vasorelaxant+activity+of+R%2CS-1-%28substituted+phenyl%29-4-%5B3-%28naphtha-1-yl-oxy%29-2-hydroxypropyl%5D-piperazine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives</span></div><div class="casAuthors">Fu, Xiaozhong; Tang, Lei; Yuan, Mu; Shi, Jingshan</div><div class="citationInfo"><span class="NLM_cas:title">Yaoxue Xuebao</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">735-740</span>CODEN:
                <span class="NLM_cas:coden">YHHPAL</span>;
        ISSN:<span class="NLM_cas:issn">0513-4870</span>.
    
            (<span class="NLM_cas:orgname">Yaoxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">According to the results of activity-structure relationship (SAR) studies of α1-adrenoceptor antagonists hydantoin-phenylpiperazine and benzimidazo-arypiperazine derivs., to design and synthesize a series of novel phenylpiperazine α1-adrenoceptor antagonists with more potent vasorelaxant activity, active metabolites of naftopidil were used as lead compds.  Ten novel R, S-1-substituted phenyl-4-[3-(naphthal-yl-oxy)-2-hydroxy propyl]-piperazine were designed and synthesized.  Their vasorelaxant activity was evaluated by calcg. inhibition rate of phenylephrine-induced vasocontraction of rabbit artery trips.  Five compds. exhibited vasorelaxant activity, and the o,p-di-OCH3 deriv. showed significant vasorelaxant activity in vitro.  At 0.01 and 1 μmol/L-1, its inhibition rates were 7.03% and 22.72%, resp.  This compd. possessed ideal vasorelaxant activity in vitro, and would be selected for further anti-hypertension evaluation in vivo.  Moreover, by analyzing the primary activity and structure relationship of these compds., it could be concluded that the SAR results of the reported phenylpiperazine α1-adrenoceptor antagonists could be used for ref. in designing novel derivs. of naftopidil with optimal pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPQpBsu4X787Vg90H21EOLACvtfcHk0ljoxPMPVNI5Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1eisQ%253D%253D&md5=d9d083e05933ae578ccb429d417db197</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%2BT.%26aulast%3DLei%26aulast%3DYuan%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%2520and%2520vasorelaxant%2520activity%2520of%2520R%252CS-1-%2528substituted%2520phenyl%2529-4-%255B3-%2528naphtha-1-yl-oxy%2529-2-hydroxypropyl%255D-piperazine%2520derivatives%26jtitle%3DYaoxue%2520Xuebao%26date%3D2007%26volume%3D42%26spage%3D735%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tsuruta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grewe, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cote, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskay, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebabian, J. W.</span><span> </span><span class="NLM_article-title">Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=1981&pages=463-465&author=K.+Tsurutaauthor=E.+A.+Freyauthor=C.+W.+Greweauthor=T.+E.+Coteauthor=R.+L.+Eskayauthor=J.+W.+Kebabian&title=Evidence+that+LY-141865+specifically+stimulates+the+D-2+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuruta%26aufirst%3DK.%26aulast%3DFrey%26aufirst%3DE.%2BA.%26aulast%3DGrewe%26aufirst%3DC.%2BW.%26aulast%3DCote%26aufirst%3DT.%2BE.%26aulast%3DEskay%26aufirst%3DR.%2BL.%26aulast%3DKebabian%26aufirst%3DJ.%2BW.%26atitle%3DEvidence%2520that%2520LY-141865%2520specifically%2520stimulates%2520the%2520D-2%2520dopamine%2520receptor%26jtitle%3DNature%26date%3D1981%26volume%3D292%26spage%3D463%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Banno, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshiro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span> </span><span class="NLM_article-title">Studies on 2(1<i>H</i>)-quinolinone derivatives as neuroleptic agents I. Synthesis and biological activities of (4-phenyl-1-piperazinyl)-propoxy-2(1<i>H</i>)-quinolinone derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1988&pages=4377-4388&author=K.+Bannoauthor=T.+Fujiokaauthor=T.+Kikuchiauthor=Y.+Oshiroauthor=T.+Hiyamaauthor=K.+Nakagawa&title=Studies+on+2%281H%29-quinolinone+derivatives+as+neuroleptic+agents+I.+Synthesis+and+biological+activities+of+%284-phenyl-1-piperazinyl%29-propoxy-2%281H%29-quinolinone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanno%26aufirst%3DK.%26aulast%3DFujioka%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DOshiro%26aufirst%3DY.%26aulast%3DHiyama%26aufirst%3DT.%26aulast%3DNakagawa%26aufirst%3DK.%26atitle%3DStudies%2520on%25202%25281H%2529-quinolinone%2520derivatives%2520as%2520neuroleptic%2520agents%2520I.%2520Synthesis%2520and%2520biological%2520activities%2520of%2520%25284-phenyl-1-piperazinyl%2529-propoxy-2%25281H%2529-quinolinone%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1988%26volume%3D36%26spage%3D4377%26epage%3D4388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kiss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemethy, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laszlovszky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugovics, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazekas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornok, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orosz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyertyan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agai-Csongor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tihanyi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szombathelyi, Z.</span><span> </span><span class="NLM_article-title">Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist–partial agonist antipsychotic candidate: in vitro and neurochemical profile</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">328</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1124%2Fjpet.109.160432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=20093397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=2010&pages=328-340&author=B.+Kissauthor=A.+Horvathauthor=Z.+Nemethyauthor=E.+Schmidtauthor=I.+Laszlovszkyauthor=G.+Bugovicsauthor=K.+Fazekasauthor=K.+Hornokauthor=S.+Oroszauthor=I.+Gyertyanauthor=E.+Agai-Csongorauthor=G.+Domanyauthor=K.+Tihanyiauthor=N.+Adhamauthor=Z.+Szombathelyi&title=Cariprazine+%28RGH-188%29%2C+a+dopamine+D%283%29+receptor-preferring%2C+D%283%29%2FD%282%29+dopamine+receptor+antagonist%E2%80%93partial+agonist+antipsychotic+candidate%3A+in+vitro+and+neurochemical+profile"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3/D2 dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile</span></div><div class="casAuthors">Kiss, Bela; Horvath, Attila; Nemethy, Zsolt; Schmidt, Eva; Laszlovszky, Istvan; Bugovics, Gyula; Fazekas, Karoly; Hornok, Katalin; Orosz, Szabolcs; Gyertyan, Istvan; Agai-Csongor, Eva; Domany, Gyorgy; Tihanyi, Karoly; Adham, Nika; Szombathelyi, Zsolt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">333</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">328-340</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cariprazine {RGH-188; trans-N-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea hydrochloride}, a novel candidate antipsychotic, demonstrated approx. 10-fold higher affinity for human D3 vs. human D2L and human D2S receptors (pKi 10.07, 9.16, and 9.31, resp.).  It displayed high affinity at human serotonin (5-HT) type 2B receptors (pKi 9.24) with pure antagonism.  Cariprazine had lower affinity at human and rat hippocampal 5-HT1A receptors (pKi 8.59 and 8.34, resp.) and demonstrated low intrinsic efficacy.  Cariprazine displayed low affinity at human 5-HT2A receptors (pKi 7.73).  Moderate or low affinity for histamine H1 and 5-HT2C receptors (pKi 7.63 and 6.87, resp.) suggest cariprazine's reduced propensity for adverse events related to these receptors.  Cariprazine demonstrated different functional profiles at dopamine receptors depending on the assay system.  It displayed D2 and D3 antagonism in [35S]GTPγS binding assays, but stimulated inositol phosphate (IP) prodn. (pEC50 8.50, Emax 30%) and antagonized (±)-quinpirole-induced IP accumulation (pKb 9.22) in murine cells expressing human D2L receptors.  It had partial agonist activity (pEC50 8.58, Emax 71%) by inhibiting cAMP accumulation in Chinese hamster ovary cells expressing human D3 receptors and potently antagonized R(+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydronaphthalene HBr (7-OH-DPAT)-induced suppression of cAMP formation (pKb 9.57).  In these functional assays, cariprazine showed similar (D2) or higher (D3) antagonist-partial agonist affinity and greater (3- to 10-fold) D3 vs. D2 selectivity compared with aripiprazole.  In in vivo turnover and biosynthesis expts., cariprazine demonstrated D2-related partial agonist and antagonist properties, depending on actual dopaminergic tone.  The antagonist-partial agonist properties of cariprazine at D3 and D2 receptors, with very high and preferential affinity to D3 receptors, make it a candidate antipsychotic with a unique pharmacol. profile among known antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk5eSWEiD1ibVg90H21EOLACvtfcHk0lhakza8wjqe1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFGktLs%253D&md5=3a949dfc5f907c0a72f24b61af2a944e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fjpet.109.160432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.109.160432%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DNemethy%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DE.%26aulast%3DLaszlovszky%26aufirst%3DI.%26aulast%3DBugovics%26aufirst%3DG.%26aulast%3DFazekas%26aufirst%3DK.%26aulast%3DHornok%26aufirst%3DK.%26aulast%3DOrosz%26aufirst%3DS.%26aulast%3DGyertyan%26aufirst%3DI.%26aulast%3DAgai-Csongor%26aufirst%3DE.%26aulast%3DDomany%26aufirst%3DG.%26aulast%3DTihanyi%26aufirst%3DK.%26aulast%3DAdham%26aufirst%3DN.%26aulast%3DSzombathelyi%26aufirst%3DZ.%26atitle%3DCariprazine%2520%2528RGH-188%2529%252C%2520a%2520dopamine%2520D%25283%2529%2520receptor-preferring%252C%2520D%25283%2529%252FD%25282%2529%2520dopamine%2520receptor%2520antagonist%25E2%2580%2593partial%2520agonist%2520antipsychotic%2520candidate%253A%2520in%2520vitro%2520and%2520neurochemical%2520profile%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D333%26spage%3D328%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">van Wijngaarden, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heyden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulp, M. T.</span><span> </span><span class="NLM_article-title">2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1934</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00118a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1934-1940&author=I.+van+Wijngaardenauthor=C.+G.+Kruseauthor=J.+A.+van+der+Heydenauthor=M.+T.+Tulp&title=2-Phenylpyrroles+as+conformationally+restricted+benzamide+analogues.+A+new+class+of+potential+antipsychotics.+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00118a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00118a011%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWijngaarden%26aufirst%3DI.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3Dvan%2Bder%2BHeyden%26aufirst%3DJ.%2BA.%26aulast%3DTulp%26aufirst%3DM.%2BT.%26atitle%3D2-Phenylpyrroles%2520as%2520conformationally%2520restricted%2520benzamide%2520analogues.%2520A%2520new%2520class%2520of%2520potential%2520antipsychotics.%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1934%26epage%3D1940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">van Wijngaarden, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heyden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulp, M. T.</span><span> </span><span class="NLM_article-title">2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">2099</span><span class="NLM_x">–</span> <span class="NLM_lpage">2104</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00394a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=2099-2104&author=I.+van+Wijngaardenauthor=C.+G.+Kruseauthor=R.+van+Hesauthor=J.+A.+van+der+Heydenauthor=M.+T.+Tulp&title=2-Phenylpyrroles+as+conformationally+restricted+benzamide+analogues.+A+new+class+of+potential+antipsychotics.+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00394a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00394a028%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BWijngaarden%26aufirst%3DI.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3Dvan%2BHes%26aufirst%3DR.%26aulast%3Dvan%2Bder%2BHeyden%26aufirst%3DJ.%2BA.%26aulast%3DTulp%26aufirst%3DM.%2BT.%26atitle%3D2-Phenylpyrroles%2520as%2520conformationally%2520restricted%2520benzamide%2520analogues.%2520A%2520new%2520class%2520of%2520potential%2520antipsychotics.%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D2099%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bohn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefkowitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainetdinov, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peppel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. T.</span><span> </span><span class="NLM_article-title">Enhanced morphine analgesia in mice lacking beta-arrestin 2</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">2495</span><span class="NLM_x">–</span> <span class="NLM_lpage">2498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=2495-2498&author=L.+M.+Bohnauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=K.+Peppelauthor=M.+G.+Caronauthor=F.+T.+Lin&title=Enhanced+morphine+analgesia+in+mice+lacking+beta-arrestin+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DPeppel%26aufirst%3DK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.%2BT.%26atitle%3DEnhanced%2520morphine%2520analgesia%2520in%2520mice%2520lacking%2520beta-arrestin%25202%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D2495%26epage%3D2498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Nordquist, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risterucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kienlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunnecke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freichel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riemer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2008&pages=405-416&author=R.+E.+Nordquistauthor=C.+Risterucciauthor=J.+L.+Moreauauthor=M.+von+Kienlinauthor=B.+Kunneckeauthor=M.+Macoauthor=C.+Freichelauthor=C.+Riemerauthor=W.+Spooren&title=Effects+of+aripiprazole%2FOPC-14597+on+motor+activity%2C+pharmacological+models+of+psychosis%2C+and+brain+activity+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNordquist%26aufirst%3DR.%2BE.%26aulast%3DRisterucci%26aufirst%3DC.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3Dvon%2BKienlin%26aufirst%3DM.%26aulast%3DKunnecke%26aufirst%3DB.%26aulast%3DMaco%26aufirst%3DM.%26aulast%3DFreichel%26aufirst%3DC.%26aulast%3DRiemer%26aufirst%3DC.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DEffects%2520of%2520aripiprazole%252FOPC-14597%2520on%2520motor%2520activity%252C%2520pharmacological%2520models%2520of%2520psychosis%252C%2520and%2520brain%2520activity%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D54%26spage%3D405%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Gottlieb, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotlyar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nudelman, A.</span><span> </span><span class="NLM_article-title">NMR chemical shifts of common laboratory solvents as trace impurities</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">7512</span><span class="NLM_x">–</span> <span class="NLM_lpage">7515</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo971176v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7512-7515&author=H.+E.+Gottliebauthor=V.+Kotlyarauthor=A.+Nudelman&title=NMR+chemical+shifts+of+common+laboratory+solvents+as+trace+impurities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">NMR chemical shifts of common laboratory solvents as trace impurities</span></div><div class="casAuthors">Gottlieb, Hugo E.; Kotlyar, Vadim; Nudelman, Abraham</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7512-7515</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 1H (300 MHz) and 13C (75 MHz) NMR chem. shifts for >30 common impurities, such as lab. solvents, stabilizers, greases and water, are reported in 7 deuterated NMR solvents.  The temp. dependence of the chem. shift of the proton residual peak (HDO) in D2O is established for the entire liq. range of this sample.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocnoOemocS9LVg90H21EOLACvtfcHk0lhakza8wjqe1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVClsbo%253D&md5=c297adda99f8c10e9f9b0ab9fe5f55be</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo971176v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo971176v%26sid%3Dliteratum%253Aachs%26aulast%3DGottlieb%26aufirst%3DH.%2BE.%26aulast%3DKotlyar%26aufirst%3DV.%26aulast%3DNudelman%26aufirst%3DA.%26atitle%3DNMR%2520chemical%2520shifts%2520of%2520common%2520laboratory%2520solvents%2520as%2520trace%2520impurities%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7512%26epage%3D7515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Barnea, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strapps, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrada, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kloss, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. J.</span><span> </span><span class="NLM_article-title">The genetic design of signaling cascades to record receptor activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300603y&amp;key=10.1073%2Fpnas.0710487105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300603y&amp;key=18165312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300603y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvV2ktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=64-69&author=G.+Barneaauthor=W.+Strappsauthor=G.+Herradaauthor=Y.+Bermanauthor=J.+Ongauthor=B.+Klossauthor=R.+Axelauthor=K.+J.+Lee&title=The+genetic+design+of+signaling+cascades+to+record+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The genetic design of signaling cascades to record receptor activation</span></div><div class="casAuthors">Barnea, Gilad; Strapps, Walter; Herrada, Gilles; Berman, Yemiliya; Ong, Jane; Kloss, Brian; Axel, Richard; Lee, Kevin J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-69</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors have developed an exptl. strategy to monitor protein interactions in a cell with a high degree of selectivity and sensitivity.  A transcription factor is tethered to a membrane-bound receptor with a linker that contains a cleavage site for a specific protease.  Activation of the receptor recruits a signaling protein fused to the protease that then cleaves and releases the transcription factor to activate reporter genes in the nucleus.  This strategy converts a transient interaction into a stable and amplifiable reporter gene signal to record the activation of a receptor without interference from endogenous signaling pathways.  The authors have developed this assay for three classes of receptors: G protein-coupled receptors, receptor tyrosine kinases, and steroid hormone receptors.  Finally, the authors use the assay to identify a ligand for the orphan receptor GPR1, suggesting a role for this receptor in the regulation of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ugB7pgEqlrVg90H21EOLACvtfcHk0lilMszsjqhKeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvV2ktA%253D%253D&md5=3b49dfdb2949d947e145084ac87bb343</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710487105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710487105%26sid%3Dliteratum%253Aachs%26aulast%3DBarnea%26aufirst%3DG.%26aulast%3DStrapps%26aufirst%3DW.%26aulast%3DHerrada%26aufirst%3DG.%26aulast%3DBerman%26aufirst%3DY.%26aulast%3DOng%26aufirst%3DJ.%26aulast%3DKloss%26aufirst%3DB.%26aulast%3DAxel%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520genetic%2520design%2520of%2520signaling%2520cascades%2520to%2520record%2520receptor%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D64%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/jm300603y">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01418"></div></div></div></div></div><hr /></hr><p class="last">Radioligand binding affinities of compounds <b>19</b> and <b>35</b> at select dopamine and serotonin receptors. <sup>1</sup>H and <sup>13</sup>C NMR spectra of compounds <b>35</b> and <b>37</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300603y/suppl_file/jm300603y_si_001.pdf">jm300603y_si_001.pdf (171.4 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300603y&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm300603y%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-16%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300603y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994c5fd9e43d3c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
